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Abstract. 
An Investigation into the Mechanisms of Action of the B-Lactamase Enzymes I and 2 from 
B. cereus 5691H. 
By David. G. Proctor. 
The pH dependence of the B-lactamase enzymes I and 2 catalysed hydrolysis of 
penicillin and cephalosporin derivatives has been investigated. It was shown that the B- 
lactamase I catalysed hydrolysis of n-alkyl penicillins of increasing chain length produced 
an increase inkcaVKm up to the octyl derivative. Despite this it is believed that the active- 
site of the B-lactamase I enzyme does not display a strong recognition for B-lactams 
containing a hydrophobic C6 side-chain. 
It was found that the pH dependence for the enzyme catalysed hydrolysis of 
benzyl penicillin and benzyl cephalosporin did not decline as expected at low pH, but 
instead the rate levels off. 
The incorporation of a negatively charged group into the phenyl C7 side chain of 
cephalosporins resulted in lower activity at pH7 compared to that for benzyl cephalosporin, 
but at low pH much higher activity is seen: 2-carboxyphenyl cephalosporin was 10 fold more 
reactive at pH3 than at pH7. The B-lactamase I catalysed hydrolysis of phenyl substituted 
penicillins containing a negatively charged functional group in the phenyl side chain was 
more complex. 2-Carboxyphenyl penicillin shows higher activity at low pH, while the 3,4- 
carboxyphenyl penicillin derivatives show a typical 'bell-shaped' profile, but with the pKa I 
value shifted up-field. This was further investigated by preparing the cis/trans isomers of 2- 
carboxycyclohexyl penicillin and cephalosporin. It was found that the cis 2- 
carboxycyclohexyl penicillin compound displayed high activity at low pH, while the trans 
compound did not. Neither of the corresponding cepbalosporin derivatives showed evidence 
of higher activity at low pH. 
The C3 ester and C3 alcohol of penicillins and the C4 cephalosporin lactone were 
synthesised. The penicillin alcohol and the cephalosporin lactone were found to be 'good' 
substrates for the B-lactamase I enzyme and produced 'normal' pH-rate profiles. 
It was found that with the B-lactamase 2 enzyme hydrolysis of n-alkyl penicillins 
proceeded at comparable rates irrespective of the length of the C6 side chain alkyl group, 
and that the enzyme hydrolysis rate at pH 7 was minimally affected by substituent changes 
in the C6/C7 side chains of penicillin and cephalosporin but the behaviour was more 
complex when the negatively charged carboxyphenyl B-lactams were investigated. The 
enzyme catalysed hydrolysis was greatly reduced when the C3/4 carboxylate group of the 
substrate was converted into an alcohol, ester or lactone, suggesting the importance of this 
group in the 13-lactamase 2 hydrolysis mechanism. 
These results raise important questions about the the existing hypotheses which 
attempt to explain the mechanism of action of the B-lactamase I and 2 enzymes. 
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Introduction. 
1.1 Background. 
The aim of this introduction is not to give an extensive treatise of the chemistry 
of B-lactam antibiotics or the enzymes responsible for bacteria] resistance, the 
B-lactamases, it is however to review the main areas where recent advances have been 
made in antimicrobial chemotherapy. 
B- Lactamases (EC 3.5.2.6, 'penicillinases')have been known for as long as 
penicillin has been used in chemotherapy (1). The production of B-lactamase has long 
been recogiiised as the most important mechanism of resistance used by bacteria to 
combat the pathogenic effects of B-lactarn antibiotics. (2,3,4). 
The term "penicillin" was introduced by Fleming in 1929 to describe the 
antimicrobial behaviour of an entity capable of antagonising the growth and 
development of bacteria (5). However, it was not until ten years later, as a result of the 
work done by a group in Oxford, investigating the susceptibility of micro-organisms 
to penicillin, led by Flory and Chain, that the chemistry of B-lactams became important 
(6). Even at this time it was observed that the bacteria being studied developed 
resistance to the action of penicillin (6). This was attributed to the production of an 
enzyme, capable of inactivating the penicillin, this they named 'penicillinase' and was 
the first reported observation of a heterogeneous group of enzymes capable of 
hydrolysing a wide array of B-lactams, now called the B-lactamases (7). 
Penicillins (Fig. 1) are fused bicyclic structures, joining a five membered 
thiazolidine ring to a four membered B-lactam ring. Later, a structurally similar class of 
compounds were discovered (8), the cephalosporins, (Fig. 21 which have the four 
membered B-lactam joined to a six membered dihydrothiazine ring. 
RCONH 
S CH3 
2 
Z7 CH3 
0/ 
0H 2 
Fig. IA penicflhn. 
RCONH 
_7 
-- 
r6 
2 
53 N4- ""CH200C)CH3 
o/; 
rO-, 
H 2 
Fig. 2 A cephalosporin. 
These compounds exert their lethal action by inhibiting the later stages of 
bacterial cell wall development, by binding to essential penicillin binding proteins 
(herein referred to as PBVs), resulting in cell lysis/stasis. The B-lactamases prevent 
this process by hydrolysing the B-lactams to antimicrobially inactive penicilloic and 
cephalosporoic acids. (Fig. 3 and 4) 
RCONH 
H 
RCONH 
S CH3 0 
CH3 N 
0 o"I 
H 
2H 
Fig. 3 Penicilloic acid. 
+ CH3COý 
CH2 
02., H 
Fig. 4 Cephalosporoic acid. 
By the late fifties, partly in response to the increasing bacterial resistance to the 
natumlantibiotics a new species of semi-synthetic and wholly synthetic penicillin and 
cephalosporin derivatives began to emerge. The semi-synthetic B-lacLmns are produced 
by acylating the 6 and 7 positions of 6-aminopenicillanic and 7-aminocephalosporanic 
acid, which are used as the antimicrobial nuclei (9) (Fig. 5) 
NH2 
CH 3 6 
0 
42 
3 CH3 
02H 
6-aminopenicillanic acid 
(6-APA) 
NH2 
53 
"4 "ý"CH20MCH3 "rO, 
H 2 
7-aminoceomlosporanic acid 
(7-ACA) 
Fig. 5 
Varying the nature of the functional group(s) in positions 6 and 7 has resulted in 
penicillins, and cephalosporins with enhanced phannacokinetic properties. The inclusion 
of basic groups produces acid stability and has led to orally administrable antibiotics, 
such as ampicillin, while incorporating acid groups produces enhanced activity against 
pseudomonal bacteria, such as Paurgenosa, the first commercially significant compound 
2 
being carbenicillin, introduced in 1968. The use of an oxime group in the side chain of 
C7 derivatised cephalosporins (Fig. 6) produces enhanced bacterial activity and stability 
to a wide range of B-lactamases, and has led to the production of the third generation 
cephalospofinsPO). Furthermore, the syn (x - alkoxyimino isomers have been found to be 
more stable to the effects of B-lactamases than the anti isornersO 1). (Fig. ý 
0 
H2N H 
_N 'k., 
FTN 
s 
sN 'N 
02H 
ýH 
3 
x MIC/jig'ml 
CH2 > 100 
1.6 
OCH3 
Fig. 6 The effects of an alkoxyarnino group on antimicrobial activity. 
3 
0 
H2N- H \<N 
a,, -ý-N 
s 
CH2OAc 
H02CCH20- 0 0,, H 2 
Stereochemist 
at a. 
Relative rates of 
bydrolysis. 
R-TEM 
syn 
anti 
0.1 
2111 
Fig. 7 Stereochemical effects on the rate of B-lactamase hydrolysis of the 
alkoxyarnino group. 
In the seventies the discovery of 7- a- methoxycephem (cepharnycin Q (Fig. 8) in 
streptomvcm was found to have increased stability towards B-lactamase hydrolySiS(12) 
This led to the resurgence of the use of micro-organisms as sources of new B-lactams, 
and to the production of semi-synthetic 6-(x-methoxypenems and 7-a-methoxy 
cephems, establishing a whole new range of sernisynthetic antibiotics, the carbapenems. 
Moxalactam illustrates this point (13). (Fig. 8a) 
CO2H\ 
CH(CH2)3 M 
NH2 / 
Fig. 8 Cephamycin C. 
H QcH3 
NS 
N 
0 CH2()CONH2 
02H 
4 
HO 
0HX 0 0 
S, 
N 
'N 
02H 
3 
x E. Coli E. Goacae 
H> 100 > 100 
OCH3 0.8 > 100 
Fig. & Effect on enzyme stability of introducing 7-(x-metboxy group. 
Bacteria bave also yielded novel monocyclic antibiotics, nocardicin A (Fig. 9) 
from nocardia(14) and mono-bactams, such as sulfazelin (15) (Fig 10). 
HO2C 0 
"'ýCH 
- 
(CH2)2-'o H 
H2 NT OH 
ýH oýýZN 
0 
CO2H 
Fig. 9 Nocardicin A 
H02C 00 
HýH PCH 
(CH2)2--N--CH-ý _N 3 
H2N ýH3 N 
\S03H 
Fig. 10 Sulazelin 
5 
Combining the knowledge gained from the production and subsequent analysis 
of semi-synthetic antibiotics together with the features from natural isolates has 
resulted in the production of hybrid compounds such as aztreonam (Fig I b. (16) 
0 
8H H2N 
-N 
CH3 
ýE \0 S03H 
ý(CH3)2C02H 
Fig. II Aztreonam. 
Consequently, today there are several categories of B-lactam compounds 
available for the treatment of bacterial disease, these can be placed into broad 
categories based on structure (Table]), (Table 2) lists chronologically, the general 
introduction of antibiotics of particular importance over the last thirty years. 
6 
R 
[I] 
RCONH 
s 
12 N d Rl 
CO2H [21 
02H 
OCH3 
RCONH 
os 
Rl 
02H 
[31 
RCONH 
0 ýq 
]N -"'os 
--R 
[51 02H 
H3C\ H 
HO-- 
Table. I( 17) 
SCH2CH2NH2 
RCONH 
s 
., 0 
0 
, 
1z 
:: 
N] 
0 
[41 
02,, H 
1 1. -4 
- 
CCH2OH 
0 z2 
H 
[61 CO2H 
RCONH 
j 
[81 
RCONH 
0; 
N 
-, -SO3H 
191 
C02H 
[II Penicillins (penams) - B-lactams fused to a thiazolidine. 
[21 Cephalospodns (cephems) - B-lactwns fused to a dihydrothaizine. 
[31 Cephamycins - 7-(x-metho)cycephalospofim. 
[41 Oxacephems - replacement of the S for 0 in cephalosporins. 
[5] Penems - C2 double bond in the 5-membered thiazolidine ring. 
[61 Clavulanic acid - B-lactarn fused to an oxazolidine. 
[71 Thienarnydn (carbapenems) - no heteroatorn in the ring. 
[81 Nocardicins - monocyclic B-lactwns. 
[9] Monobactams - monocyclic B-lactarm of sulphamic acid. 
OH 
7 
N 11-IoNk 
IN 
srN0 y 
0 
Ný4 Ly 223447 
RCDNH 
Nocardicin 
N 
0 
// 
RODNH 
s 
Penein N, 
pla 
0 
cx)p 
RODNH 
N 
0 
Oxacephem 
002H 
0 
OH 
99 
1990 
9 
1960 
RODNH 
1.00 
s 
N 
0 
//Uý 
55'1ýýRj 
C)02H 
Cephalosporin 
77 
RCONH 
SOH 
OH 
Monobactam 
SCl-12CH2NR 
1.10 
0 
Cý 
CKOH 
N 
0 Clavulanic 
CD2" Acid 
RCDNH s 
N 
0/ 1ý 
CP2H 
Cephamycin 
RODNH 
s 
N Penicillin 
1920 
Table. 2 The general introduction of B-lactarn antibiotics. (18) 
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The driving force behind the continuing research and development of new B- 
lactam antibiotics is the growing resistance from bacteria which are continually 
rendering clinically useful antibiotics obsolete (19). One solution to the problem has 
been to use synergistic combinations of antibiotic and B-lactamase inhibitor, such an 
approach has recently re-introduced ampicillin into clinical use, by combining it N&rith 
sulbactam, giving enhanced stability and a broader range of application. (20) 
Whatever the aim, the more that can be understood about substrate specificity 
and the mode of action of the PBP target(s), and of the inhibitory enzymes, the B- 
lactamases, will produce a clearer picture of the mechanism ofenzyme action (17,2 1) 
leading to the rational design of more effective antibiotics. This will be achieved by 
combing traditional chemical studies with enzyme mutagenesis and the enzyme 
crystallographic data which is now beginning to appear. 
1.2 Mode of action of B-lactams. 
B-Lactams interact with two major types of microbial enzymes, the cell wall 
synthesis enzymes and the B-lactamase enzymes, %ith essential activity centring around 
the CO-N bond of the B-lactam. 
The B-lactams exhibit antibacterial action by their ability to disrupt bacteria] cell 
wall synthesis by binding to penicillin binding proteins located in the cytoplasmic 
membrane of the bacteria. PBP are involved in the peptidoglycan cell wall synthesis 
process, confin-ning structural rigidity to the bacteria enabling them to withstand the 
high internal osmotic pressures. Inhibiting this process results in either cell stasis or 
lysis. 
To be an effective antibiotic the compound has to be able to successfully 
negotiate three essential stages: 
(i. )Must be capable of entering or reaching the active-site. 
(ii. )Must evade or be resistant to the B-lactamase enzymes. 
(iii. )Must bind to and inactivate the essential PBP. 
As a general rule B-lactams are more effective against Gram positive bacteria, 
where the B-lactamases are either cell bound or excreted into the surrounding media. In 
Gram negative bacteria the imposing presence of an outer membrane, which in the 
9 
absence of the defence provided by B-lactamases, can be an effective barrier to the 
action of B-lactams. However, there are important exceptions to this generality, the 
third generation cephalosporins, cefatoxime and ceftazidime and the mono bactam. 
aztreonam show lethal action against a wide range of Gram negative bacteria and yet 
produce little response with Gram positive species. (21) 
The potency of the B-lactams was initially attributed by Tipper and Strominger(22) 
to the B-lactams acting as mimics, "substrate analogs, " of the natural substrate, whicb 
forms part of a penta peptide side cbain of a NAM (NAM: N-acetylmuramic acid; NAG: 
N-acetylglucosan-fine)unit involved in the crosslirfldng of adjacent (-NAG-NAM-) 
peptidogylcan strands. The reactions involved in cross-linkdng are catalysed by 
carboxypeptidase (C Pase) and transpeptidase (T Pase) enzymes and botb involve 
acylation of the enzyme, (pm: diaminopimelic acid) (Fig 12). 
10 
A. Tran%leptidase Acfion. 
-NAG-N, -NAG- 
L- ala 
D- glu 
NH2 - Arm D- ala 
D -dla + NH 
D d1a. D- glu 
L- Ala 
-NAG-NAM-NAG- 
L- ala 
D- jlu 
ID- ala NH2 - A2pm 
D -dla - Nn - A2pm 
\ 7e-OIH 
- NAG - NAM - NAG - 
Nucleophile. 
R-NH 
_CH H 
0 
Lz 
glu 
la 
D- ala 
-NAG-NAM-NAG- 
B. Carboxytpeptidase Action. 
NAG - N, - NAG - 
/1Fn7lnn 
- NAG - N, - NAG - 
L- ala 
Enzyme-OH 
L- ala 
D- glu D- glu 
NH2 - Arm + 
H20 NH2 - A2pm 
D -dla D- 
! 
]a 
D- Ala NuclecpWle. 
D- ala 
Fig. 12 The action of Carboxypeptidase and Transpeptidase in cell wall synthesis. 
Iffie polysaccbaride peptidogylcan strands are crosslinked by pentapeptide 
chains. The ten-ninal alanine is cleaved by C Pase when water is the acceptor molecule 
and crosslinked by T Pase when the acceptor is the D-Ala cleaved by C Pase. The 
substrate forms an acyl-enzyme intermediate with both C Pase and T Pase, and it is this 
acyl-enzyme inten-nediate that is thought to be stable when formed by the B-lactams, 
resulting in inhibition. Tipper and Strominger proposed that there exists a resemblance 
between the D-Ala-D-Ala bond and the B-lactams (Fig]3), activity is attributed to a case 
of mistaken identity on the part of the enzyme. 
0 
R-ý-NH 
CH3 H 
CH N3 
H, 
zw 
CO2H 
0 
R-ý-NH 
H 
S CH3 
B. N, CH 3 
CD2H 
Fig. 13 Comparison between the D-Ala-D-Ala bond and the B-lactams. 
Closer examination of this original proposal, which still receives wide spread 
support, raises a number of questions. Fiistly, comparing the structures of D-Ala-D- 
Ala to that of a typical B-lactam reveals a configurational deviation around the C6 chiral 
carbon centre of penicillin, resulting in mismatch, and it is widely accepted that even 
minor deviations in the structure of antibiotics can result in large effects in enzyme 
recognition. 
An example is given by comparing the activities of 6-((x, B)-benzylpenicillin 
(Fig. 14) with the B-lactamase of Saureus. The (x isomer is more stable to hydrolysis 
than the B isomer, but it is also less active as an antimicrobial agent by a similar 
magnitude. (23) Monocyclic B-lactamS(24) show similar behaviour. 
12 
PHCH2CONH 
S CH3 
0// 
N ICH3 
C02H 
Relative rates of hydrolysis. 
by B-lactamase 1. 
6 (x 2.2 
6ß 100 
Fig. 14 The relative activities of 6-((x, B)-benzylpenicillin. 
It has also been shown that stereoisomerism is capable of producing P., - 
lactamase stability. (25). (Fig. 15) 
CONH 
NHý 
N ý'N 
s CH3 
Stemochemist! y MIC-/P9/1ni. 
at (x) E. Cloacae 
0.6 
25 
Fig. 15 The effect of stereoisomerism on antibacterial activity. 
The problem NNrith stereochernistry was recogrýised by Tipper and Strominger who 
suggested that substituting a methyl group at the 6(x or 7 (x position would increase the 
resemblance to the D-Ala-D-Ala bond. (26) The discovery of 7 (x-methoxycepbalosporin 
(12) strongly supported this proposal, opening up a new area of production of antibiotics, 
though it has now been shown that a methyl group in the (a) position reduces 
effectiveness. 
Secondly, 'primary target' PBPs other than C-Pase and T-Pase are also 
known, such as endopeptidases and translycosylase, (27,28) however the exact role that 
these enzymes play during cell growth and subsequent division is not fully understood, 
consequently the molecular basis for their mode of action and inhibition remains largely 
unresolved. It is known that depending upon the primary target, which may vary, 
bacteria undergo a variety of morphological responses. In E coliand A acruginosa 
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the action of antibiotics can cause spheroplast forrnation and rapid lysis if the primary 
target PBFs are la/lb. Other responses include cells rounding up to form spherical 
cells if the antibiotic has the highest affinity for PBP 2 or for PBP 3 to produce 
filaments prior to lySiS. (29,30,31,32) Therefore it seems reasonable that there is more 
than one mechanism responsible for the bacterial activity and lysis of the cell(s). 
It is also proposed that the presence of B-lactams induces the production of 
autolysins, peptidogylcan hydrolases, which are involved in a regulatory role in the 
peptidogycan biosynthesis, hydrolysing the crosslinks produced by the action of T- 
Pase and C-Pase and it is the action of these enzymes which is pathological to the cells, 
in essence the B-lactarns result in bacteria killing themselves. (33) 
Whatever, the mechanism for cell death, the original hypothesis of Tipper and 
Strominger still receives strong support, with groups of workers being involved in 
chemical and crystallographic investigations of the T Pase and C Pase enzymes. 
1.3 Penicillin binding proteins. 
Work by Spratt (34) has identified six major PBP's of Ecoli and subsequent 
experiments by Waxman and Strominger (35) has elucidated the physiological roles of 
these proteins. ( Table. -ý The use of mutant strains in which certain PBPs have been 
altered can be correlated to decreased affinity for B-lactarn and the emergence resistant 
strains of bacteria, which suggests an evolutionary response mechanism used by 
bacteria to the effects of pathogenic antibiotics. 
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Table. 3 'nie identification of PBP's and their physiological roleS(35). 
PBP Aporen Abundance Mo! pholopical effects Activities PEMsed in-vivo 
M. W M total PBP'S) of inactivation 
function 
IA 90,000 6 minor transpeptidase, 
can compensate for 
PBP 1B. 
1B 87)000 2 rapid lysis T-pase, major transpeptidase 
trans-glycosylase of cell elongation 
2 66,000 0.7 ovoid cell cell shape 
formation deten-nination 
3 60,000 2 fdamentation implicated in cell 
division and 
cross-wall formation 
4 49,000 4 C-pase, secondary T-pase 
T-pase, increasing cross- 
endopeptidase linking 
5 42,000 65 C-pase, regulate cross- 
(T-pase) linking 
6 40,000 21 C-pase, (T-pase) 
Mechanistically, both PBPs and B-lactamases bind to substrates via a serine 
acyl-enzyme inten-nediate, with the difference in relative activity being the de-acylation 
step. In B-lactamases this is a rapid process, while PBPs do this relatively 
SloWly. (36,37) Understanding this relationship and the individual mechanisms of the 
enzymes could provide a vital key to the design of better B-lactarns. The considerations 
of the close relationship existing between C Pase. /T Pase and other PB? s and the B- 
lactamases makes it difficult to design a 13-lactarn that will interact well with PBFs and 
yet be unaffected by 13-lactamase enzymes. (38,39) 
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1.4 Location of B-lactamase egKMes. 
The location of the B-lactamase enzymes varies depending upon the type of 
bacteria. Some are cell bound, others occupy the periplasmic space of Gram negative 
bacteria. Whilst others are extracellularly located, in both the Gram positive and Gram 
negative species. In the case of the Gram negative bacteria, the periplasmic B- 
lactarnases have also been found outside the cell, which is not the result of cell lysis 
releasing the enzymes. (40) 
To reach the cytoplasmic membrane of Gram negative bacteria B-lactams 
have to negotiate the outer membrane wall, bypass the periplasmic B-lactamases and 
bind to the primary target PBVs. (Fig. 16) In Racruginosa one of the main 
contributory factors for resistance to hydrophillic antibiotics is the low rate of 
permeation across the outer membrane. (41-44) Rates of pen-neation being 10- 100 fold 
less than the corresponding rates for E coli. Changing the nature of the C6/C7 side 
chains of penicillins and cephalosporins will affect both the rates of outer-membrane 
penetration as well as the stability to the B-lactamase enzymes(45). 
Therefore, the effectiveness of B-lactamases depends not only on their kinetic 
ability, but also on the rate at which the B-lactarn enters the bacteria] cell, penetrating the 
outer membrane barrier, the extent to which the B-lactam can penetrate the outer 
membrane can be expressed by a dimensionless pen-neability number; 
P. A. K, /V.. ax 
where (P) is the permeability coefficient, and (A) is the area of the outer 
membrane, Km is the Michaelis constant and Vn= the maximum velocity of 
hydrolysis achievable by the B-lactamase. As the permeability number approaches 
unity then pen-neability plays a part, as it goes below unity that role becomes the 
predominant one. (39) 
Nikaido and Non-naW4)) have recently investigated the interplay of these two 
parameters for E coli and defined the term "target access index" as a quantitative 
expression of the result of interaction of the barriers, reflecting the probability of 
success for antibiotics to reach the targets. Consequently, producing a B-lactamase 
stable antibiotic need not necessarily produce an increase in efficiency of its pathogenic 
capabilities. 
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Fig. 16The mode of action of B-lactams in Gram- negative bacteda(47) 
Finally, it is known that B-lactams are only effective against fully grown cells, 
inhibiting only the later stages of cell construction. they are ineffective on growing 
cells, implying that the exopolysaccharide 'glycocalyx', used to hold together the 
multicellular biofilms is resistant to the effects of antibiotics. In contrast freely 
suspended cells when subject to the same treatment are sensitive. (48) The mechanism of 
this resistance has yet to be agreed'(49) several hypotheses exist, but none enjoying a 
consensus of opinion. (49-52) 
1.5 Outer membrane Maneability. 
The ability of an antibiotic to reach its site of activity is a prerequisite for drug 
action. The permeation through the outer-membrane of Gram negative bacteria has been 
extensively reviewed by Hancock. (53) With E coli in particular receiving attention. (54-57) 
In addition, Nikaido (58) and Sawai (59) have shown, that the size and charge of an 
antibiotic affect the pen-neation into the cell, via stetic and charge interactions with the outer 
membrane. 
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The outer membrane consists of lipopolysaccharides, phospholipids and protein 
material, the lipid components controlling the entering and egress of hydrophillic 
compounds into the cell. The lipopolysaccharides (LPS), containing phosphate groups 
protruding into solution, provide an effective barrier to hydrophobic species, while 
divalent metal ions form salt bridges between adjacent LPS via electrostatic attraction of 
the phosphate groups, helping to stabilise the outer membrane surface. (60,6 1) 
However, in order to survive bacteria require essential nutrients from solution. 
This function is supplied by the existence of water filled pores which traverse the outer- 
membrane. These pores are created by protein F, (porhis), and via size exclusion can 
act as an effective barrier to B-lactams. It has been shown that the porins exist as 
trimeric aggregates in the outer membrane of E coli (62). Studies using electron 
microscopy and image reconstruction have revealed that the trimer contains three 
distinct openings at the external surface of the membrane which coalesce to a single 
channel in the centre of the membmne wall. (63) 
Estimates of pore diameter vary form species to species, for instance estimates 
for A aeruginosa are in the region of 2 nrn (64-66) while for Ecoli values of 1.16 
nm have been reported. (67) Such differences may account for the differences observed 
for the in vivo activity of penicillins and cephalosporins, B-lactams with large side 
chains being less effective towards Ecoli while retaining activity towards species with 
large porin channelS. (68) This then extends to the ease of passage of charged species 
through the various sized pores, the smaller the pore the greater the interaction with the 
functional groups of the channel walls. (69) However, the importance of the porin 
proteins and their respective roles is still a subject of great debate'(70) and it has also 
been argued that the outer membrane actually possess few defencive qualities and that 
the pen-neability restrictions are derived from periplasmic proteins/glycoprofiens 
forraing a secondary barrier, preventing B-lactams reaching the cytoplasmic membrane 
and PBP's. (7 1) 
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1.6 The B-Lactamase gizMes- 
Most bacilli have the genetic capability to synthesise f3-lactamase enzymes, the 
genes being located in the bacteria] chromosome. In addition to which are plasmid 
encoded B-lactamases, which may exist on transposons, with the ability to "jump" 
between genetic elements providing a powerful mechanism for the inter genus spread 
of B-lactamase mediated resistance. (72) 
These enzymes are recognised as the most important mechanism of defence of 
bacterial cells. (73) Since studies were initiated on the the action of B-lactamases, there 
have been numerous attempts to classify the behaviour and activity of the different 
enzymes. Initially this was done by describing the enzymes as "penicillinases" and 
"cephalosporinases, " but this soon became inappropriate and ambiguous. Subsequent 
attempts have used a wide range of criteria in an attempt to classify the enzymes, for 
example, isoeletric point, molecular mass, gene expression and complex substrate 
profiles. (74-76) A number of excellent reviews comprehensively cover this complex 
topiC. (77) 
Today, despite its growing limitations, the most widely adopted classification is 
that of Ambler (78) , based on the amino acid primary sequence homologies, in which 
B-lactamases are placed into three broad groups A, B and C. Class A enzymes are serine 
proteases, class B enzymes are a small group of metallo enzymes and class C are serine 
proteases with a primary structure dissimilar to class A types. 
1.7 A question of evolution. 
The evolutionary origin of B-lactamase has been the subject of much debate. 
The main point to establish is whether B-lactamases, are produced in response to the 
presence of B-lactams, or serve some as yet unidentified metabolic function . 
(79) 
In 1967 Pollock (80)found a B-lactamase present in a strain from B. fichenformis 
of a plant sample in the British Museum, preserved since 1689, and which was similar 
to present-day strains, long before Flemines discovery of penicillin. However it is 
known that plant organisms naturally produce low levels of B-lactams, either as a side 
product from a biochemical pathway or in an attempt to secure a niche in a competitive 
ecological environment. (8 1) 
It has been suggested that B-lactamases may have evolved from PBVs. (82) 11is 
theory is supported by findings showing several Gram-negative low molecular weight 
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PBFs possessing weak levels of 13-lactamase activity. Waxman and Strominger (83) 
have shown active-site sequence homology between class B-lactamases and D-alanine 
C-Pase of B. subtifis. Similar observations are reported for E coli and PBP 5/6. (8) 
Kelley et al (85) has also shown a similarity between class C B-lactamases and R6 I -C 
Pase from Streptomyces R6 1. Waxman and Strominger (84) have demonstrated that the 
homologies between PBPs and B-lactamases extends beyond the active-site, pointing 
to the possibility of divergent evolution. In contrast, Sammouri etal (86) using X-my 
crystallography found that R6 I- C-Pase and B-lactamase I from B. cereus 569/11 lack an 
amino acid sequence homology, though they had very similar tertiary structures. Given 
this similarity and applying the hypothesis of Pechere and Levesque (87) an argument 
could be put forward that the enzymes show divergence from a common evolutionary 
origin. However, it could also be argued that the similarities in tertiary structures 
reflect a convergent response to the presence of B-lactams. 
In order to try and clarify this problem the question must be asked: " do B- 
lactamases, perfon-n another physiological function, or are B-lactams the only substrates 
for these enzymes ?" Support for B-lactamases performing a physiological role initially 
came from the work of Saz and Ozer. (88) They proposed that the B-lactamase enzymes 
play an essential, but unknown, part in spore formation. Support for the physiological 
importance came from Sabath, (89) who was unable to eliminate the chromosomally 
located B-lactamase gene from Ps. aeiuginosa 
Further evidence was produced by Ambler (90) who when isolating B-lactamase 
from S. aureus found two mole equivalents of a peptide (GlY5 Aln2 Glu Lys) were 
attached. This peptide sequence was later shown to be the same as that involved in the 
crosslinking of S. aureus. (91) Experiments have also been conducted demonstrating 
that B-lactamase possess C Pase and T Pase activity. (92) However, when these 
experiments were repeated they failed to find that either peptides or peptidoglycan 
intermediates to be substrates for B-lactamase(93,94). More recently "depsipeptides" 
(Fig. Iý have been shown to be substrates of B-lactamase 1(95). 
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Fig 17 The depsipeptide phenylacetylglycyl-lactate. C-1 
An alternative proposal for the responses shown by B-lactamases comes from 
changes brought about by the inactivation of PBFs by B-lactams, 13-lactamase 
inducement being caused as a secondary consequence to the presence of antibiotics, 
due to the build up of peptidogylcan intermediates. It has been shown that the build up 
of peptidoglycan. can lead to the production of B-lactamases in some cases (96-98). 
What ever the cause, the wide spread introduction of B-lactam antibiotics has 
led to the proliferation and further evolution of the B-lactamase enzymes, with new 
species continually being found. The result being the evolution of novel enzymes 
which will hydrolyse specific classes of substrate. Korfirriann (99) identified a plasmid 
mediated B-lactamase which has an affinity for third generation cephalosporins. Yvule 
Quin has demonstrated the selective resistance of two R-Tem enzymes, Tem-2 and 
Tem- 10. The Tem- 10 B-lactamase preferring only substrates possessing an "oxime" 
side chain. (100) 
1.8 Characterisation of the active-site of B-lactamase egKaes. 
Until recently the active-site of B-lactamases has remained largely undefined, 
this is rapidly changing due to high resolution crystallographic investigations and 
detailed primary sequence data. Detailed infon-nation of the active-site residues 
surrounding the essential catalytic serine group of several B-lactamase enzymes is now 
available, and a number of theories have been proposed to explain the mechanism of 
enzyme action. Prior to the X-ray studies most of the information regarding the 
essential acfive-site residues involved in the bond breaking-bond formation came from 
affimity labels, active-site directed reagents and other chemical studies. 
Experiments with diisOPropylphosphofluoridate, (Fig. 18) used as a substrate 
analogue in the irreversible inhibition of chymotrypsin by forming a complex with a 
serine residue, (Fig. 19) when used against B. cereusB-lactamase I resulted in no loss 
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Of activity-001) This led to claims that the B-lactarnases, lacked an essential serine group 
in the active-site. 
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Fig. 18 Diisopropylphosphofluoridate. (DIPF) 
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Fig. 19 Proposed mechanism of serine protease inhibition. 
Work carried out looking at the effects of iodine on B. cereus B-lactarnase bad 
been linked to the presence of an essential tyrosine. /tryptophan residue(102) and this 
received support from related studies carried out on the B-lactamase of Ecoli, using 
tetranitromethane(103,104) (a tyrosine-specific reagent ). However, it had been also 
shown that nitration of the Saureus B-lactamase resulted in only partial deactivation 
and this was shown to be the result of polymerisation of the protein and not tyrosine 
nitration. 005) The use of X-ray data, has, for a class C enzyme, re-introduced a 
tyrosine residue as essential active-site residue, with the residue acting as a general 
base(153). 
I-Estidine had earlier also been implicated as an active-site residue, 006) but this 
was later disputed when the use of histidine specific reagents failed to inhibit the action 
of B. cereLLs B-lactamase 1. 
(107) 
HF 
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The existence of an acid residue present at the active-site of B-lactamases, had 
been dismissed early on in the investigations (108). However, Waley (109) using 
carbodiirnides (a carboxyl-specific reagent) demonstrated the possible presence of an 
essential acid residue at the active-site of B. cereus B-lactamase 1. This was further 
substantiated by investigating the activity of the enzyme, with penicillin G over the pH 
range 5- 10. The pH-rate profile produced a nonnal bell-shaped curve, showing two 
essential pKa7s, one at 4.86 indicating the presence of an acid, and one at 8.6, which 
may be indicative of a protonated amine group. 
Ibus the early experiments using group-specific reagents failed to achieve any 
consensus of opHon regarding the exact groups necessary in the active-site of the 
enzymes. However, the information they did provide was essential for the experiments 
which were to follow. In spite of the investigation carried out using group-specific 
reagents it was not until the end of the 1970's and the use of active-site directed 
reagents (inhibitors) did anything significant emerge. 0 10) 
The first of these was a B-lactarn compound, clavulanic acid, isolated from a 
natural source, Streptomyces 0 11) (Fig. 20). This compound is now used 
commercially in combination with penicillins and cephalosporins, which would 
otherwise be clinically ineffective. It is classed as a mechanism-based inhibitor or a 
"suicide inhibitor". Unfortunately, clavulanic acid fragments once in the active-site 
making it difficult to characterise the chemistry of the acyl-enzyme fori-nation and 
subsequent inactivation. The same problems are encounteredMth the peniciflanic 
sulphone, (Fig. 21) another commercial suicide inhibitor. 
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Fig. 20 Clavulanic acid 
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Fig. 21 Perkillanic acid sulphone. 
The compound which overcame this problem of fragmentation once in the 
active-site, unlocking the door to active-site studies was 6B-bromopenicillanic 
acid(I 12,113). (Fig. 22) 
s 
OIZ 
N, 
_< _CO2H 
Fig. 22 6B-bromopenicillanic acid. 
Using radioactively labelled inhibitor, it was found that a serine bydroxyl group 
had become covalently bound to the inhibitor. The mechanism of inactivation is thought 
to be due to the rearrangement of the inten-nediate, with the opened thiazolidine ring 
expanding to a dihydrothiazine ring. (Fig. 23) 
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Fig. 23 Proposed mechanism of inHbition of B-lactamase by 6B- 
bromopenicil lanic acid. (113) 
The discovery of a serine group as the catalytically essential residue, was not 
surprising, since serine groups feature in the active-sites of many proteolytic enzymes. 
The fact that the B-lactamases lack a histidine group, which fonns part of the normal 
catalytic apparatus of many other proteases, indicates that the enzyme mechanism of B- 
lactamases differs fundamentally. In the early 1980's class C B-lactamases were also 
shown to have an essential active-site sefine residue. (114) 
Evidence produced for acyl-enzyme mechanism was provided by Knowles et 
al (115) who used infra-red absorption techniques to follow the acylation and 
deacylation of the active-site sefine of a class A enzyme, this was made possible by 
using a particularly "sluggish" substrate, dansyl-penicillin. Waley et al, (116) using 
methanol/Water solvents produced methyl penicilloate as a by-product of the enzyme 
catalysed hydrolysis for a class C enzyme, which also provided evidence of an acyl- 
enzyme mechanism. 
It is known that enzyme catalysed reactions can be significantly slowed down 
by the use of 'cryosolvents', typically water/methanol mimres. Douzou et a] 0 17) 
pioneered the work to prove that cryosolvents can be used effectively to study the 
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reactions of enzymes in crystals, to see 'acyl-enzyme intermediates', and the 
mechanisms of acylation and deacylation. Recently, the use of cryosolvent systems and 
single turnover experiments have shown evidence of an acyl-enzyme intermediate for 
the serine B-lactamases (118). 
1.9 X- ray investigations of B-lactams and B-lactamase egKMes. 
The rational design of B-lactamase resistant antibiotics requires detailed 
knowledge of the three dimensional structure of the enzyme binding site. 
Crystallographic studies carried out on both active and inactive compounds with the 
enzymes will immensely aid the formulation of structure activity relationships and the 
mechanism of enzyme hydrolysis. Ile production of the X-ray structures of benzyl 
penicillin, (Crawfoot 1949)(119) ended years of speculation, and that of cephalosporin 
C, (Hodgkin 1961)(120) produced a profound effect on the ideas concerning B-lactarn 
chemistry(121). Recently this information has been used in the model building 
experiments whereby the crystal structure of the substrate is superimposed into that of 
the enzyme active-site, from which binding interactions are established and hydrolysis 
mechanisms are proposed. 
The production of a three-dimensional structure for a serine B-lactamase has 
taken a long time to achieve, the first reports emerging in the late 1970's. But it was not 
until the late 1980's that high resolution data has been available. A comparison of the 
arrangement of secondary structure elements of B-lactamases with those of C Pase and 
T Pase PBP show striking similarity, despite the lack of homology in the respective 
primary structure sequences(142). 
1.10 CoLstallography of B-lactams. 
X-ray studies show that penicillin adopts one of two confon-nations of the 
thiazlodine ring. (Fig. 24) One with the C3 below the plane of the ring, the C3 
conformation, and the other with the SI above the plane of the ring, the S, 
confonnation(121). X-Ray studies show that while penicillin G and penicillin V adopt the 
C3 conformation, ampicillin prefers the SI conformation(I 23). VvUle NMR studies show 
that in solution the S, conformation is generally adoptedby penicillins(122,152). 
Cephalosporin compounds adopt only one conformation, S 1. 
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Fig. 24. Possible conforniations adopted by the penicillin thiazlodine ring. 
1.11 Ciystallogmphy of B-lactamases. 
The crystallographic studies of four class A enzymes are now well advanced , 
S. aureus(124,141,149), B. licheniformis(125,126,142,151), B. CereUS(127,139,143-46) and 
EcofiR-TEM (128,136-38) Crystal structures of class B and class C enzymes have also 
been reported, (129,130,140,147,153) along with the crystal structures of the cell wall 
penicillin-sensitiveD-alanyl-D-alaninepeptidases. (131,148) Despite the lack of primary 
sequence homology the results of these studies show that there are strong tertiary 
structure similarities. 
Any claim that crystallography may make a significant contribution to the 
elucidation of enzyme mechanisms carries the implication that the crystal lattice of 
enzymes is an accurate representation of the enzyme in solution. This aspect has 
received the attention of a number of research groups. 0 32- 134) The arguments 
supporting this relationship include: 
X-ray structures, produced in a variety of conditions, are identical and 
reproducible. 
Related proteins fold in the same manner. 
Crystallisation of the enzymes does not disrupt protein folding. 
Enzymes remain catalytically active in crystals. 
Arguments against include: 
If more than one conforner is possible, only one will be adopted in the crystal. 
The flexible loops in polypeptides maybe frozen into a panicular confon-nation 
The side-chain rotations of surface residues may provide a misleading picture 
from the time-space averages used to develop electron density information. 035) 
27 
Despite these limitations, the information gained from crystallographic studies 
has proved invaluable to mechanistic investigations. 
For many years the main problem with the B-lactamase enzymes was the 
production of large stable crystals, as this technique was being developed, information 
became available of the amino-acid residue sequences, greatly helping the interpretation 
of early X-rays and clearer pictures of the active-site began to form. 
Despite the absence of primary structure homology between the DD-C/17 pase 
enzymes and the B-lactamases, the close resemblance of the tertiary structures can 
provide a strong argument for a common ancestor. The obvious extension therefore is 
to postulate that the tertiary structures of class A and C B-lactamases would have very 
strong similarities and consequently share the same ancestor. The same argument 
applies to the zinc dependent C-Pase from Streptomyces albus G and the zinc 
dependent B-lactamase class B enzymes. 
In 1987 Herzberg and MoUlt (149) presented a paper which combined chemical, 
active-site directed studies and detailed crystallographic data of Saureus PC] 13- 
lactarnase at 2.5 A resolution, to produce a model explaining the mechanistic action of 
the B-lactarnase enzyme. The tertiary structure of the 257 residue long peptide has a two 
domain structure, one formed by an anti-parallel five strand B-pleated sheet and three 
helices, which pack against the face of the sheet and a second domain of eight helices, 
the buried nature of the B-sheet is considered unusual for an antiparallel anangement, 
though common for parallel sheet structures. Also described are two clefts, present in 
the enzyrne, formed at the interface of the two domains both adjacent to the (x-2 helix, 
one of which contains the active-site serine residue. One cleft is a long naffow channel, 
the other a closed cave with a narrow exit to solvent available from the side of an fl- 
loop, around tyrosine 17 2 and lysine 177, an opening to the active-site depression is 
blocked by a salt bridge formed between lysine 73 and glutamic acid 166 residues. 
The cave volume is approximately 330 A3 jarger than non-nally observed in 
globular proteins containing closed cavities. Furthermore, this void could be partially 
occupied by solvent. The implication being that the loose packing results in possible 
conformational flexibility which could affect the shape of the substrate binding site. 
7be possibility of this being a conserved feature of the B-lactamases must now raise 
questions as to the relevance of the X-ray studies of the B-lactarnases to their 
mechanism of action. In order to be a predictive tool the enzyme in the crystal should 
resemble that in solution, and even though the enzyme may remain active within the 
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crystal this may represent a conformationally restricted enzyme, consequently the 
information gained will not be of the enzyme acting in its native optimal state. 
Using this infonnation and the X-ray data of B-lactarns, it was possible via 
model building to propose the mode of binding of the substrate to the active-site 
cavity, in this particular case ampicillin was used. The model building was achieved by 
exploiting the requirements of electrostatic, hydrophobic and shape complimentarity 
between the enzyme and the substrate. However, this relies upon the assumption the 
protein undergoes no large confon-national changes, although the existence of the large 
internal cavity would allow such changes to take place. 
Allowing for this the following points were used to model bind ampicillin to the 
B-lactamase of S. aureus PCP 
(i. ) The carbonyl-carbon of the B-lactarn must approach the oxygen of the 
serine-70 residue, in order to fon-n theacyl-enzymecomplex. 
(ii. ) The C3 carboxyl group of the thiazolidine ring, which will be shielded 
from solvent as a consequence of the above requirement, will forrn the 
appropriate electrostatic interaction with the ammonium group of the lysine-234 
residue. 
(iii. ) Having established the approximate position of the substrate using points 
(i. ) and (ii. ) leaves two possible orientations of the fairly rigid substrate. One 
places the carbonyl oxygen of the B-lactarn over lysine-73, the other over the 
two exposed main chain amides of serine-70 and glutamine-237. The latter of 
which is considered the more likely, based upon hydrogen bonding 
requirements. 
(iv. ) ýFhe C6 side chain amide bond makes hydrogen bonds with the 
side chain of asparagine- 132 and the carbonyl of glutarnine-237. The 
positively charged side chain ammonium group of the B-lactam is reported to be 
partially desolvated, interacting electrostatically with the side chain of 
aspapgine- 170 and the main chain carbonyl oxygen of glutamine-237. 
Having established the co-ordinates for substrate binding, a theory is then 
proposed to explain the mechanism of B-lactamase enzyme hydrolysis. (Fig. 25) 
29 
CH3 
VAL H3C-CH 
103 -Cfi .. -. I ASN 132] , CH3' 
ýH2 
ASN 170 
ýH3 
=0 
NH2 """\H3ýN 
\\ 
H-N*ý 
Cýo 
GLN '' 'I , H--ýý 
2-1 
N H/ 
S CH3 
/0 
N- 'ýýCH3 
LYS 73 +H O"C-\O// 
Tj/ 'H 
GLU 
166 
Fig 25.. Proposed binding of ampicillin into the active site of Saureus PC] B- 
lactamase. (149) 
What is required for catalysis is the detachment of a hydrogen from the 
hydroxyl group of serine-70 and the subsequent placement of another or the same 
hydrogen onto the B-lactarn ring nitrogen. Then the acyl-enzyme has to undergo 
hydrolysis, regenerating the enzyme and the ring opened acid. To be capable of 
catalysing both of these stages requires flexibility on the part of the enzyme, this could 
conceivably be provided by the internal cavities. 
Both the acylation and deacylation stages require the carbonyl carbon of the B- 
lactam to change from trigonal to tetrahedral, which requires at least one of the two 
attached oxygen atoms to adopt partial negative charge. This requires the intermediate 
stages to form hydrogen bonded structures with the enzyme, groups positioned for this 
role include either the main chain amides of serine-70 and glutamine-237 or lysine-73, 
which occupies the same spatial position with respect to the active serine group, as a 
catalytic histidine residue, present in other proteolytic enzymes such as subtilisin, an 
arrangement known as a the 'oxyanion hole'. 
0H 
H-N 
SER 70 
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Since catalysis is often mediated by the presence of charged groups the possible 
functions of glutamate- 166 and IYSine- 73 will now be considered. The suggested role 
of the glutamate- 166 in the catalytic mechanism, is in the deacylation step, 
deprotonating the incoming water molecule, thus acting as a general base. However, 
this residue could act in a similar capacity in the acylation process by deprotonating the 
serine-70 residue. In the model the location of the binding site of the water molecule, 
Places it between the the peptide bond of the B-lactam C6 B-side chain and the enzyme 
surface, at the bottom of the depression, hydrogen bonded to the main chain carbonyl 
of glutamine-237 and side chain of asparagine-170 and the carbonyl ofglutamate-166- 
The interaction with glutamate- 166 may enhance the nucleophiflicity of the water 
molecule. The authors suggest that PBP's lack a corresponding binding site for water 
molecules and results in a slow decay of the enzyme-substrate complex, which 
produces the effective antibiotic action. It is also suggested that glutamate- 166 could be 
the general base(I 50) removing the acid proton from mechanism based inhibitors, 
though in this model the distance is too large. 
Finally, the role that the lysine-73 residue, a conserved group in both class A 
and class C serine B-lactamases, as well as transpeptidase, plays in the catalytic 
mechanism remains speculative. In the present model, it is suggested that though the 
residue is unable to act as a temporary resting place for the transient proton, it is 
positioned to orientate the serine-70 proton towards the B-lactarn nitrogen, providing a 
potential gradient reducing the energy barrier for proton transfer and to polarize the 
nitrogen, to receive the incoming proton. This seems unlikely, since it would require a 
concerted mechanism with the formation of a four membered ring in the transition- 
state. However, it may be that the Lysine-73 in fon-ning a salt bridge with the 
glutamate- 166 serves to orientate the position of the carboxy group into that required 
for catalytically activity. 
A recently published refined three dimensional structure of the class C B- 
lactamase from Citrobacterfreundii at 2A resolution further confirms the relationship 
existing between the class A and class C G-lactamases and other B-lactarn target 
enzymes, based upon structural similarities, adding additional proof to the theory of a 
common evolutionary origin. (153) Reported is an acyl-enzyme complex fon-ned with a 
0 monobactarn inhibitor aztreonam refined to 2.5 A, which defines the enzyme active- 
site of a class C B-lactamase. This information is used together with molecular model 
building to propose a mechanism of hydrolysis. This proposal introduces the use of a 
tyrosine residue, not previously implicated for a serine B-lactamase, as a general base. 
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Using the modeling approach of Herzberg and Moult and superimposing the 
image of trypsin onto the B-lactamase shows that the phenolic oxygen of tyrosine- 150 
occupies the same location as N of the essential histidine-57, suggesting a general base 
role for this residue. It is also argued that, in the deacylation stage, to use the same 
Catalytic residues an approaching water molecule must come from the same direction in 
which the 13-lactarn nitrogen is expelled, requiring rotation around the C3-C4 bond of 
the acyl-enzyme intermediate must occur, to remove the nitrogen from the path of the 
nucleophile. This in turn will remove the sulphonate group from its interaction with 
lysine-315 and allow the original hydrogen bonded network to refon-n, resulting in the 
tyrosine being less basic and consequently less effective in the deacylation step. This is 
consistent with the observed rate limiting deacylation. 054) 
The presence of the two positively charged lysines are claimed to lower the pKa 
(=I 0) of the tyrosine residue , keeping it in the anionic fon-n well below that found in 
solution, and justifying its role as a general base group. The presence of positive 
groups lowering the pKas of amino acid residues in proteins has been reported 
elsewhere. (155,156) It is suggested by the authors that this mechanism is extendible to 
both R61 carboxypeptidase and the class A B-lactamases, in which the tyrosine is 
replaced by a serine group. 
The participation of a serine anion acting as a general base for class A B- 
lactamasps is a unique suggestion, but has drawbacks associated with it. Firstly, it 
would require the pKa of serine to be lowered substantially, though this may be 
possible. Secondly, the proposed model mechanism fails to mention a glutamate, a 
conserved residue as being involved in the active-site. Finally, within the confmes of 
this model it is also possible that a lysine residue could act as the general acid/base. 
The conclusion from these observations is that it would appear that the B- 
lactamases and the PBP`s evolved from a common ancestor, as originally suggested by 
Pollock. As to the exact nature of the evolution, whether convergent or divergent 
remains unclear, but if B-lactams are produced as either by products or purposefully, in 
order to secure a place in the biological world then the ability to produce 13-lactamases 
as a defence mechanism would be of great advantage. If this enzyme originated from a 
mutated PBP this would explain the difficulty in producing a 13-lactam with the 
appropriate activity, namely acylating PBP`s while avoiding the 13-lactamases. ýffie 
difference between their activity is manifested in their relative rates of deacylation, 
which occurs quickly for the 13-lactarnases and slowly for the PBP`s. 
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There exists the argument that B-lactamases perform an essential function 
besides hydrolysing B-lactams, this maybe the case but the fact that the B-lactamases 
are very efficient enzymes in their ability to hydrolyse B-lactams makes it difficult to 
believe that these enzymes also catalyse the reactions of other substrates. 
1.12 Muta-genesis e&? eriments of the B-lactamase enzDies. 
If the hypothesis of Ofner(153) is correct then the class A and the class C B- 
lactarnases operate, despite the close similarities of structure, by different catalytic 
mechanisms, which offers evidence of evolutionary divergence. For the class A 
enzymes Herzberg and Moult (149) propose a mechanism of acylation involving the 
direct proton transfer of the Ser-70 proton to the B-lactarn nitrogen during acylation 
added by the Lys- 73 residue which provides the necessary potential gradient aiding the 
transfer, while Glu- 166 acts as a general base deprotonating the nucleophilic water 
molecule in the deacylation step. In contrast, Waley et al 0 09) favour a mechanism in 
which the Glu- 166 residue is involved in both acylation and deacylation, but this would 
require a confon-national change bringing the carboxylate group closer to the hydroxyl 
of the serine residue. 
'nie newly developing techniques of enzyme mutagenesis(157-180) provide a 
powerful accompaniment to the three dimensional data obtained from x-ray studies in 
the assessment of the possible roles of various amino acid residues implicated in the 
hydrolytic mechanism of the B-lactamase enzymes. Two approaches have been 
developed. In one a specific variant of the enzyme is generated and its effect analysed, 
often referred to as 'site-directed mutagenesis'. The second uses 'random mutagenesis' 
to generate many mutant variants and allows a much broader search of the effects of 
changes on the properties of the enzyme, including those mutants which would not 
have been created under the more mflonalised approach. 
It has been shown that for the serine protease enzymes that the mutation of the 
catalytically essential Glu- 166 residue, thought to be involved in the process of 
acylation and deacylation, affects only the rates of deacylation. Similar experiments 
show that the Lys-73, a highly conserved amino-acid, residue is important in the 
process of acylation. This evidence supports the mechanistic proposal of Herzberg and 
Moult. Mutagenesis of the Lys-234 residue(163), which is thought to be involved in 
substrate recognition, shows that enzyme activity is retained, but with the ground state 
and transition state binding being affected, therefore the role of this residue while it is 
clearly non-essential is more complex than originally thought. 
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With the zinc (U) B-lactamase the results of X-ray investigations show that there 
exists uncertainty surrounding the role of either Glu-37 and Glu-212045,172), both of 
these residues have been proposed as acting as an active-site essential general 
acid/base. These were subjected to mutagenesis by Lim and Nne. 080)Each of the acid 
residues was replaced by glutamine and it was found that neither residue is essential for 
catalytic activity. However, it was found that replacing His-28 by Asp-28 (a non-metal 
co-ordinated histidine) reduced activity towards ampicillin by 50% and cephalosporin C 
by 10% and by converting His-28 to Try-28 the resistance of E coli to grow in the 
presence of either B-lactarn could not be detected. Tberefore, while His-28 is an 
important residue it is non-essential for enzyme activity, perhaps playing a role in 
substrate recognition. The corresponding conversion of His-88 to Try-88 (a metal co- 
ordinated histidine) resulted in a loss of enzyme activity confirming the essential role of 
this residue in the tetrad of residues surrounding the active-site Zinc(H) ion. 
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1.13 Kinefics and reactivity. 
The B-lactamase-catalysed hydrolysis of B-lactarns proceeds by about 109 fold 
faster than the non-enzyme catalysed hydrolysis. Values of this magnitude are common 
for enzyme catalysed reactions both in aqueous and hydrophobic media, leading to their 
increasing use synthetic chemistry. The question is, "bow do enzymes gain enough 
energy to overcome the loss of translational, rotational and vibrational entropy that 
occurs in complexation to achieve this rate enhancement and bow are these changes 
expressed in the transition-state TV 81) 
A qualitative evaluation of the rate differences between the B-lactamase enzyme 
catalysed and the non-enzyme catalysed hydrolysis of B-lactams shows that the rate 
enhancement is the product of the mechanism by which the enzyme utilizes binding 
energies, active-site functional groups, nucleophiles, general acids and general bases. 
Uncatalysed reactions in solution requires the bringing together of several 
molecules at the transition-state, with the concomitant loss of entropy and the fon-nation 
of unstable charged species. This problem is lessened with enzymes, charges can be 
stabilised electrostatically by groups present in the active-site, where catalytic residues 
responsible for covalent bond formation are already present, reducing the entropic 
losses involved in bringing reacting groups together. Since the process of bond 
breaking and making in enzyme catalysed reactions are not unusual, then the forces 
involved in binding the non- reacting parts of the substrates must be used to lower the 
activation energy of the transition-state. 
Experimentally f3-lactamases show typical Michaelis-Menten kinetics, 
E+Sý 
Ks 
-[ ES 
Ik cat -o, - E+P 
and with the appropriate mathematics this reduces to the classical Michaelis-Menten 
equation: 
Rate = Vmax (S) = kcat (Eo) (S) 
Km + (S) Krn + (S) 
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Schematically, the process of hydrolysis follows the pathway. (Fig. 3-ý 
Vmax 
Fig. 26. Reaction rate plotted against substrate concentration for a reaction 
obeying Micbaelis-Menten kinetics. 
At saturation when Sý: Km the rate is independent of the substrate, with the first 
order rate constant kcat. 
Dn 
jL-, ate = kcat ( Eo 
At lower concentrations when S-< Km, the rate becomes dependent upon the 
substrate concentration and bas the apparent second order constant kcaVKm. 
Rate = kcat (Eo ) (S) 
Km 
Although this equation holds for many enzyme catalysed reactions, it is not 
always obeyed. The experimentally measured values of Km and kcat are not always 
expressed by the dissociation constant Ks. The apparent Km can be less than Ks if 
additional intermediates are fon-ned during the reaction pathway and the rate limiting 
step is the breakdown of one of these additional intermediates, this will give apparent 
fighter binding. Km can also be larger than Ks if the rate of breakdown of the Michaelis 
complex back to starting materials is comparable to or less than the magnitude of kcat. 
This can be seen from the steady-state treatment of the basic Michaelis-Menten 
equation. 
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Km 
k- 1 k2 
E+S- [ES] N' E+P 
kl 
d (ES) 
d=k1 
(E) (S) - k2 (ES) - k- 1 (ES) 
(ES)= (Eo) (S) 
(S) + (k2 + k- 1) 
«Eo) = (E) + (ES» 
kl 
Rate = kcat (Eo) (S) 
(S) + (k2 + k- 1) 
since Ks = k- I 
kl 
kl 
Km= k2+k-1 
kl kl 
The results of in-vitro studies often lead to conclusions being drawn about how 
good or poor a substrate is based upon the individual values of kcat and Km. However 
since in-vivo activity is non-nally the result of competition between substrates, if two 
substrates competing for the same enzyme are then evaluated based on their respective 
kcat or Km values, then the specificity correlated to these values could produce very 
different conclusions from comparing the magnitude of the apparent second order rate 
constants kcat / Km for the competing substmtes. It can be shown for an enzyme with 
two competing substrates that the rate of reaction, above or below saturation for one or 
both substrates obeys(I 82): 
ua [A (kcat/Km) a 
ub [B (kcat/Km) b 
Specificity is therefore a function of the relative values of kcat / Km and not the 
individual values of kcat or Kin. 
Km = Ks + k2 
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Transition-state theory can be used to show that the apparent second order rate 
constant kcat/ Km relates to the free energy difference AGt between the enzyme- 
substrate transition-state [ESIt and the free unbound states. 
AG+ 
+S-, [ ES 
kcal / Km 
kcat Kr exp AG 
, 
/p 
,T Km h 
T'herefore the maximum relative rate for the enzyme catalysed reaction between 
two substrates possessing the same chemical activity, will be the difference in the free 
energy of binding of the non-reacting parts of the different substrates to the enzyme in 
the transition-state, less the difference in free energy of the respective ground states. 
One way of measuring the contribution of the non-reacting part of different 
substrates to the binding, AAGb, is to compare the dissociation constants of a sefles of 
uniformly modified substrates from the enzyme; 
ý, AG ,L RT In (Km) a 
(Km)b 
But this often underestimates the binding energy contribution, since enzymes 
utilize binding energy to lower the activation energy of the transition-state, rather than 
to give tighter binding. Therefore a much better method is to compare the values of 
kcaVKrn rather than just Km's. This quantity includes both the activation energies and 
the binding energies and avoids any underestimation using dissociation constants 
alone. 
1.14 Binding energies and acfivation eneEgjes. 
Since the binding process involved in enzyme substrate reactions is the result of 
an exchange reaction, with the substrate exchanging its solvation shell for the binding 
site of the enzyme, it is difficult to separate the individual contributions made by the 
various bonding interactions. The net energy gained representing the differences 
between the two physical states. 
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The transition-state theory is particularly useful in analysing enzyme catalysis. 
Applying this approach to Michaelis-Menten kinetics it can be demonstrated that 
binding energies can be used to lower the activation energy of kcaVKm via kcat. 
G+ 
E+S' [ES]+ 
kcat / Km 
Km kcat (äi) E+S -' b- AG , 
[ES] 
AG *> 
[ES]+ ýE+P 
s 
The equilibrium between E and S and the transition-state [ES]t is proportional 
to the activation energy AGI of kcaVKm. This activation energy is comprised of two 
terms, AG *, the activation energy of the chemical steps involved in bond breaking and 
making, and AGs, the utilisation of binding energy. 
, LG ZýG + AGS 
(AG$ and AG* are algebraically positive and AGs is negative. ) 
Using equilibrium thermodynamics, kcat/Km can then be expressed in terms of 
the transition-state theofy; 
RT In kcat 
- RT In Kr 
Km h 
AGS - AG 
The specificity for competing substrate's is controlled by kcat/Km, if the rate of 
reaction of substrate A is ua and for B is ub then; 
ua [AI(kcat/Km) a 
ub [B I (kcat/Km) b 
If the difference between the two substrates is due to a group R, which is not 
directly involved chemically in the reaction, then ignoring inductive effects the 
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difference will be set by the differences in the binding energies (AAGb) of the two 
substrates. 
RTIn kcat 
- RTIn Ki - AG* -( AGS + AGb) 
KM h 
where A Gb is the incremental binding energy of the group R. 
(kcat/Km) 
a 
(kltlKl) b 
exp ! ýýL GO 
RT 
The utilisation of binding energy is maximised when each binding sub-site in 
the enzyme is matched by a binding group on the substrate. But since the structure of 
the substrate is continually changing during the course of the reaction, then the 
'undistorted' enzyme can only be complementary to one forrn of the substrate. 
Catalytically, it can be shown using energy diagrams, that the enzyme should be 
complementary to the transition-state rather than to that of the original substrate 
structure. (18 1b) The increase in binding energy on fon-ning the transition-state will 
lower AG$, the activation energy associated with kcat. Conversely, if the enzyme is 
complementary to the ground state of the substrate, increasing AGs, this will effectively 
increase AGI. 
Although the kinetics of binding may control the reaction if complimentarity is 
too strong and the motility and mobility of the enzyme is restdcted, it seems unlikely 
that this is the general case. When considering the complimentarity of the various 
enzyme-substrate complexes along the reaction pathway, the differences between the 
ground states and the transition states is often exaggerated. The actual distances 
involved in atoms moving to reach the transition-state is often not much more than 
those experienced in normal bond vibrations. Perhaps, more important to the increased 
binding and complimentarity associated with the transition-state, are the changes in 
electron density distribution surrounding the reacting centres, providing increased 
favourable interaction between the enzyme and substrate(182). 
Accepting that enzymes evolve to be complimentarity to the transition-state, this 
involves kcaVKm reaching a maximum, with both a high Km and a high kcat value. 
This contradicts the widely held belief that strong binding, and thus a low Km, is an 
important component of enzyme catalysis. 
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For chymotrypsin the binding energy increases as the size of the leaving group 
increases. The incremental binding energy in this instance being used to increase kcat 
rather than to lower Km (183). 
It will be shown that for a series of modified penicillins and cephalosporins, that 
the values of the Michaelis-Menten parameters can be explained by consideration of the 
complimentarity between the various structures and the PP-lactarnase enzymes I and 2 in 
the transition-state. 
1.15 pH Rate profiles. 
Since the active-site of many enzymes contain both acids and bases it is not 
unusual to observe changing activities with pH. These changing activates can be used 
to characterise active-site residues and provide valuable infon-nation about enzyme 
hydrolytic mechanisms. However, the simple interpretation of pH-studies, can easily 
lead to erroneous conclusions. For instance, glutamate dehydrogenase has an essential 
catalytic lysine residue with a pKa of = 8. The 'normal' pKa of lysine lies in the region 
9.4 - 10.6. As mentioned earlier, a similar proposal involving a reduced pKa of a 
serine residue has recently been used to explain the class A B-lactamase enzyme 
catalysed hydrolysis of B-lactams. 0 53) 
The Michaelis-Menten parameters kcat, Km and kcat/Krn are affected in 
different ways by the changing ionisations of the enzyme and enzyme substrate 
complex. 'Ibe pH rate profiles involving enzyme reactions usually involve single or 
double ionization curves, due to the ionisation of the catalytically essential active-site 
residues. This makes the simplifying assumption that other non active-site residue 
ionisations are responsible for maintaining motility and mobility of the protein, 
maintaining an active confori-nation. It has been shown for a class A B-lactamase that 
the enzyme does not appreciably unfold over the pH range 3- 10 (184). Below pH 3 the 
enzyme begins to unfold and loose activity. Recently it has been reported that lowering 
the pH still further results in the enzyme refolding. (185) 
Making four simplifying assumptions (186), the Michaelis-Menten equation can 
be re-written to show the effects of a single ionisation as: 
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vo Axa 
ES 
kcat 
E+P 
Ke Kes 
K's 
HE ý 
HES 
The ionisation constant of the free enzyme is Ke, for the enzyme substrate 
complex Kes, and the dissociation constant for ES is Ks and for FIES is K's. 
The following relationship holds: 
Ke K's = Kes Ks 
and if Ke = Kes, then Ks = K's and there is no pH dependence for binding the 
substrate. But if Ke 0 Kes or Ks * K's then: 
Ks = K's 
Ke 
Kes 
0 
where the binding of S is pH-dependent. A similar approach can be used to 
demonstrate a double ionisation of the enzyme. 
The kinetic parameters kcat and Km may show dissimilar dependence on pH, 
and their separate effects should be determined in order to elucidate the importance of 
ionisable groups. 
42 
1.16 pH DgILendenceofKm and kcat. 081) 
lbe pH dependence of the observed rate (U H) I 
for the scheme shown above can 
be obtained from by expressing the concentration of ES in terms of Eo, to give the 
following equation: 
uH :- 
kcat ( Eo) (S) 
Ks + (S) (I+ (H )/Kes) + Ks (H )/Ke 
When S )) Ks, then the dependence is; 
u=( Eo kcat) 
kcat ( Eo ) Kes 
HH Kes + (H) 
The denominator shows that kcat follows the ionisation of the enzyme-substrate 
complex. Similarly, the pH dependence of Km is found by re-an-anging the basic 
Michadis Menten equation: 
(Km) 
H= Kes + (H) 
Km follows the ionisation of the enzyme-substrate complex. 
When S << Ks and re-arranging equation x gives the pH dependence of kcat/ 
Km. 
( kcat ) Lat x 
Km H Ks 
Ke iL U 
Ke + (HJ 
The value of kcat / Km follows the ionisation of the enzyme. 
Making the assumption that each apparent pKa obtained from the pH-rate 
0 
profile represents the ionisation of a single residue in the active-site of the enzyme, then 
if the ionisation of interest is K, for the process: 
EH -ý E-+ H 
K 
Ks Kes + (H ý Ks Kes/Ke 
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(E-) (HI 
K (K = Kes) 
(EH) 
also allowing for enzyme conservation, 
et = (EH) + (EI 
Thus, for [EHI as the active species: 
et = (EH) + (EH) K 
(EH) = 
et 
(H+) 
(l+K ) 
W- 
et = (EH) ( I+ K) (EH) = 
et ( H) 
H+ (H+) +K 
Therefore, for EH as the active species: 
Vmax = kcat " 
et = kcat ( EH ) 
Vmax = kcat (M 
et = 
kcat et ( H+) 
(H+) +K 
kcat kcat (H ) 
K+ (H) 
11- 
I lere, (HI) is saturating the enzyme with protons to give EH, the enzyme in the active 
form. 
If instead of EH being the active fonn, E- is, then: 
Vmax = kcat et = kcat el Ke 
( H+) + Ke 
re-arranging into a linear fon-n, 
0 
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kcat 
"= 
kcat -( kcat )H( 
H+) 
Ke 
kcat kcat -( kcat )H 1ýa 
( W) 
for E- as the active fonn. 
for EH as the acfive forrn. 
Regardless of whether the protonated or the unprotonated species is the active 
form, the appropriate pKa may be obtained by plotting log Vmax against pH. 
If EH is the active form, then; 
Vmax = Vmax (t,,,, ) 
I+ K/(H) 
In Vmax = In Vmax (tn,, ) - In (I+K/(H 1) 
Vmax is experimentally obtained and Vmax(true) is the theoretical maximum, if all the 
enzyme was present in the active form. 
Thus, when H+ >> K, then the equation reduces to, 
( 
In Vmax = In Vmax (true) - In I 
and when H+<< K, 
In Vmax = In Vmax (tu, ) - In K+ In (H 
I 
Iberefore, a plot of log Vmax against pH gives two straight lines and the intercept is 
-TT = pH pKa. If the pKaýs are separated by more than 4 pH units, then this process can be 
extended to two ionisable groups. 
However, as the case with the B-lactamase enzymes, if the pKa's are less than 4 
pH units apart, then the plateau region disappears and a bell-shaped curve results. This 
is a result of the two ionisation steps overlapping, and the enzyme never approaches the 
true Vmax. Consequently, inspection of the pH-rate curves yields pKa values displaced 
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from the 'true' values. In this case the approach of Alberty and Massey (187) Must be 
used to obtain the 'true' pKSs. 
For the scheme: 
KI 
EH2 -0 - EH ---0- E 
K2 
If EH is the active species, then lowering the pH converts it to EI-12' and with 
increasing pH to E-, with ionisation constants KI and K2. Then the fraction of the 
enzyme in the active form F can be shown to be, 
EH (H) 
et K2+ (H+) + (H 
KI 
Differentiation with respect to (H+) shows F reaches a maximum of, 
KI/ (KI + 21(KI K2) 
when (H) = V- (KI K2) 
Therefore knowing the expression for the maximum, the mid-points of the slopes of 
the pH-rate profile can be found by substituting, 
F=0.5 KI /(K2 +2; (Ki K2)) 
into the above equation and solving the resulting quadratic for (H+), for the roots x and 
y. 
x. y = KI. K2 
and 
+y= KI + 4.1 (KI. K2) 
There are however limitations to this approach, if the ionisations do not result in 
complete loss of activity, then the plot of log Vmax against pH will not be linear. 
Furthermore, using the kinetic constant Vmax or kcat can be misleading as it may be a 
composite function of several rate constants, reflecting only the activation energy of 
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[ESI complex. This applies with greater force to interpreting the pH dependence of 
Km, as it is always a function of a least two rate constants. Generally, it is much better 
to use the specificity constant (kcaVKm) for the interpretation of pH- rate dependence of 
enzymic behaviour. A more rigourous treatment of the points raised here is given by 
Dixon and Webb. (188) 
1.17 Reactivilyof the B-lactam ring. (17) 
For a long time the biological activity of 13-lactam antibiotics was attributed to 
the four membered B-lactarn ring. Activity being correlated to the the release of strain 
energy(189) upon ring opening and to the reduced amide resonance of the non-planar 
ring. 090) 
From the crystallographic studies the penicillin molecule has been shown to 
have a butterfly shape in either the S1 or C3 confon-nation. (Fig. 36) 
RCONH 
s 0- 
R' CO2H 
R' 
Fig. 27. The butterfly arrangement of a typical penicillin. 
The non planar arrangement of the C, O and N atoms of has been interpreted as 
disrupting the delocalisation of the nitrogen ir electrons, preventing the stabilisation of the 
lactam. bond. The penicillin nitrogen is 0.4 - 0.5A out of the plane and cephalosporins are 
0.2 - 0.3 
A out of plane. It is estimated that resonance stabilisation, stabilises amides by 
about 75 KJ mol -1. This would mean that any reduction of this stabilisation will enhance 
activity. ne pyramidalisation of the nitrogen reducing Tr overlap, will result in a longer C- 
N bond and a shorier GO bond of the lactarn. 
Similarly the energy released on opening a four membered ring, reducing 
strain, is of the order of 108 - 120 KJ mol- 1. Therefore, any reaction involving the 
release of ring strain would result in enhanced activity when compared to a non- 
strained analog. Therefore, if either strain or resonance were significant for either 
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Penicillins or cephalosporins the effect would be easily observable, chemically, as well 
as enzymatically. 
Any effects involving the changes in planarity or delocalisation would be 
manifest in changes in the infra-red stretching frequencies, bond lengths and the 
degree of non-planarity of the bicyclic B-lactams. ( Table 4) It is not surprising that 
attempts have been made to produce ring structures which increase ring strain and 
reduce the delocalisation, 09 1) It is also not surprising that attempts have been made to 
correlate the changes in bond length with the degree of inhibition of amide resonance to 
produce an index of activity. 092-195) 
Compound C=O stretch Distance of N B-lactarn C=O B-lactam. C-N 
cm-1 from plane /A bond length /A bond length /A 
Peniciffins 1770-1790 0.38-0.4 1.17-1.21 1.34-1.46 
A3-Cephalospotins 1760-1790 0.24 1.21 1.38 
, &2-Cephalospoiins 1750-1780 0.06 1.22 1.34 
AnhydfopeniciUins 1810 0.41 1.18 1.42 
Monocyclic B-lactum 1730-1760 0 1.21 1.35 
Amides 1600-1680 0 1.24 1.33 
Table 4. Structur-al parameters of B-lactams and acyclic amides. 092-195) 
It would seem that the variations in bond length and the infra-red stretching 
firequencies for penicillin and cepbalosporin derivatives are the result of the effects of 
the nature of the substituents and the minimisation of unfavourable strain energies 
caused by the geometry of the molecule. To attribute the differences to the inhibition of 
amide resonance and ring strain seems speculative, being supported by only a limited 
number of examples. 
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1.18 Mechanism of cephalospotin eflZMe hy-drol3Lsis. 
The hydrolysis mechanism of cephalosporins diffets fundamentally from the 
hYdrolysis of penicillin B-lactams, involving the elimination of the group at C3. These 
substituents are also capable of affecting the binding in the active-site of B-lactamases. 
For a long time controversy existed around the mechanism involving the 
expulsion of the group at C3, whether the process was concerted or involved a step- 
wise elimination. 
The earliest theories interpreted the B-lactarn ring-opening as a concerted 
mechanism. (Fig. 28) 
RCONH s 
RCONH 
4411 14ý 
N N 
l" 0 CH22 u u 
02H 
Nu 
2 
+ 
Fig. 28. The proposed "concerted" mechanism for cephalosporin hydrolysis. 
If the changes are not coincident, then there must be at least two interrnediates 
fort-ned during the reaction. (Fig. 29) 
ON 
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Fig. 29. The proposed "stepwise" mechanism for cephalosporin hydrolysis. 
Substitution reactions at a carbonyl group proceed by mechanisms that are 
enforced by the life-times of the intermediates. If the bond between the carbonyl carbon 
and the incoming nucleophile is fon-ned before the leaving group bond is broken, a 
tetrahedral intennediate results. 
50 
If the nucleophilic addition is reversible then the detection of the tetrahedral 
inten-nediate will depend upon the rates of breakdown to either starting materials or 
Product and will be a function of k- I and U. Therefore, the existence of an 
inten-nediate can be postulated if a change in the rate-determining step can be seen by 
varying the reaction conditions. 
Reactions involving amines with cephalosporins show that arninolysis obey the 
following rate law. (6) 
kobs ' ko[ OH- 1+ k [ RNH2 1+ kb [ RNH2 ] 2+kOH 1 RNH21 1 OH- 1 
kobs is the observed pseudo first-order rate constant for cephalosporin 
hydrolysis, ko is the hydroxide ion catalysed hydrolysis, ku is the second-order rate 
constant for the uncatalysed aminolysis, kb is the third-order rate constant for the 
general base catalysed reaction and kOH is the hydroxide ion catalysed reaction. 
It is found that there is a non-] inear dependence of the second order rate 
constants upon the concentration of hydroxide ion. At low concentration of hydroxide 
ion the rate is first order, while at high concentrations the rate becomes independent of 
base, indicating a change in the rate deten-nining step of the reaction, and that the 
addition of nucleophiles to the B-lactam carbonyl of cephalosporins, is not a concerted 
reaction. 
Bicknell and Waley(196), using cephalosporin C, 7-dinitrophenyl-deacetoxy 
cephalosporin and RcereusB-lactamase I demonstrated the existence of an acyl- 
enzyme inten-nediate. In the experiment, the hydrolysis were followed under single 
turnover conditions and steady-state conditions. Burst kinetics were observed and 
interpreted as the deacylation of the intermediate being the rate deten-nining step. 
However, if the 13-lactamase I catalysed hydrolysis of cephalosporins proceed via an 
acyl-enzyme inten-nediate and if the deacylation is rate limiting, then the addition of 
suitable nucleophiles to the reaction may increase the rate of the reaction and give 
products other than those of simple hydrolysis. Experiments such as this have shown 
the existence of an acyl-enzyme inten-nediate in the reaction of benzyl penicillin with 
13-lactamase 1(197) and carboxypeptidase. (198) But results of experiments with 
cepbaloridine using methanol and ethanol as the nucleophiles produced no observable 
rate increase, suggesting that deacylation of the enzyme is not the rate limiting 
step. 099) 
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Faraci (200) et a] demonstrated that two spectrophotometrically observed phases 
in the reaction of PADAC with Saureus were due to the fon-nation of the the acyl- 
enzyme intermediate followed by partitioning, one path leading to the normal 
cephalosporonate from the leaving group is spontaneously eliminated and a second path 
involving the elimination of the C3 substituent to give a second acyl-enzyme whose 
hydrolysis results in the the same final product. This second acyl-enzyme intermediate 
was found to be relatively inert to hydrolysis, giving the transient inhibition of the 
enzyme often seen for cephalosporin substrates. The intermediate was 
chromatographically isolated and was found to be without the C3 substituent. 
1.19 Aims of the sLuýd. 
The aim of this work was to investigate the mechanism of enzyme hydrolysis of 
B-lactz-uns by B. cereus B-lactamase I and 2 and to try and clarify the complex picture 
which has emerged from the combination of kinetic experiments, the X-ray analysis of 
the enzymes active-sites and the results of the more recent mutagenesis experiments. 
If the attacking nucleophile in the serine enzyme is bonded to an ionisable 
proton, then a general base will be required to facilitate the reaction by the removal of 
this proton. Similarly, CO-N bond cleavage of the B-lactarn requires the protonation of 
the leaving group nitrogen, a role requiring the aid of a general acid catalyst. The 
tetrahedral intermediate (Fig. 30) fon-ned by the attack of the B-lactamase serine on a 
penicillin is likely to require a general base to remove the proton from the serine oxygen 
and a general acid catalyst to protonate the B-lactam nitrogen before the acyl-enzyme 
can be formed. 
I 
Ser 
Fig. 30. The tetrahedral inten-nediate. 
In chymotrypsin both functions are carried out by a histidine residue and it is 
possible that a corresponding single amino acid residue may perfon-n this task for the 
13-lactamases. Mentioned previously from the crystallographic studies, a tyrosine 
residue has been proposed for the class C enzymes, suggesting that a serine group may 
capable of perfon-ning the same task for the class A enzymes. However, the pH-rate 
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study profiles of the B-lactamases suggest that two different residues perform these 
functions. An acid acting as a general base, with a pKa of around 4 and a base acting as 
a general acid, with a pKa value of around 8 (Fig. 31). 
, 
ElxN---_ 
0H 
'A 
Ho 
ýr 
Fig. 31. The use of a general acid and general base, for the B-lactamase hydrolysis of B-lactams. 
The first part of the investigation involved the preparation of C6 aliphatic alkyl 
penicillins to test for the existence of a hydrophobic binding site, a bonding interaction 
utilised by many enzymes, for both substrate recognition and the lowering of the activation 
energy. The second part involved the preparation of novel B-lactams containing charged 
groups in the 6/7B side-cbain. The reason behind this is that at this time for the serine B- 
lactamase enzyme there exists two predominant mechanisms. The first, proposed by 
Herzberg and MoUlt'(149) involves the Lys-73 residue, in the proton transfer between the 
active-site serine and the B-lactam thiazolidine nitrogen, in process of acylation. 'I'he second 
mechanism involves the use of Glu- 166, as a general base in the deprotonation of the 
serine residue, in the acylation process. By preparing 13-lactams containing negatively 
charged groups in the OB phenyl side chain it was hoped would show a charge interaction 
with the enzyme and therefore the existence of a charged group close to the Ser-70 residue. 
]Me enzyme-substrate reactions were followed over the pH range 3- 10, this allowed the 
respective pKa values of the free enzyme and substrate to be calculated and therefore 
speculation of their relevance to the enzyme catalysed hydrolysis mechanism. 
For the B-lactamase 2 enzyme one predominant mechanism has existed, proposed 
by Waley et al, (146) but this has recently been shown to be incorrect by the mutagenesis 
experiments of Lim and Pene. 080) Calculating the Michaelis-Menten second order rate 
constants for the prepared B-lactams derivatives described above over the pH range 3- 10 
with the B-lactamase 2 enzyme allowed for speculation about the possible enzyme 
mechanism. Finally, an unsuccessful attempt was made to prepare a B-lactam aldehyde 
derivative, it was hoped that this would be a potential inhibitor of the serine enzyme. 
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Chapter 2. 
Experimental. 
Chgpter 2. 
Expgtimental Procedures. 
2.1 Prenaiadon otN-glk I-penicillins. 
MethodA. (201) 
0H 
CH3(CH2)ný-N 
1.000 
_C02- Na+ 
It was generally found that the reported methods used for synthesising the 
substituted penicillins were unsatisfactory, giving impure compounds in low yield. Attempts 
were made to recrystallise the final products. This worked for the cephalosporin compounds 
but not the penicillin compounds, although purification was achieved for the penarn 
derivatives using semi-prepatative B? LC. 
MethodA. (201) 
Based on the method of Buckwell, (201) the following procedure was developed. 
The alkyl acid (I Onu-nol) was added with stirring to 15ml of dioxane and 50ml of 
acetone in an ice bath 0-50CTo this solution 1.4ml of tdethylamine (I Ommol) was added 
and the solution allowed to mix for 30 minutes, (produces a precipitated opaque 
solution). To this 1.4ml of alkylchlorofonnate was added dropwise, ( producing further 
precipitate and fumes ). The temperature was maintained at 0-50C for I hour. 
In a separate vessel (I Ommol) 2.16g of 6-aminopenicillanic acid (6-apa) was mixed with 
1.4m] of triethylamine and 40ml of water, cooling the solution to 0-50C After 20 minutes. 
This solution was then added to the mixed anhydride solution, producing a final clear 
solution. After 30 minutes the reaction was quenched and the product isolated by the 
following procedure. The contents of the reaction vessel were transferred to a separating 
funnel and covered with a layer of ether and the pH adjusted to pH 8 by adding sodium 
hydrogen carbonate and extracted with ether W), retaining the aqueous layer. The 
resulting aqueous extract was covered with a layer of fresh dry ether and the pH adjusted 
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to pH 2 using 2M hydrochloric acid and extracted (0, retaining the ether layer. The 
combined extracts, were washed twice with ice-cold saturated saline solution and dried 
over magnesium sulphate. 
The sodium salt was prepared by adding sodium -2-ethylhexanoate (211) dropwise 
to the dried ether solution and allowing to stand, filtering the precipitate and repeating the 
process until no further precipitate is fonned-The solid was dried in vacuo. 
Method B. (202) 
The following procedure was based on the method of Glombi=. (202) 
6-Apa (I Ommol, 2.16g) and 2.3ml of (I I mmol) of hexamethyldisilazan were 
heated under reflux in dichloromethane (I 00ml) until completely dissolved, then cooled in 
ice water whilst 1.4ml (I Ommol) of triethylamine was added, followed by portions of the 
acid chloride, adding dropwise. The temperature of the mixture was gradually adjusted to 
room temperature and allowed to react for I hour. 
The work up procedure was as described in the previous method. 
2.1.2 Method variations. 
(i) During the work-up procedure activated charcoal is added to the final organic 
fraction and then isolating as descfibed. 
(ii) Using method B, success can also be achieved using the mixed anhydride 
instead of the acid chloride. Prior to the reaction work-up, the dichloromethane can be 
removed under vacuum at 400C and cooled to -50C before adding water. 
(iii) The product sodium salt can be further treated by dissolving in water and 
solvent extracting any organic impurity, followed by the freeze-drying of the aqueous 
fraction. 
(iv)It is also possible to dissolve the free acid/sodium salt in acetone and precipitate 
the product by adding ether and cooling. 
Using these methods the following compounds were prepared. 
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Eth vl penicillin. (n =2) 
Infra-red. ( Nujol ) 
1782.1 cm- 1 (ß-lactam), 1668.7 cm- 1 (ainide), 1718.8 cm- 1 (carboxylate) 
1H Nmr. (D6 DMSO) 60 MHz. 
b(l. 5 1, s, 3H, cc - CH3) (1.6, s, 3H, B- CH3) ( 5.4, m, 2H, 6- CH -5- CH) 
(4.16, s, 1H, 3-CH) (7.8, d, IH, NH) (1.0, t, 3H, CH3CH2) ( 2.25, q, 2H, CH3CH2) 
Analysis: calculated C: 40.0; H: 5.76; N: 8.48; S: 9.70 
found C: 39.97; H: 5.25; N: 8.54; S: 9.30 
for CIIH15N204SNa. 2H20 
P-Lo. v2vl penicillin. (n=3) 
Infra-red. (Nujol) 
1780 cin- 1 (ß-lactam), 1665.4 cm- 1, (amide), 1715.4 cm- 1 (carboxylate) 
1H Nm r. (D6 DMSO) 60 NlHz 
6(l. 5, s, 3H, a- CH3) (1.62, s, 3H, B-CH3) ( 5.46, m, 2H, 6-CH - 5-CH) 
(4.1, s, IH, 3-CH) ( 7.8, d, 1H, NH) ( 0.9 - 2.5, m, 7H, CH3(CH2)2) 
Analysis: calculated C: 44.17; H: 5.83; N: 8.59 
found C: 43.28; H: 5.99; N: 7.90; 
for C12Hl7N204SNa. H20 
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Butv] penicillin. (n=4) 
Infra-red. ( Nujol ) 
1768.8 cm- 1 (ß-lactam), 1658.7 cm- 1, (amide), 1692. lcm- 1 (carboxylate) 
IH Nmr. (D6 DMSO) 60 MHz 
6( 1.5, s, 3H, a -CH3) ( 1.6, s, 3H, B-CH3) (5.5, m, 2H, 6-CH-5-CH) 
( 4.1, s, IH, 3-CH) (. 8.1, d, IH, NH) ( 0.85 - 2.35, m, 9H, CH3(CH2)3 ) 
Analysis: calculated C: 45.75; H: 6.45; N: 8.21 
found C: 45.68; H: 6.58; N: 7.83; 
fOf* C13HjqN204SNa. H20 
Pent vl penicillin. (n =5) 
Infra-red. (Nujol) 
1788.8 an- 1 (ß-lactam), 1658.7 cm -1 (amide), 1718.8 cm -1 (carboxylate) 
1H Nmr. (D6 DMSO) 60 NH-lz 
6( 1.5, s, 3H, a- CH3) ( 1.6, s, 3H, B-CH3) ( 5.5, m, 2H, 6-CH-5-CH) ( 4.18 9 
IH, 3-CH) (8.5, d, 1H, NH) (0.88 - 2.6, m, I IH, CH3(CH2)4) 
Analysis: calculated C: 48.69; H: 6.38; N: 8.11 
found C: 48.40; H: 6.59; N: 8.00; 
for C14H2lN204SNa. i/2H20 
H! L, x I pýnicillin. (n= E, - 
Infra-red. (Nujol ) 
1778.8 cm- 1 (ß-lactam), 1665.5 cm- 1 (amide), 1718.8 cm- 1 (carboxylate) 
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1H Nmr. (D6 DMSO) 60 MHz 
6( 1.5, s, 3H, a- CH3) ( 1.6, s, 3H, B- CH3) ( 5.4, m, 2H, 6- CH- 5- CH) (4.16) 
IH, 3-CH) (7.85, d, IH, NH) (0.77 - 2.6, m, 13H, CH3(CH2)5) 
Analysis: calculated C: 50.26; H: 7.33; N: 7.07 
found C: 49.74; H: 6.94; N: 6.88; 
for C16H25N204SNa. H20 
Octvl penicillin. (n=8) 
Infra-red. ( Nujol ) 
17 88.8 cm- 1 (ß-lactam), 1652.0 cm -1 (amide) , 1720cm- 
1 (carboxylate) 
1H Nmr. (D6 DMSO) 60 MF[z 
6( 1.5, s, 3H, a- CH3) ( 1.6, s, 3H, B- CH3) ( 5.4, m, 2H, 6- CH- 5- CH) 
(3.9, s, IH, 3-CH) (0.82 - 2.6, m, 17H, CH3(CH2)7) (7.8, d, 1H, NH) 
Analysis: calculated C: 52.7 1; H: 7.24; N: 7.04 
found C: 52.0; H: 6.99; N: 7.20; 
for C17H27N204SNa. i/2H20 
Dec v] penicillin. (n= II 
Infra-red. ( Nuiol ) 
1778.8 an- 1 (ß-lactam), 1645.3 cm- 1 (amide), 1725.4 cm- 1 (carboxylate) 
1H Nmr. (D6 DMSO) 60 NfHz 
b( 1.5, s, 3H, (x - CH3) ( 1.6, s, 3H, ß-CH3) ( 5.5, m, 2H, 6-CH-5-CH) ( 4.1, 
1H, 3-CH) (8.65, d, 1H, NH) (0.82 - 2.65, m, 23H) 
Analysis: calculated C: 57.14; H: 7.86; N: 6.67 
found C: 56.50; H: 7.5 1; N: 6.04; 
for C20H33N204SNa 
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Trimethy Lacetyl L? enicillin. 
Infra-red. ( Nujol ) 
1778.8 cin-I(B-lactam), 1648.7cm-l(ainide), 1688.7an-l(carboxylate) 
IH Nmr. (D6 DMSO) 60 MHz 
6( 1.5, s, 3H, a- CH3) ( 1.6, s, 3H, B-CH3) ( 5.4, m, 2H, 6-CH-5-CH) ( 4.1, 
1H, 3-CH) ( 7.8, d, 1H, NH) ( 1.1, s, 9H, (CH3)3) 
Analysis: calculated C: 46.93; H: 6.89; N: 7.90 
found C: 46.99; H: 6.99; N: 6.02; 
for Cl 3H 1 9N204SNa. 1/2H20 
3-Meth vlbutvl penicillin. 
Infra-red. ( Nujol ) 
1775.5 cm- 1 (ß-lactam), 1652.0 cm- 1 (amide), 1688.7 cm- 1 (carboxylate) 
1H Nmr. (D6 DMSO) 60 MHz 
b( 1.5, s, 3H, (x - CH3) ( 1.6, s, 3H, ß-CH3) ( 5.5, m, 2H, 6-CH-5-CH) ( 4.15, 
IH, 3-CH) (0.95 - 2.1, m, 9H, (CH3)2CHCH2) (8.0, d, 1H, NH) 
CLglohexyl Mnicillin. Ltdeth vlamine salt) 
Infra-red. ( Nujol ) 
1775.5 cm- 1 (ß-lactam), 1652.0 cm- 1 (amide), 1688.7 cm- 1 (carboxylate), 3290.0 
an- I (an-Me NH) 
IH Nmr. (D6 DMSO) 270 MHz 
ö( 1.5, s, 3H, (x - CH3) ( 1.6, s, 3H, ß-CH3) ( 5.3, d, H, 6-CH-5-CH) ( 5.3, dd, Hg 
6-CH-5-CH) (4.05, s, 1H, 3-CH) ( 1.2 - 2.4, m, I IH, cyclohexane CH) ( 8.35, d, IH, 
NH) 
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2.2 Arepamlionofca&, henvlpenicillins. 
Me ýocl C meta, para derivatiVeS. (202) 
0H 
8-N 
M 02C >'1000 
0// --- -CO2 M 
M' = HN+(C2H5)3 , 
Na+ 
Sodium (Y, 4'-carboxjpheny])penicilhn 
6-Apa 2.16g (I Ommol) of and 2.3ml (I I mmol) of hexamethyldisilazan were 
heated under reflux in I 00ml of dichloromethane until completely dissolved, then cooled 
in ice and 1.4ml (I Ommol) of triethylamine added. In a separate flask 2.03g (I Ommol) of 
the (iso, tera) phthalic acid/ phthaloyl chloride was added with stirring to 15ml of dioxan 
and 50ml of acetone, cooling in ice water bath 1.4ml (I Ommol) of triethylarnine was 
added(this produces a viscous precipitated slurry) and the solution allowed to mix for 30 
minutes. To this alkylchlorofonnate (10mmol) was added dropwise (producing more 
precipitate and fumes). The temperature was maintained at 0-50C for I hr. (the solution 
becoming less viscous) The silylated 6-apa was added and the temperature allowed to 
gradually reach room temperature for 40 minutes. 
The work up procedure is as described earlier, with additional steps of removing 
solvent under vacuum and cooling to 0-50C before adding water, and filtering off the 
precipitated silylating group when the pH is adjusted to pH 2 with 2(M) HCI. The isolated 
sodium salt, by the treatment with sodium ethylhexanoate, were purified by preparative 
BPLC. 
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Sodium salt of(3-carboxyphenyl)penicillin. 
Infra-red. (Liquid film) 
1787.0 cm- 1 (ß-lactam), 1654.0 cm- 1 (amide), 1725.0 cm- 1 (alkyl carboxylate), 
1607.5 cm- 1( aryl carboxylate), 3300.0 cin- 1( amide NH) 
1H Nmr. (D6 DMSO) 270 MHz 
6( 1.5, s, 3H, a -CH3) ( 1.6, s, 3H, B-CH3) (5.5, m, 2H, 6-CH-5-CH) 
( 3.95, s, IH, 3-CH) ( 7.2 - 8.45, m, 4H, aromatic CH) ( 9.6, d, 1H, NH) 
Sodium salt of (4-carboxjphenyl)penicillin. 
Infra-red. ( Liquid film ) 
1784.0 cm- 1 (ß-lactam), 1650.0 cm- 1 (amide), 1725.0 cm- 1 (alkyl carboxylate), 
1608.5 cm- 1( aryl carboxylate), 3308.0 cm- 1( amide NH) 
1H Nmr. (D6 DMSO) 270 NIHz 
-%-. L 1) 6( 1.48, s, 3H, a- CH3) ( 1.56, s, 3H, B-CH3) ( 5.6, d, I H, 6-CH "-"TJI 
j) ( 4.2, s, IH, 3-CH) ( 7.95, m, 4H, aromatic CH) ( 9.4, d, 5.05, dd, I H, CH- 5-CH 
IH, NH) 
2.2.1 Method D. 2- carboAKwhenyl and gq6qnLcyclohgMI detivatives of niCillia (203) 
Following the method of Perron et a] (203) 
6-Apa 2.16g (10mmol) of and 4.2ml (3mmol) of triethylamine were stiffed in 
40ml of dimethylfon-namide (DMF) for I hr at 0-50C. A solution of 1.48g (10mmol) of 
phthalic (cislims cyclohexane dicarboxylic) anhydride in 30m] of DMF wss then added 
dropwise, keeping the temperature below I OOC, the mixture was then allowed to adjust to 
room temperature, and was stirred for 4hr. This produces a yellow solution, which was 
filtered and diluted with anhydrous ether, to give a viscous oil. Repeated decantation and 
further addition of dry ether followed by cooling, produces the crystalline triethylamine 
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product, which was slurried with acetone, filtered, washed with more ether and dried in 
vacua 
The sodium salt was prepared by dissolving the product in water, covering with 
ether, chilling and lowering to pH2 with 2M hydrochloric acid. The aqueous phase was 
repeatedly extracted with ether, the combined extracts were then treated with activated 
charcoal, chilled saturated saline solution and dried with magnesium sulphate. 
The final ethereal solution was treated with soduirn 2-ethyl hexanoate, precipitating 
the product, which was filtered, washed with acetone and dried in vacuo. 
Sodium salt ofT-carboxyphenylpenicillin. 
CO2M 
H 
M HN+(C2H5)3 
Infra-red. ( Nujol ) 
'1000 
C02 M 
1785.0 cm- 1 (ß-lactam), 1650.0 cm- 1 (amide), 1725.0 cm- 1 (carboxylate) 16 10.0 
cm-I(carboxylate) 3310. Ocm-I(amideNH) 
1H Nmr. (D6 DMSO) 270 Mllz 
b( 1.45, s, 3H, (x - CH3) ( 1.55, s, 3H, ß-CH3) ( 5.48, d, IH, CH- 5-QD 
( 5.5 1, dd, IH, 6-CH-CH) ( 4.1, s, 1H, 3-CH) ( 7.5, m, 3H, aromatic) ( 7.7, m, IH, 
aromatic) ( 10.0, d, 1H, NH) 
Analysis: calculated C: 56.77; H: 6.67; N: 9.03 
found C: 55.98; H: 6.84; N: 9.07; 
for C16Hl5N206S. HN+(C2H5)3 
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Cis-tn&hylammonium 6-(2-carboxycyclohexylpenicillin. 
0H 
S. 
Of M+ 
0 
_C02- M+ 
M+ HN+(C2H5)3 
Infra-red. ( Nuj ol ) 
1767.0 cm- 1 (ß-lactam), 1675.0 cm- 1 (amide), 1618.0 cm- 1 (carboxylate) 328 1.0 
an-l(amideNH) 
1H Nmr. (D6 DMSO) 270 NUlz 
6( 1.5, s, 3H, a- CH3) ( 1.6, s, 3H, B-CH3) ( 5.3, d, IH, CH- 5-CH) ( 5.4 19 
ddg IH, 6-CH-CH) ( 4.0, s, IH, 3-CH) ( 1.2 - 2.0, m, 1 OH, cyclohexane CH) ( 8.35, d, 
IH, NH) 
Analysis: calculated C: 56.05; H: 7.86; N: 8.91 
found C: 55.50; H: 7.75; N: 8.84; 
for C16H2lN206S. HN+(C2H5)3 
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Tians-t, tied7ylammonium 6-(2'-cw-boxycyclohe*)penicillin. 
02- M+ 
H 
C-N s 
0 
0// 
N 
M+ = HN+(C2H5)3 
C02-M+ 
Infra-red. ( Nuj ol ) 
1769.0 cm- 1 (ß-lactam), 1673.0 cm- 1 (amide), 1620.0 cm- 1 (carboxylate) 3284.0 
an-l(amideNH) 
1H Nmr. (D6 DMSO) 270 NIE[z 
Two compounds were identified in the nmr spectrum: (diastereoisomeis) 
(i) ö( 1.44, s, 3H, (x -CH3) ( 1.56, s, 3H, ß-CH3) (5.28, d, IH, CH-5-" 1: 121 
( 5.25, dd, IH, 6-CH-CH) ( 3.9 1, s, 1H, 3-CH) ( 1.2 - 2.37, m, IOH, cyclohexane CH) 
( 8.37, d, 1H, NH) 
(ii) 6( 1.46, s, 3H, cc - CH3) ( 1.59, s, 3H, B-CH3) ( 5.32, d, 1H, CH-5-_CB 
( 5.44, dd, IH, 6-CH-CH) ( 3.95, s, IH, 3-CH) (1.2 - 2.37, m, 1 OH, cyclohexane CH) 
( 8.6, d, 1 H, NH) 
Analysis (both compounds): calculated C: 56.05; H: 7.86; N: 8.91 
found C: 55.80; H: 7.80; N: 8.82; 
for C16H2lN206S. HN+(C2H5 3 
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2.3 Preparation ofthe sodium salt ofo, m, p nit"henvl penicillins. 
The following compounds were prepared using Method A described on p. 54. 
Infia-red. ( Nujol ) 
1774. Ocm-I(B-lactam), 1669. Ocm-l(amide), 1734. Ocm-l(carboxylate) 3372.0 
cm- I (amide NH) 
1H Nmr. (D6 DMSO) 270 MHz 
6( 1.5, s, 3H, (x-CH3)(1.6, s, 3H, B-CH3)(5.5, d, IH, CH- 5-CH)(5.6, dd, 
IH, 6-CH-CH, ) ( 4.25, s, 1H, 3-CH) ( 7.55, d, 7.6, t, 7.7, t, 8.1, d, 4H, aromatic H) 
( 9.7, d, I H, NH) 
Analysis: calculated C: 42.55; H: 4.26; N: 9.93 
found C: 4 3.4; H: 4.4 1; N: 9.9 8; 
for C15Hl4N306SNa. 2H20 
Sodium salt of3-nitrophenylpenicillin. 
Infra-red. ( Nujol ) 
1778. Ocm-I(B-lactam), 1665. Ocm-l(amide), 1730. Ocm-l(carboxylate) 3365.0 
an- I( amide NH ) 
1H Nmr. (D6 DMSO) 270 NI[iz 
b(1.5, s, 3H. (x -CH3)(1.6, s, 3H, ß-CH3)(5.6, d, IH, CH- 5-CH)(5.65, dd, 
1H, 6-CH-CH) (4.3, s, 1H, 3-CH) ( 7.8, t, 8.3, d, 8.4, d, 8.8, s, 4H, aromatic H) 
( 9.8, d, I H, NH) 
Analysis: calculated C: 42.55; H: 4.26; N: 9.93 
found C: 42.3; H: 4.30; N: 10.02; 
for C15Hl4N306SNa. 2H20 
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4-Nitrophenylpenicillin. 
Infra-red. (Nujol) 
1775. Ocm-I(B-lactam), 1670. Ocm-l(amide), 1735. Ocm-l(carboxylate) 3330.0 
an- I (amide NH) 
IH Nmr. (D6 DMSO) 270 Mliz 
6( 1.5, s, 3H, (x - CH3) ( 1.65, s, 3H, B-CH3) ( 5.6, m, IH, 6-CH- 5-CH j) 
(5.66, dd, 1H, 6-CH-CH)(4.3, s, 1H, 3-CH)(8. I, dd8.3, dd, 4H, aromatic H) 
( 9.7, d, I H, NH) 
Low resolution FAB scan. 
M+ Relative Intensity 
160 100 
289 15 
338 10 
366* 100 
399 24 
519 5 
731 10 
*Molecular ion (M-H+) 
Analysis: calculated C: 43.58; H: 5.08; N: 10.17 
found C: 44.10; H: 5.11; N: 10.02; 
for C15H15N306S. 3H20 
0 
66 
2.4 Aldehvdesvnthesis. 
2.4.1. 
-- 
Synthesis ofbenzv]Denilloaldeh (205) (2-N(phenyJaCetaMjdo)ethMaj) 
/' 
00H OCH3 
CH2-C7 CH -ý-ý-CH-C/ ""C, 
CC 
22 
OCH3 
KOH 
+ 0 Oc 
ether IMHCI 
H2N-CH2-C 
OCH3 
ir 
ý 'OCH3 
0H OH 
CH2-ý-NI -CH C/ DD-- Tý\ 
OH 
oluene, 
reflux 
0H0 
CH2-ý-ý-CHZ--Cýý I >- 
H 
Aminoacetaldehyde dimethylacetal (7.25g, 69mmol) was cooled in an ice-salt bath 
with stining(205). A solution of potassium hydroxide in water (9. Ig in 14m]) was 
introduced dropwise, after the addition of 2ml of the potassium hydroxide, phenylacetyl 
chloride (10. Ig, 66mmol) was then added dropwise at the same rate. This produced a 
precipitate which was dispersed by the addition of ether. The reaction is stirred for one 
hour at room temperature, the product was extracted with ether (0), washed with iced 
saline solution and dried over anhydrous magnesium sulphate. 
The phenylacetylaminoacetaldehyde dimethyl acetal (5g, 2mmol) was dissolved in 
20ml of ether. To this solution a mixture of saturated sodium chloride (5ml) and LOM 
hydrochloric acid (6ml) was added and the mixture stirred vigorously for four hours, at 
room temperature, then neutralised with sodium carbonate. The remaining ether was then 
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driven off by adding solid carbon dioxide, followed by cooling in an ice bath for four 
hours. This gave a precipitate which was collected by filtration, washed with water and 
dried in vacuo. This compound was converted to phenylactylaminoacetaldehyde by 
reflUXing with toluene until completely in solution, filtering and allowing to cool 
producing a crystalline product. The product was recrystallised from chloroform and 
ether (2 : 8). 
Infra-red. ( Nujol ) 
1748. Ocm-I(aldehyde), 1643. Ocm-I(amide), 3264. Ocm-I(amideNH) 
IH Nmr. (D6 DMSO) 270 NlHz 
6( 3.5, s, IH, PhCH2) ( 3.9, d, 2H, CH2) ( 7.3, m, 5H, aromatic H) ( 8.45, t, 
1H, NH) (9.4, s, 1H, CHO) 
13C Nmr. (D6 DMSO) 67 MHz 
b(PhCH2,41)(CH2,50) (aromatic H, 126,128,129,136)(CO, 171)( CHO, 
200) 
AN 114 - 115.5 OC (fit. value 113.5-115.5 
OQ205) 
Analysis: C: (67.69 %) N: (7.9 %) H: (6.30 %) 
CII HI 3NO3 requires C: ( 67.78 %)N: ( 7.9 %)H: ( 6.26 %) 
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2.4.2. Synthesis of2meth_vl-beizzvlpenilloaldehvde(2-(Phenvlacetamido)-N-PMPa-nal) 
(206,207) 
triethylamine, 
0 
H 71 
-ýH 
0 CH2-ý-N-CH-C\ _CH2- -N-CH-C 
CC 
- &3 0-H ýH3 0 
alWchloroformate 
CH3 
DW NaSH 
IF 
0H 
CH2-8-N-CHCH3 
Ph-N"'-kN-Ph 
Li 
Raney nickel, 00 
THF, 6H 
4 -CH2- -N-CH-C 
acetic acid, 
Q 
ýH3 S-H 
1,2 dianilinoethane 
-toluene sulphonic acid, dichloromethane, 
acetone, ether and water 
0H0 
: D>-CH2- N-CH-C\ 
H &3 
Based on the method of Gottstein et al(206,207) 
The amino acid, alanine (0. Imoles) was added to 250ml of LOM sodium 
hydroxide and stirred until fully dissolved. To this phenylacetyl chloride (I 5.46g, 
0.1 moles) was added, producing a suspension of the acid chloride, stirring was continued 
until completely in solution (= 60mins). Concentrated hydrochloric acid was then added 
dropwise, with stirring to produce the precipitated product, which was filtered and 
washed with water. The product was recrystallised from boiling water. 
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Infra-red. ( Nujol ) 
1712.0 cm- 1 (acid), 1647.0 cm- 1 (amide), 3262.0 cm- 1( amide NH ) 
1H Nmr. (D6 DMSO) 270 Nffilz 
6( 3.45, s, 2H, PhCH2) ( 1.3, d, 3H, CH3) ( 7.3, m, 5H, aromatic H) ( 8.4, d, 
IH, NH) (4.2, quintet, IH, CH) ( 12.5, s, IH, C02H) 
The acid product (10 mmol) was added to a 250ml round bottom flask to which 
1.5ml of triethylamine was added, the mixture was stirred and cooled to -50C -I OOC and 
I Ommol ( 1.1 g) of ethyl chloroformate added dropwise, and sti rred for 30m in. A solution 
of sodium sulphide 20mmol (1.9g) in dimethyl fon-namide DMF (50ml), dried over 
magnesium sulphate, was added at once and stirred for 60min. The solution was then 
poured into iced water and acidified to pH2 with dilute hydrochloric acid and extracted 
(0) with ethyl acetate, washed with iced saline solution and dried over magnesium 
sulphate. This produced after vacuum distillation an oily thiol residue, which, when 
treated with sodium ethyl hexanoate produced an amorphous sodium salt. The product 
was used without further purification. 
Raney active nickel (52g) was washed by decantation three times with I 00ml of 
absolute ethanol and then four times with I 00ml portions of tetrahydrofuran (THY). The 
washed catalyst was added to 200ml of TBF to which 1.5ml of glacial acetic acid and 
3.18g (I 5mmol ) of NN-diphenylethylenediamine (1,2 dianilinoethane) and 4ml of water 
were added. The temperature was lowered to 0--5 OC in an iced salt bath and I Ommol 
of the thioacid derivative, dissolved in 50ml of THF and 1.5ml of water was added at 
once. The mixture was stiffed for 40mins and the catalyst removed by decantation, 
washing the used catalyst (x2) with 30ml TBE The combined washings were then filtered 
to remove the last traces of catalyst, then dried with magnesium sulphate and the volume 
reduced by vacuum distillation. Addition of ether produced a precipitate which was 
isolated and refluxed in ether for 60mins until dissolved. 
Filtering and adding a small amount of ethyl acetate and leaving to stand for 12hr 
produced slight turbidity which is removed by filtration. The addition of more ether to the 
pale yellow filtrate produced a crystalline product, which was recrystallised from ethyl 
acetate and ether. 
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Infra-red. ( Nujol ) 
1648.0 cm-l(amide), 3300.0 cm- I (amide NH) 
1H Nmr. (CDC13) 270 MHz 
6( 3.5, s, 2H, PhCH2) ( 1.05, d, 3H, CH3) ( 6.75 - 7.4, m, 5H, aromatic H) 
4.6, quintet, IH, CH3CH )(5.35, d, I H, CH )(3.5 - 3.6, m, 2H, CH2 )(3.65 - 
3.7 5, m, 2H, CH2 ) 
The 1,2 dianilinoethane protected aldehyde (5mmol) was dissolved in 50ml of 
acetone and 50ml of dichloromethane and 150ml of ether. To this was added (10 mmol) of 
p-toluene sulfonic acid dissolved in 20ml of dichloromethane, 20ml of acetone, 50ml of 
ether and 0.5ml of water. This immediately produced a very heavy precipitate which was 
stiffed for 60mins, at room temperature. To this was added 400ml of ether and the 
precipitate removed by filtration, the filtrate was washed with iced saline solution (x2) and 
dried over magnesium sulphate. Reducing the volume by vacuum distillation and cooling 
in an ice bath produced the crystalline aldehyde product. 
Infra-red. ( Nujol ) 
1747. Ocm-I(aldehyde), 1643. Ocm-I(amide), 3266. Ocm-I(amideNH) 
IH Nmr. ( CDC13 ) 270 MHz 
ö( 3.6, s, 2H, PhCH2) ( 1.3, d, 3H, CH3) ( 7.4, m, 5H, aromatic H) ( 8.45, t) 
I H, aromatic H) ( 9.5, s, I H, CHO) ( 4.4, quintet, I H, CH 
13C Nmr. (D6 DMSO) 67 MHz 
b(PhCH2,43) (CH, 55) ( aromatic H, 127,129,130,135) ( CO, 17 1) ( CHO) 
199 ) (CH3,76.5,77,77.5 
M. Pt 152 - 154 OC 
Analysis: C: (63.79 %) N: (6.32 %) H: (6.69 %) 
CII HI 3NO3 requires C: 
( 63.76 %)N: ( 6.32 %)H: ( 6.76 %) 
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All attempts at using penicillin V and G as the starting material failed to give the 
desired penicillin C3 aldehyde, although the thioacid was easily made. 
2.5 C7 Aminoacetaldeh yde dimeth Ylacetal of C3-kLz I P! micillin meth Yl ester x 
0H 
DCH2ý-NI 
-s 
Nj 
0 ýCO2 CH3 
+ 
H2NCH2CH(OR)2 
0 
ether 
CH2ý 
10 
ethylacetate 
Methyl, Ethyl group 
H 
I 
-N 
ý's 
ýN, Cr 
NH 
0'( ýH2 02CH3 
OR OR 
C3-Benzyl penicillin methyl estel<211) 5g (I 5mmol), or benzy] penidllin 
(15mmol) was dissolved with stining in 100ml of ether, /ethyl acetate (40: 60), to this 
solution was added 30mmol of the arninoacetaldehyde dimethylacetal, this immeadiately 
produced a heavy precipitate. The solution was left to stir at room temperature for 72hrS. 
The final precipitate was filtered and dried in Vacuo. The product was recrystallised from 
acetone/ ether( 10 : 90). Attempts at deprotecting the aldehyde using acid hydrolysis were 
unsuccesful, resulting in decomposition of the penicillin compound. 
C7 Aminoacetaldehyde dimethylacetal of C3-ba2zylpenicillin methyl ester. 
Infra-red. ( Nujol ) 
1648.0 cm- 1 (amide), 1650.0 cm- 1 (amide), 3300.0 cm- 1( amide NH ), 3480.0 
an- I (wnide NH), 1750.0 cm- I (ester) 
IH Nmr. (D6 DMSO) 270 MHz 
6( 1-1, s, 3H, (x - CH3) ( 1.5, s, 3H, B-CH3) (3.5, s, 2H, PhCH2) ( 3.55, s, 3H, 3'- 
02CH3)(4.5, t, IH, 6-CH- 5-CH)(4.9. t, IH, 6--CH-CH)(4. I, dd, IH, 4NH)(3.4, 
d) 1H, 3-CH) ( 4.2, t, I H, T-CH) (4.1, dd. IH, T-CH2) ( 7.23, m, 5H, aromatic H) 
( 8.1, t, 1H, NH) ( 8.3, d, 1H, NH) ( 3.1, dd, IH, NH) ( 3.25, s, s, 6H, OCH3) 
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C7 Aminoacetaldehyde dimethylacetal of C3-benzylpenicillin. 
Infra-red. (Nujol) 
1648.0 cm- 1 (amide), 1650.0 cm- 1 (amide), 3300.0 cm- 1( amide NH ), 3480.0 
cm- 1( amide NH ), 173 1.0 cm -1 (acid) 
1H Nmr. (D6 DMSO) 270 MHz 
6( 1.15, s, 3H, a- CH3) ( 1.55, s, 3H, B-CH3) (3.3, s, 2H, PhCH2) ( 4.5, t, IH, 6-CH- 
5-fB(4.85, d, 1H, 6-CH-CH)(3.5, s, 1H, 3-CH)(3. I, m, IH, 4NH)(3.4, t, IH, 
T-CH) (4.3, m. 2H, T-CH2) ( 7.23., m, 5H, aromatic H) ( 8.1, t, I H, NH) ( 8.3, d) 
IH, NH) ( 3.1, dd, IH, NH) ( 3.25, s, s, 6H, OCH3) 
2.6 Pe -fonn LlLhenyl penicillin. (201) LMiation of4 
This compound was prepared using Method A p. 54. 
Infra-red. ( Nujol ) 
1776. Ocm-I(ß-lactam), 1652. Ocm-I(amide), 1699. Ocm-I(carboxylate) 3299.0 
an- 1( amide NH ), 17 10.0 cm- 1 (aldehyde) 
1H Nmr. (D6 DMSO) 270 MHz 
b( 1.5, s, 3H, (x -CH3)(1.6, s, 3H, ß-CH3)(5.4, d, IH, CH- 5-CH)(5.5, dd, 
IH, 6-CH-CH) (4.1, s, IH, 3-CH) ( 7.9 - 8.1, d, 4H, aromatic H) ( 9.5, d, IH, NH) 
( 10.1, s, 1H, CHO) 
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2.7 Hydroboration. 
2.7.1.7hexvlbromobofane-dimethvlsulLhide. (2,3dimethyl-2-butvl)bromoboiane- 
tý t-W 
diMethl! ]SUI, hide. (208) 
(77ixBhBr- 
Mono-bromoborane dimethyl sulphide (1.5mol) was injected into a nitrogen 
flushed 250ml three-necked round bottom flask containing 65ml of dichloromethane and 
15ml of dimethyl sulphide. The flask was immersed in a ice-salt bath to which 196ml 
(1.65mol) of 2,3 dimethyl-2-butene was added dropwise with stirring over 60min. The 
mixture was stirred for a further 120min at 0- -I OOG then 24hr at room temp. Ibe 
resulting solution was 3M in TlixBHBr-SMe2. 
2.7.2. Ca&pU ýIic acid reduction. 
Phenoxymethyl penicillin (1.75g (5mmol)) was placed in a nitrogen flushed 150ml 
round bottom flask to which 20ml of dichloromethane was added and 3.5ml of carbon 
disulfide. The flask was immersed in an ice-salt bath and the temperature maintained at - 15 
-- 200C. To this was added 2ml ( 6.4 mmol) of ThxBHBr-SMe2 dropwise with stirring. 
After the complete evolution of hydrogen the reaction was stirred for further 20min and 
gradually allowed to reach room temperature, and a further 2ml of the reagent was added 
and the reaction stirred for 60mins. The mixture was then poured onto I 00ml of ice cold 
water and stirred vigorously for 15min, then saturated with sodium chloride and extracted 
(x2) with 50ml of dichloromethane and dried over magnesium sulphate. Reducing the 
volume by vacuum distillation gives an oily product which was refluxed for 60min in 
toluene, cooling should give the aldehyde as an amorphous solid. This was not achieved. 
Attempts at using NaHS03 isolation procedure also failed to give the aldebyde. 
2.7.3 Lithium 9-boiatabicvcliclo(3.3.1)nonane. (Li9-BBAH)(209) 
In a three-necked flask fitted with a septum cap and reflux condenser, 40ml of 
THY was added and 4.88g (0.4mol) of 9-borobicyclononane (9-BBN) and 4.77g 
(0.6mol) of lithium hydride. The system was then flushed with nitrogen and refluxed with 
stirring for 24hr, folowed by cooling and stirring for another 24hr at room temperature. 
The reaction mixture was then filtered to remove unreacted LiH, to give a clear filtrate 
which was stored under nitrogen. 
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2.7.4. CaltgnLlic acid reduction. 
To a three-necked round bottom flask, flushed with nitrogen, was added 0.65g 
(5mmol) of 9-BBN and 20ml of THE To this 1.89g (5mmol) of benzyl penicillin in 30ml 
of TBF was added dropwise with stirring at 0- -50C over Mrs, stirring continued until the 
evolution of hydrogen has ceased. To the reaction was added 5.5mmol of Li9-BBNH, 
dropwise with stining, the mixture was then wan-ned to room temperature and stirred for 
lhr. 
The isolation procedure was as described in experiment 1.1, but was 
unsuccessful. 
2.8 C- 7Methvl ester ofbenz I enicilloicacid , I, p 
0H 
C02H 
0H 
Triethylamine 
0 CH2ý-NI 
Medmwl 0= HNJ `li 
C 
ýH Z: 
-'02H 
Benzyl penicillin (5g, 14mmol) is dissolved in 100m] of methanol and 4ml of 
triethylamine and the mixture stirred under nitrogen for 72hrs. The solvent is then 
removed by vacuum distillation and the residue dried in vacuo. The product is 
recrystallised from ether and methanol ( 95: 5). 
Infra-red. ( Nujol ) 
1750.0 cm- 1 (ester), 1650.0 cm- 1 (amide), 1620.0 cm- 1 (carboxylate) 3380.0 cm- 
(amide NH) 
IH Nmr. (D6 DMSO) 270 NfHz 
6( 1.15, s, 3H, cc - CH3) ( 1.3, s, 3H, B- CH3) ( 4.9, d, I H, CH- 5 -CW ( 4.3 
1H, 6-CH-CH) ( 3.3, s, 1H, 3-CH) ( 7.3, m, 5H, aromatic H 3.5, s, 2H, PhCH2 
( 8.5, d, I H, NH) ( 3.6, s, 3H, OCH3 ) 
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2.9 C- 7Meth_vIN4 fonnvl-D-boUjl Lenicilloic aCi&210) 
0H 
CH2ý-Nl 
s 
0 HN 
-'02H ýH3 '7 
0H 
85% forrnic acid 
Q 
CH28-NI s 
'1000 Acetic anhydride N 
, h, - - 
ýI 
=o - H3 ý C02H 
ne C-7 methyl ester of benzy1penicilloic acid (3g (8nunol)) was dissolved in 5ml 
of 85% fon-nic acid and 2ml of acetic anhydride and stirred ovemight at room temperature. 
The volume was then reduced by vacuum distillation and triturated with ether. The 
product was recrystallised from methanol and ether (10 : 90). 
Infra-red. ( Nuj ol ) 
1741. Ocm-I(ester), 1651. Ocm-I(amide), 3257.0,3281.0 cm-I(amideNH) 
1648. Ocm- l(fonnamide) 
IH Nmr. (D6 DMSO) 270 MHz 
b( 1.3, s, 3H, (x - CH3) ( 1.5, s, 3H, ß-CH3) ( 5.6, d, IH, 6-CH- CH) ( 4.8, dg 
1H, CH- 5-CH) ( 3.9, s, IH, 3-CH) ( 7.3, m, 5H, aromatic H) 8.5, d, 1H, NH) 
( 8.7 , s, I H, COH 
)(3.5 5, s, 2H, PhCH2) ( 3.5 6, s, 3 H, CH 3 
2.10 C3-Meth v] ester of benzvl penkillin (211) 
0H0H 
D)CH2 s Diazomethane 
: D)CH2ý-Nl 
s 
'100 0. '1000 NN Ether - 
00 
C02H ý'02 CH3 
Following the method of Gensmantel. (21 1) 
Benzyl penicillin was dissolved with stirring in I 00ml of ether, to give a clear 
solution. To this was added diazomethane(212) dropwise with stining, until the appearance 
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of a faint pale yellow colour, indicating an excess of diazomethane. Reducing the volume 
by vacuum distilation gives a white crystalline product, which was recrystallised from 
carbon tetrachloride. 
Infra-red. ( Nujol ) 
1781. Ocm-I(ß-lactam), 1675.0 cm-I(amide), 1530.0 cm-I(ester), 3282.0 crn-1 
(amide NH) 
IH Nmr. (D6 DMSO) 270 MHz 
b( 1.46, s, 3H, (x -CH3) ( 1.65, s, 3H, ß-CH3) (5.5, m, 2H, 6-CH- 5-CH) 
( 4.4, s, IH, 3-CH) ( 7.4, m, 5H, aromatic H 3.5, s, 2H, PhCH2 8.9, d, IH, 
NH) ( 3.8, s, 3H, OCH3 ) 
Analysis: calculated C: 58.6; H: 5.75; N: 8.0 
found C: 58.11; H: 5.80; N: 7.90; for C17H20N204S 
M. Pt. 89-9 1 OC Lit. 88-89 OC(21 1) 
2.11 C7 Meth vl/pMp vllbenzvl am ides arkgzy] pen icillin. 
0H 
ýDCH28-ý 
C02H 
0H 
Alkyl arnine 
: D)CH2ý-Nl 
s 
'1000 
ether 
0 
H 
to2-M+ 
R= CH3, (CH2)2CH3, CH2 Ph M' = Methyl, Propyl, Benzyl amine salts 
Benzyl penicillin 5g (I 5mmol) was dissolved with stirring in I 00ml of ether**, to 
this clear solution was added 30mmol of the amide ( propyl, benzy] ), this immediately 
produced a heavy precipitate ( the amine salt of benzyl penicillin). The solution was left to 
stir at room temperature for 72hrs. The final precipitate was filtered and dried in vacuo. 
Ibe product was recrystallised from acetone / ether ( 10 : 90). 
**(It is posssible to avoid precipitate fon-nation by using acetone/ dioxan(40: 60) 
as the solvent instead of ether. ) 
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C7-Propyl amide. 
Infra-red. ( Nujol ) 
1678. Ocm-I(amide), 1654. Ocm-I(arnide), 3310.0 cm-1 (amideNH), 3484.0 
cm- 1 (amide NH), 1735 cm- 1 (acid) 
1H Nmr. (Acetone) 270 MHz 
6( 1.15, s, 3H, cc - CH3) ( 1.5, s, 3H, B-CH3) ( 4.85, d, I H, CH- 5-CH) ( 4.2) 
dd, IH, 6-CH- CH j) ( 3.3, s, I H, 3-CH) (7.3, m, 5H, aromatic H) ( 3.55, s, 2H, 
PhCH2 ) (8.0, t, 1 H, NH) ( 8.3, d, 1 H, NH) 
C7-BepZ)jl amide. 
Infra-red. ( Nuj ol ) 
1655.0 cm- 1 (amide), 1638.0 cm- 1 (amide), 3315.0 cm- 1( amide NH ), 3480.0 
cm- I( wnide NH ), 17 10 an- I (acid) 
1H Nmr. (Acetone) 270 MHz 
6( 1.2, s, 3H, a-CH3) (1.55, s, 3H, B-CH3) (4.9, d, 1H, CH- 5-CH) (4.35) 
dd, IH, 6-CH- CHJ ( 3.5, s, IH, 3-CH) ( 7.4, m, I OH, aromatic H)(4.0, s, 2H, 
PhCH2 )(8.4, d, 1H, NH) ( 8.6, tý IH, NH) ( 4.0, s, 2H, PhCH2') 
ULý_ -Methv 
2.12 3-H, ddrq, ýMethvl-6,6-phenQx I penicillin. (213) 
Following the method of Balsarno et al (213) 
6B-Phenoxymethyl penicillin 5. Og (14.3mmol) was stirred in anhydrous THY 
(40ml) and cooled to - 10 OC. To this triethylamine 1.45g (I 4.3mmol) was added 
dropwise with stirring, this was followed by a solution of alkyl chlorofonnate ( 1.55g, 
14.3mmol) in 15ml of anhydrous TBE After stirring for 2hours at - 10 OC, sodium 
borohydride (NaBH4) 1.08g ( 28.6mmol) was added in small quantities over 10 minutes. 
The reaction mixture was then brought gradually to room temperature and reacted for 30 
minutes. At the end of this time water I 00ml was added and the alcohol extracted three 
times (3x 50ml) with dichloromethane, the combined extracts were washed with iced 
saline solution, filtered and dried over magnesium sulphate. Reducing the volume under 
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vacuum and treating with acetone/bexane produced the crystalline product. The isolated 
product was purified by dissolving it in a small quantity of dichloromethane, which was 
chromatographed through a silica gel column, eluting ffist with dichloromethane and then 
ethyl acetate. 
3-Hydioxymethyl-6B-phenoxymethylpenicillin. 
Infra-red. ( Nujol ) 
1779.0 cm- 1 (ß-lactam), 1686.6 cm- 1 (amide), 3370.5 cm- 1( amide NH ) 
IH Nmr. (D6 DMSO) 270 MHz 
b( 1.50, s, 6H, (x -CH3, ß-CH3)(5.3, d, IH, 6-CH- 5-CH)(5.4, dd, IH, L- 
CH- 5-CH) ( 3.75, t, IH, 3-CH, J 7.18 Hz) ( 6.9, q, 3H, 7.3, t, 2H, aromatic H) 
( 4.6, s, 2H, PhOCH2 )(8.55, d, 1H, NH, J 7.7 Hz) ( 4.9, t, I H) OH, J 5.42 Hz ) 
(3.5, m, 2H, 3-CH2) 
IH Nmr. (D20) 270 MHz 
6( 1.50, s, 6H, oc - CH3 , 
B-CH3) ( 5.4, d, 1H, 6-CH- 5-CH ( 5.45, d, IH, 6-C - 5- 
CH) ( 3.75, t, IH, 3-CH, J 5.56 Hz) ( 7.0, q, 3H, 7.3, t, 2H, aromatic H 4.65, s, 
2H, PhOCH2) (3.45 - 3.55, m, 2H, 3'-CH2) 
Analysis: calculated C: 57.14; H: 5.95; N: 8.33 
found C: 57.20; H: 5.92; N: 8.40; C16H20N204S 
M. Pt. 129-13 IOC Lit. 128-130 OC(213) 
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2.13 Attempted oxidation of 3: H enicillin b ydroxvmeth YI-613-P-henQ=eth VI p 
tetgp pylammonium j2gn-uthenate (TpAP). (214) 
OCH2C0NH 
Ns 
/ Nj `li 
0Z "/CH20H 
OCH2C0NH 
TPAP s 
N2 
, dichloromethane /PN 
11 
3-Hydroxymethyl-6B-phenoxymethyI penicillin. 
TPAP: CH CH CH 
+1223 
CH3CH2CH2 -N-CH2CH2CH3 
RU04 
&2CH2CH3 
Following the method of Griffith et A (214) 
-C-H 
6 
Phenoxymethyl peniciffin aldehyde. 
3-Hydroxymethyl-6B-phenoxymethyI penicillin 2g ( 6mmol) and N- 
methy1morpholine N-oxide 1.05g ( 9mmol) and powdered 4A molecular sieve 500mg were 
stiffed in dichloromethane (50ml). The temperature was lowered to -I OOC and solid TPAP 
0.1 g(0.3mmol, 5mol%) was added in one portion, the reaction, under nitrogen was then 
adjusted gradually to room temperature and allowed to react for I hour. The reaction 
mixture was then filtered through a pad of silica and washed with dichloromethane and 
ethyl acetate, the solvent evaporated and the residue chromatographed through a silica gel 
column. 
Using these conditions 40% of the starting material was recovered. No product 
was isolated. 
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Cohalospgiin Synthesis. 
2.14 Methodf. 
7 -Aca (I Ommol (2.7 2g)) and 2.3m] of (I I mmol) of hexamethyldisflazan were 
heated under reflux in dichlromethane until completely dissolved, cooling in ice water 
1.4m. 1 (I Ornmol) of triethylamine was added, followed by portions of the phenylacetyl or 
cyclohexane carbonyl chloride (I Ommol) - The mixture temperature was gradually adjusted 
to room temperature and allowed to react for I hour. 
Iffie work up procedure is as described for the penicillin derivatives, extracting 
with ethyl acetate, filtering off the precipitated silylating group when the pH was lowered 
to pH 2 with 2(M) HCI. The cephalosporanic acid was converted to the sodium salt by the 
addition of sodium-2-ethyl hexanoate. The product filtered, washed with ethyl acetate and 
recrystallised from boiling acetone and water (95: 5 ). 
Sodium 7-benzy1cephalospodn. 
Infra-red. ( Nujol ) 
1775 cm- l(ß-lactam), 1649 cm- 1 (amide), 16 10 cm- l(carboxylate), 1738 cm -1 
(ester), 1615 cm- I( carboxylate), 3300 cm- I( amide NH) 
1H Nrnr. (D6 DMSO) 270 NEFIz 
6( 2.1, s, 3H, 3'-CH3) ( 3.20, d, 3.47) d, 2H, 2-CH2) ( 4.6, d, 4.86, d, 2H, Y- 
CH2) ( 4.95, d, IH, 6-CH) ( 5.50, dd, IH, 7-CH) ( 7.4, m, 5H, aromatic H) ( 3.6 , s, 
2H, PhCH2 )(9.25, d, 1H, NH) 
Analysis: calculated C: 55.4; H: 4.65; N: 7.20 
found C: 55.9; H: 4.75; N: 7.5; Cljil8N206S. Na 
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Sodium 7-cyclohexyl cephalospoiin. 
Infra-red. ( Nuj ol ) 
1750 cm- l(ß-lactam), 1649 cm- l(amide), 1620 cm- l(carboxylate), 1735 cm- 
(ester), 1615 cm- I( carboxylate), 3295 crn- I( arnide NH) 
IH Nmr. (D6 DMSO) 270 MHz 
ö( 2.0, s, 3H, Y- CH3) ( 3.2, d, 3.5 5, d, 2H, 2- CH2) ( 4.2, d, 4.9 5, d, 2H, 
3'-CH2) ( 4.90, d, I H, 6-CH) ( 5.45, dd, I H, 7 -CH) ( 1.2-2.4, m, IIH, cyclohexane 
H) ( 8.6, d, I H, NH) 
2.15 Method F 7he pMMration of the meta, pgra cai-Loxy-phen v] gWha (202) L 
So&um saN of 7- (3,4- cw-boxyphenyl cephalospoianic acid). 
0H 
+s M 02C 
N 
"m 0 OM 
0112 
_ýCH2OCOCH3 02M 
M+ = HN+(C2H5)3, Na 
7-Amino cepbalosporanic acid (7-aca) (2.72g (10mmol)) and 2.3n-fl (I Immol) of 
hexamethyldisilazan were heated under reflux in dichloromethane until completely 
dissolved, then cooled in an ice bath and 1.4m] (10nunol) of triethylamine added. (202) 
In a separate flask 2.03g (I Ommol) of the (iso, tera) phthalic acid was added with 
stirring to 15ml of dioxan, 50ml of acetone and IAMI 0 Ommol) of triethylamine in an ice 
bath (this produced a viscous precipitated slurrY). To this 10mmol of a]Wchlorofon-nate 
was added dropwise (producing more precipitate and fumes). Tlie temperature was 
maintained at 0-50C for lhr. (the solution became less viscous). The silylated 7-aca, was 
added in one step and the temperature allowed to gradually reach room temperature, for 40 
minutes. The work up procedure was as described for the penicillin derivatives, extracting 
82 
with ethyl acetate instead of ether, filtering off the precipitated silylating group when the 
pH was lowered to pH 2 with 2(M) HCl. 
Altematively, in a separate vessel 7-aca 2.72g (I Ommol) was mixed with 1.4m] of 
triethylamine in 40ml of water, cooling the final solution to 0-50C. After 20 minutes this 
produced a clear pale solution. This solution was then added to the mixed anhydride 
solution. After I hour the reaction was quenched and the product isolated using the 
conditions described above. The product was recrystallised from boiling acetone and 
water. 
Under these conditions the bifunctional ised phthaloyl B-lactam compound (see 
below) was produced as an impurity, identified by the retention times when purifying by 
IIPLC and the 1H Nmr proton integral ratios. For the para derivative the conditions were 
established which produced this compound in preference to the mono derivatised 
compound. 
Sodium 7-(Y-carboxjpheny] cephalospoianic acid). 
Infra-red. ( Nujol ) 
17 75 cm- 1 (ß-lactam), 1654 cm- 1 (amide), 1728 cm- 1 (ester), 1608 cm- 
(arylcarboxylate), 1694cm-I(alkylcarboxylate), 3284 cm-I(anüdeNH) 
1H Nmr. (D20) 270 NEFIz 
6( 2.1, s, 3H, CH3) ( 3.4, d, 3.65, d, 2H, 2-SCH2) ( 4.2, d, 4.95, d, 2H, 
3-CH2) ( 5.25, d, I H, 6-CH) ( 5.9, d, IH, 7-CH) ( 7.6, t, 7.95, d, 8.1, d, 8.3, s, 4H, 
aromatc 
Analysis: calculated C: 48.8; H: 3.66; N: 8.54 
found C: 49.3; H: 4.00; N: 8.20; C18H, 4N208S 
Sodium 7-(4-carboxyphenylcephalospomnic acid). 
Infra-red. ( Nujol ) 
17 75 cm- 1 (ß-lactam), 1655 cm- 1 (amide), 1726 cm- 1 (ester), 16 10 cm- 
aryl carboxylate), 1694 cm- 1( alkyl carboxylate), 3290 cm- 1( an-dde NH) 
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1H Nmr. ( D20 ) 270 M[lz 
6( 2.1, s, 3H, CH3) ( 3.45, d, 3.7, d, 2H, 2-SCH2) ( 4.7, d, 5.0, d, 2H, 3-CH2) ( 5.05, dp 
IH, 6-CH) ( 5.80, d, 1H, 7-CH) ( 5.95, d, 2H, 7.9, d, 2H, 8.0, d, 4H, aromatic H) 
Analysis: calculated C: 48.8; H: 3.66; N: 8.54 
found C: 48.99; H: 4.15; N: 8.43; C18H, 4N208S 
2.16 Sodium 7-0', 4-pheny1dicevhalospofin 
7-An-finocephalosporanic acid (7-aca) (5.44g (20rnmol)) and 4.6n-fl (22 mmol) of 
hexamethyldisilazan were heated under reflux in dichloromethane until completely 
dissolved, then cooled in an ice bath and 2.8ml (20mmol) of triethylarnine added. 
In a separate flask tera phthaloyl chloride I Ommol was mixed with 20m] of 
dichloromethane and cooled in ice, to this was added the silyted 7-ACA with stirring. 
After 4 hours the reaction was quenched and the product dimeric compound isolated using 
the conditions described above. The sodium salt was prepared by the treatment with 
sodium ethyl hexanoate. The sodium salt product was recrystallised from boiling acetone 
and water (95: 5 ). 
Infra-red. (Nujol) 
1775 cm- 1 (ß-lactam), 1655 cm- 1 (ainide), 1726 cm7 1 (ester), 161 cm- 
aryl carboxylate), 1694 cm- l( alkyl carboxylate), 3290 cm- l( amide NH) 
1H Nmr. (D6 DMSO) 270 MHz 
6( 2.1, s, 3H, CH3) ( 3.20, d, 3.45, d, 2H, 2-SCH2) ( 4.7, d, 5.0) d, 2H, 3-CH2) ( 5.05, 
dy 1H, 6-CH) ( 5.70, dd, IH, 7-CH) (8.05, s, 4H, aromatic H) (8.5, d, IH, NH) 
1H Nmr. (D20) 270 Mliz 
6( 2.1, s, 3H, CH3) ( 3.20, d, 3.45, d, 2H, 2-SCH2) ( 4.7, d, 5.0, d, 2H, 3-CH2) 
( 5.05, d, 1H, 6-CH) ( 5.70, d, 1H, 7-CH) (8.05, s, 4H, aromatic H) 
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2.17 Method G. Oilho carboxv phen vl cephalos atiVeS. (203) 12Qiin deriv, 
7-Aca (2.72g (10mmol)) and 4.2ml (3mmol) of tfiethylamine are sfirred in 40ml of 
dimethy1formamide (DMF) for lhr at 0-500203) A solution of 1.48g (I Ommol) of 
Phthalic (cisItians cyclohexane dicarboxcylic) anhydride in 30ml of DMF is then added 
dropwise, keeping the temperature below I OOC, the temperature is then adjusted to room 
temperature and the solution stiffed for 4hr. This produces a yellow solution, which is 
filtered and diluted with anhydrous ether/ ethyl acetate ( 70: 30 ), producing an oil. 
Repeated decantation and addition of fresh dry ether followed by cooling, produces with 
scratching the crystalline triethylamine salt, which is slurried with acetone, filtered, 
washed with more ether/ ethyl acetate ( 80: 20 ) and dried in vacua 
The disodium salt is prepared by dissolving the product in water, covering with 
ether/ ethyl acetate ( 30: 70 ), chilling and lowering to pH2 with 2M hydrochloric 
acid. The aqueous phase is repeatedly extracted with ether/ ethyl acetate, the combined 
extracts were then washed with chilled saturated saline solution and dried with 
magnesium sulphate. The final ethereal solution is treated with soduirn 2-ethyl hexanoate, 
precipitating the product, which is filtered, washed with ether and dried in vacua 
Triethylarnmonium salt of 7-(2'-carboxjphenyl)cephalospomnic acid. 
0H 
Q0 ý-ý 
\ 
C 
--M+ s 
02 ENT 
0 
4ý -nCH20COCH3 
+ 02 M 
Infra-red. ( Nujol ) 
1776 cm-I(B-lactam), 1655 cm-l(amide), 1725 cm-l(ester), 1608 cm-1 
( aryl carboxylate), 1696 cm- l( alkyl carboxylate), 3282 cm- l( an-dde NH) 
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1H Nmr. (D6 DMSO) 270 MHz 
6( 2.0, s, 3H, 3'-CH3) ( 3.25, d, 3.5, d, 2H, 2-SCH2) ( 4.7 5, d, 4.9, d, 2H, 3'- 
CH2 )(5.0, d, IH, 6-CH) ( 5.85, d, 1H, 7-CH) ( 5.7, dd, 2H, 7.3- 7.4, m, H, 7.55, 
d, 4H, aromatic H) ( 7.8, d, IH, NE) 
Analysis: calculated C: 48.8; H: 3.66; N: 8.54 
found C: 48.65; H: 3.26; N: 8.60; for CjgH14N208S 
Cis-ttiethylammonium salt of 7-(2-carboxycyclohexamido)cephalospotanic acid). 
0H 
'1000 
ý-N 
s 
2ýýýCoi 
M+ 
0,5ýý-Ný,, ýýýCH2 (x -, ()CH3 
C02- M+ 
Infra-red. ( Nujol ) 
1774 cm- l(ß-lactam), 1671 cm- l(amide), 1602 cm- l(carboxylate) 3179 cm-1 
(amideNH) 
1H Nmr. (D6 DMSO) 270 MHz 
6(2.05, s, 3H, 3'-CH3) ( 3.3, d, 3.5, d, 2H, 2-SCH2) (4.75, d, 4.9, d, 2H, 3'- 
CH2) (5.0, d, IH, 6-CH) (5.5, dd, 1H, 7-CH) (8.6, d, 1H, NH) ( 1.5 - 2.5, m, IOH, 
cyclohexane CH) 
Analysis: calculated C: 54.75; H: 6.84; N: 7.98 
found C: 54.11; H: 6.50; N: 8.0 1; for C 18IJ20N208S 
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Trcuis-triethylammonium salt of 7-(2'-caiboxycyclohexajnido ceWaspom&c acid. 
0H 
ý-N 
s 
N >", ýCH20CoCH3 
0/ Coi M+ 
2- M+ 
Infra-red. ( Nujol ) 
1775 cm-I(B-lactam), 1672 cm-l(arrfide), 1605 an-l(carboxylate) 3180 an-I 
(amide NH) 
IH Nmr. (D6 DMSO) 270 MHz 
Two compounds were identified from the nmr spectrum: (diastereoisomers) 
(i)6(2.0, s, 3H, 3'-CH3)(3.25, d, IH, 2-SCH)(3.43, d, IH, 2-SCH)(4.69, 
d, IH, 3'-CH2) (4.89, d, IH, 3'-CH2) (4.94, d, 1H, 6-CH) (5.42, dd, IH, 7-CH) 
( 8.6, d, IH, NH) ( 1.5 - 2.5, m, IOH, cyclohexane CH) 
(ii) 6( 2.0, s, Y-3H, CH3) ( 3.25, d, 3.45, d, 2H, 2-SCH2) ( 4.69, d, 4.89, d) 
2H, 3'-CH2) (4.95, d, 1H, 6-CH) (5.54, dd, IH, 7-CH) (8.73, d, IH, NH) ( 1.5 - 
2.5, m, 1 OH, cyclohexane CH) 
Analysis (both compounds): calculated C: 54.75; H: 6.84; N: 7.98 
found C: 54.30; H: 6.95; N: 8.20; C18H20N208S 
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2.18 3-Hvdroxvmetbvl- 7-phenvlacetamLdýýVh-3-em-4-oic acid JaCtoneý215) 
0H 
ý- I 
CH2 Ns 
, 
// 
0 
0H 
HCI 
CH 2ý-N 
Acetone, water 
ýD 
2()COCH3 0 
Following the method of Cocker et a] (215) 
7-Phenylacetamidocepbalosporanic acid 5g (18mmol) in acetone and water 
(100ml) was treated with 15ml of concentrated bydrochlodc acid, adding dropwise under 
nitrogen and stirring at room temperature for 16hrs. This produced a precipitate which 
was removed by filtration, the filtrate was then extracted with dichloromethane (x2) and 
dried with magnesium sulphate. Reducing the volume by vacuum distillation produced 
further precipitate which was removed by filtration. 'Ile combined solids were 
recrystallised from ethanol. 
Infra-red. ( Nujol ) 
1760 cm- l(ß-lactam), 1665 cm- l(amide), 1780- 1795 cm- l(lactone), 3300 an- 1 
(amideNH) 
IH Nmr. (D6 DMSO) 270 Nf[iz 
6( 5.58, quartet, 2H, 2'-CH2) (4.95, s, 2H, 3'-CH2) ( 5.1, s, IH, 6-CH) ( 5.9, 
dd, IH, 7-CH)(7.3, m, 5H, aromatic H) (3.7, s, 2H, PhCH2)(9.25, d, IH, NH) 
Analysis: calculated C: 58.18; H: 4.24; N: 8.48 
found C: 58.40; H: 3.98; N: 8.55; C16H, 4N204S 
M. pt. 209-211 OC (Lit. 2 10 OQ215) 
polinS. (202) 2.19 PreDaiationofo, m, pnit[QphenylggphaloS 
These compounds were prepared using Method E. 
S 
2 
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Sodium 7- (T-nitrophenyl cephalospotin). 
Infra-red. (Nujol) 
1765 cm- 1 (ß-lactam), 1654 cm- 1 (amide), 1750 cm- 1 (ester), 1618 cm- 
( carboxylate), 3284 an- I( wnide NH) 
1H Nmr. (D6 DMSO) 270 MIU 
8( 2.1, s, 3H, CH3) ( 3.4, d, 3.45, d, 2H, 2-SCH2) ( 4.2, d, 5.05, d, 2H, 
3-CH2 )(5.15, d, IH, 6-CH) ( 5.8, dd, 1H, 7-CH) ( 7.8, t, 8.5, d, 8.85, s, 4H, 
aromatic H)(9.8, d, I H, NH ) 
Sodium 7- (Y-nitrophenyl cephalospodn). 
Infra-red. ( Nujol ) 
1760 cm- 1 (ß-lactam), 1645 cm- 1 (amide), 1752 cm- 1 (ester), 1620 cm-1 
( carboxylate), 3290 cm- 1( amide NH) 
1H Nmr. (D6 DMSO) 270 MHz 
6( 2.0, s, 3H, CH3) ( 3.4, d, 3.4, d, 2H, 2-SCH2) ( 4.0, d, 4.95, d, 2H, 
3'-CH2) ( 5.15, d, IH, 6-CH) ( 5.75, dd, IH, 7-CH) ( 7.45-8.17, m, 4H, aromatic H) 
( 9.6, d, I H, NH) 
Sodium 7- (4-nitrophenyl cephalospoiin). 
Infra-red. ( Nujol ) 
1763 cm- 1 (ß-lactam), 1650 cm- 1 (amide), 1740 cm- 1 (ester), 1615 cm- 
( carboxylate), 3290 an- 1( amide NH) 
IH Nmr. (D6 DMSO) 270 MHz 
8( 2.2, s, 3H, CH3) ( 3.4, d, 3.5, d, 2H, 2-SCH2) ( 4.0, d, 4.97, d, 2H, 
3'-CH2) ( 5.0, d, 1H, 6-CH) ( 5.75, dd, 1H, 7-CH) ( 8.1-8.5, d, 4H, aromatic H) 
( 10.0, d, 1H, NH) 
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Kinetic eMgiimental. 
Reagents. 
BenzylpeniciRin sodium salt was a gift from Beecbam Pharmaceuticals and 
phenoxymethyl penicillin was obtained from Lancaster Synthesis. 6-APA and 7-ACA 
were gifts from Glaxo. All other penicillins and cephalosporins were made in the 
laboratory. 
B. cereusf3-lactamase I (MW. 28,000) and B. cereusB-lactamase 2 were supplied 
from two sources. Initially the source of supply was Sigma Chemicals, but this was later 
to changed to Ponon Down. 
The enzyme catalysed reactions were run at 30OC in the following buffers. 
OAM Glycine/bydrochloric acid (pH 3-3.5), OAM sodium acetate/acetic acid (pH4 - 
5.5), OAM sodium dibydrogen phosphate/ disodiurn hydrogen pbospbate(pH 6- 8), 
OAM glycine/ sodium hydroxide (pH 9-9.5), OAM sodium carbonate/ sodium 
bicarbonate ( pH 9- 10). 
Ibe reagents used were Analar Grade unless otherwise stated. 
Ibe base hydrolysis and enzyme hydrolysis reactions were followed by U. V. 
spectrophotometery at the following wavelengths, 225 - 235 nm for reactions involving 
penicillin derivatives and 260 - 265 nm for the cephalosporin derivatives. These 
wavelengths correspond to X max values for the extinction coefficient (F, ), as derived 
from Beees law. 
The infra-red spectra were run on a Perkin Elmer series 1600 FIF-IR 
spectrophotometer. 
ne nuclear magnectic resonance spectra were run on a Bruker 270 MHz FT- 
spectrophotometer. 
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220 Igipment. 
The Mowing arrangement of equipment was used to generate the kinetic data for the base 
hydrolysis reactions and the enzyme/ substrate pH rate profiles. 
Epson IX-850 
Printer. 
BBCMaste-sefies 
Microvitec Cub 653. 
The assays were canied out on a Gilford 2600 single beam spectrophotmeter, 
which has a four cell compartment with an automatic cell change facility. The temperature 
was maintained at 30OCby circulating water from a Grant water bath around the cell 
compartment. The spectra were plotted on a Hewlett-Packard 7225B plotter. Using this 
arrangement any given portion of the plot obtained can be expanded full scale to A4 size. 
At the start of a run, 2x 2mls of the buffer solution were placed into quartz cells in 
the spectrophotometer and allowed to reach equilibrium. Then 2x 1-40 p] of the reagent 
(substrate) (I X 10 -20 M) was injected into the cells, giving a cell concentration of (I x 
10 -4/-5 M ), and the absorbance checked for a steady reading on the digital display, then 
I- 10 pI of the enzyme solution (IX 10 -4/-5 M) was injected into one of the cells, giving a 
cell concentration of (Ix 10 -7/-9 M) and the reaction followed as a function of time. The 
remaining cell was used as the reference cell and allowed for analysis of the buffer 
catalysed hydrolysis of the substrate. 
The data collected (absorbance veises time/ wavelength) on the Gilford 
spectrophotometer was processed manually or transferred to either a BBC Masterseries 
Cub Microvitec 'Diffenz and Gilford progmnunes' or a Microvitec 286 'Enzfitter 
programme' for processing. 
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Single Beam 
Grant U. V. Spectrophotometer. 
Hevvlett-Packard WaterBath 
7225B Plotter. 
2.21 Data analysis. 
The data timisfeffed from the Gilford spectrophotometer was analysed in the 
following ways. 
"Pseudo" inifial rate and half-life analysis. 
If product inhibition can be ignored*, then essentially all the data required can be 
generated from a single enzyme/ substrate reaction. 
From the spectrophotometer the concentration of the substrate (So) can be 
determined from the optical density at any given point along the reaction curve and the 
coffesponding rate can then be deten-nined as a tangent to that point, in the same manner as 
initial rate experiments. This can be done accurately using the plot expansion facility of the 
Gilford instrument. 
The procedure therefore is to obtain the initial and final absorbances of the enzyme 
reaction and calculate A E, using this the tangents for a series substrate concentrations can 
be obtained, from which the Michaelis- Menten parameters can be deten-nined. 
A similar approach can be used to calculate first order or pseudo first order rate 
constants from the half-life measurements, which can be calculated with accuracy when 
the plot expansion facility is used. 
Nonetheless, despite the control experiments, the major criticism of this approach 
is that the influence of the products remains unknown. 
*( from experiments involving repeated injections of the substrate into the same 
enzyme solution produced, under the conditions used, no evidence of product inhibition. ) 
Using an integrated fon-n of the Michaelis-Menten equation: 
Umax At =-Km In[S] - JSI 
[Sol 
This can be arranged into the linear fonn: 
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At + 
Km A In [S] 
x 
Als, max U n-ox A [S] 
If product inhibition occurs then the plot becomes non- linear, this was used to test 
for reaction inhibition. 
222 Computer analysis. 
(i) BBC Master Sefies. 
(A) The Gilford progfam. 
This programme uses an iterative non-linear least squares procedure, which treats 
the initial and final absorbances and the rate constant as disposable parameters, and are 
used for calculating the first order rate constant from the base and enzyme catalysed 
hydrolysis reactions. Giving values for a theoretical "calculated" curve (est) and an 
"estimated" value for the experimental data (exp), using the data input for the experiment. 
(B) The Diffenz program. 
Traditionally, for calculating the kinetic parameters from enzyme/ substrate 
reactions, linear transfon-nations, of the Michaelis - Menten equation have been used. 
11 Km 
v Vniax vmax (S) 
Lineweaver-Burke Equation. 
YIM V 
V Vmax 
(S) 
Fadie-Hofstee Equation. 
(S) (S) 
+ 
Km 
Hanes Equation. 
v Vmax Vmax 
0 
These plots tend to distort the experimental data, Comish-Bowden(272) in 
particular is major cfitic of using these transfonnations to obtain kinetic data. There are a 
number of reviews considering these effects. (273) 
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To reduce the extent of distortion from experimental error, so minimising the 
deviations from linearity of the treated experimental data the following procedures were 
adopted. 
(i) Where possible single preparations of substrate and enzyme were used. 
(ii) Duplicate runs were made to ensure the consistency of the data. 
(iii) The procedure was calibrated against a standard (benzyl penicillin, 
cephaloridine ), when a new batch of enzyme was used. 
(iv) A reference cell, containing substrate and buffer only, allowed for the non- 
enzyme catalysed hydrolysis of the substrate to be checked. 
AS 
product inhibition can be ignored and the enzyme is stable over the whole time 
period used for the kinetic determinations all the data required can be generated from a 
single enzyme reaction, avoiding the time consuming initial rate experiments, and 
generating a great many more data points, as well as cost saving from using small 
quantities of enzyme. 
From the spectrometer (So) can be determined from the optical density at any 
given point and the rate as before determined from the tangent to that point, requiring only 
that AF, be detennined accurately. This can be achieved by taking the initial substrate 
absorbance before the start of the reaction and the product absorbance at t oo. 
optical 
density 
od, 
od2 
If the reaction curve is divided into many points ( Sn ,tn) then Sn can be 
cu lated from the equaflon. 
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ti t2 time 
A (S) 
t= odt - od 
(products) 
A6 
The rate at point S2 can then be detennined from; 
Rate (U) = Aod/At 
Ae 
Di ffenz allows hundreds of data points to be generated from a single enzyme/ 
substrate reaction and from the rate data the Michaelis- Menten parameters can be obtained 
from the linear transformations ( Lineweaver-Burke, Eadie-Hofstee, Hanes ) 
The method gives good reproducibility, and the values obtained agree with the data 
produced by the manual processing of the curves, and the quoted literature values. The 
procedures were calibrated over the three year period using penicillin G and cephaloridine 
as standards. 
(c) The Enzfit program. 
Enzfitter is a commercial data analysis program for EBM compatible computers 
written by LeatherbarrOW(252) The program uses a reduced chi squared non linear 
regression analysis to calculate kinetic rate constants. 
For Michaelis-Menten kinetics, this requires the data to be input in the fon-n 
substrate/ rate, to do this an interface program had to be written to convert the Gilford 
absorbance / time data. This was achieved by adapting the 'Diffenz' data capture 
algoridim. 
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2.23 High pgrfonnance liggid cbromatogWhy. (fTLQ 
The aim was to develop a convenient method to monitor experiments, obtain 
kinetic results and also to use as a means of purification of the B-lactarn compounds. 
Methods were developed using analytical and semi-preparative C 18 reversed phase high 
performance liquid chromatography systems - 
2 31 Eqgipment. 
Two types of of IIPLC systems were used for the experimental work. A Constra - 
Metric type HG system for the analytical analysis and a Gilson semi-preparative system 
for the large scale purifications. 
Both systems comprised of a high pressure pumping system with pressure and 
flow rate controls. The analytical system used a dual piston reciprocating pump while the 
semi-preparative used a combination of a model 303 pump and a model 305 pump 
together with a model 803C manometric module for micro-processor control, for either 
isocratic or gradient elution conditions. 
Ultra-violet detectors were used for the detection of the compounds, as penicillins, 
( 230-235nm) and cephalospotins ( 260-265run) contain strong chromophores. The 
analytical system used a Pye Unicam. LO UV detector and the semi-prepamfive system a 
Gilson halochrome detector. 
The resulting chromatograms were either recorded on a Kipp and Zonan chart 
recorder, with a chart speed of 5mnVmin and full scale deflection of I Omv. Alternatively 
the data was transfered to a Vinten Tfio Trivector chromatograpby computing integrator 
for micro processor analysis. 
The columns used were: 
1. The analytical columns used were; 
(i) 250 x 4.6 mm, 8pm Dynamax C 18 column. 
(ii) 250 x 4.0 mm, Lichrosorb RP 18 Libar C 18 column. 
2. The Semi-Preparative column; 
(i) 250 x 21.4 mm, 8pm Dynamax C 18 column, protected by a 50 x 21.4 mm 
guard column. 
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ne solvents used were: 
(a) The organic solvent was HPLC grade acetonitrile. 
(b) The aqueous solvents were made from glass distiled deionised water and 
Analar grade buffer salts. For the semi-preparative separations I% ammonium acetate or 
0.1% triflouroacetic acid (TFA) were used. 
The aqueous solvents were filtered through a Millipore microfilter (0.2 pm PTFE ) 
and the eluents degassed by sonication prior to use. 
The flow rates used were: 
Analytical : Iml/min. 
Semi-preparative : 12n-d /min. 
These flow rates were chosen to allow for the changes in column dimensions, so 
the retention times (tR), from the analytical and sernipreparative systems, were comparable 
for the cephalosporin and penicillin compounds. 
The injections were perfon-ned for both systems using a Rheodyne injection valve. 
A 20 pl injection loop was used for the analytical column, and a 5ml loop for the semi- 
preparative system. 
Isocratic elution was used throughout. 
The following compounds were studied by analytical HPLC and isolated by serni- 
preparative HPLC. 
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232 7-B Benzy] cephaloMgtin. 
0H 
CH s 
CH2 ()CH3 0 rO,, 
- Na+ 2 
Column: 250 x 4mm Lichrosorb C 18. 
250 x 21.4mm Dynamax C 18. 
Solvent: A- Acetonitrile. 
B- Water + Ammonium acetate ( 2%, 1.5%, 1%,, 0.5% and 
0.1%). 
Flow rates: 12mVmin and I mVmin. 
Wavelength: 265nm. 
Injections: 20,50,100 and 250 pl of 0.5g/2 ml and 20 pl analytically. 
Run: Isocratic - 20% solvent A and 80% solvent B. 
233 7B-2', 3', 4'CarbonThenylcephalosporin. 
0 
Na+ 02C 
N "'ýCH 
c 
---e 
2 
()COCH3 
- Na+ 
M' = HN+(C2H5)3 Na+ 
From the results of the initial experiments to purify 7-B-benzy] cephalosporin, the 
following conditions were chosen to purify the carboxyphenyl derivatives. 
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Solvent: A- Acetonitrile. 
B- Water + Anunonium acetate ( 2% ). 
Flow rates: 12mVmin and I mVmin. 
Wavelength: 265nm. 
injections: 100 and 250 pI of 0.5g/2 ml and 20 pI analytically. 
Run: Isocratic - 20% solvent A and 80% solvent B. 
Results: Table II 
Peak identification was made by studying analytically the peak responses to base 
hydrolysis. 
Ile compound retention peaks using these conditions for the 7-B ortho, mewand 
pam carboxy phenyl derivatives are given in Table IL 
During the semi-preparative runs "cuts" were made as each peak eluted and the 
sample cuts were run analytically to ensure consistency of the chromatograms. 
Three products were isolated for each compound, based on the base hydrolysis 
results, and isolates were either freeze dried or solvent extracted to give the desired 
product. However, it was found that the freeze drying produced hygroscopic products, 
due to the presence of ammonium acetate. It was necessary to re-work the collected 
samples to remove the excess ammonium acetate. 
Run: Isocratic. 
Solvent : 100% solvent B. 
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2.34 6-B 2', 3', 4' CarbonThenyl penicillin. 
0 
M+ cý 
ý-N 
s 
-02 
01172 
M' = HN+(C2H5)3 Na+ 
_CO2- M+ 
Attempts at purifying the carboxyphenyl penicillin derivatives using the method to 
purify the cephalosporin analogs, using 2% ammonium acetate as the aqueous eluent, 
produced poorly resolved chromatograms when applied to penicillins. 
It was necessary to develop a new set of conditions, and after several changes a 
method was developed using 0.1% tri flouro acetic acid and acetonitfile, this produced well 
resolved chromatograms for the penicillin derivatives. 
However, these conditions did have serious limitations, the low pH of the eluent 
system caused product decomposition, this was not serious for the analytical runs but 
preparatively these conditions caused significant product loss. 
This was eventually overcome by buffering the "cuts" from the semi-preparative 
column with sodium phosphate prior to freeze-drying. 
The conditions used were: 
Solvent: A- Acetonitrile. 
B- Water + Tri fluoroacetic acid ( 0.1% ). 
Flow rates: 12ml/min and I mVn-dn. 
Wavelength: 235nm. 
Injections: 100 and 250 pI of 0.5g/2 ml and 20 pI analytically. 
Run: Isocratic - 15-25% solvent A and 75-85% solvent B. 
100 
ChaDter 
. 
Results and Discussion. 
ChLipter 
Results and Discussion. 
3.1 Synthesis. 
The availability of 6-aminopenicillanic acid (6-APA) and 7-amino 
cephalosporanic acid (7-ACA) from fermentation procedures has made possible the 
synthesis of many new and varied B-lactams. N-Acylation is one of the most important 
reactions frequently used in the synthesis and derivatisation of B-lactarn antibiotics and 
considerable effort and progress has been made in the development of various mild 
acylation metbods. (216) 
The 6B-alkylpenicillins were prepared based on the aqueous methods of 
Buckwell (201) and others(217)or using a mixed anhydride of the derivatising acid by 
the action of alkyl chlorofon-nate, originally reported by Perron et al, (218) both of 
which are variations of the Schotten-Bauman procedure. Using the mixed anhydride 
procedure had the potential disadvantage of producing the 613-alkyloxy penicillin as a 
bi-product. It was also found that care was necessary in the solvent extraction process 
as this easily resulted in loss due to hydrolysis. The prepared compounds were isolated 
as the sodium salt by the action of sodium ethyl hexanoate on the ethereal solution of 
the acid. The reported recrystallisation of the sodium salt from butanol-water<217a) was 
found not to work and attempted recrystallisations from other solvent combinations 
were unsuccessful. The products were purified from repeated trituration with diethyl 
ether or freeze-drying after solvent extraction of sodium ethylhexanoic acid. The use of 
the mixed anhydride procedure gave a low yield and purity in the preparation of the 
2,3,4 carboxyphenyl cephalosporin and penicillin derivatives. The main impurity 
being hydrolysed product particularly with the penicillin compounds. This then led to 
a search for alternative methods for the N-acylation procedure. 
Attempts at using N, N'-dicyclohexylcarbodiimide (DCCI) as a condensing 
agent to prepare the penam and cephem derivatives was tried. The procedure was based 
on the methods of Hobbs and English (219) and Chakraborty et al(220). It was found to 
be necessary to protect an acid group of the diacid starting material as this produced 
dual functionalisation as well as the desired product. The easiest method was to forrn 
the mixed anhydride by mixing equimolar amounts of the alkyl chlorofon-nate and the 
diacid starting materials prior to the addition of DCCI. However, it was found that the 
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yields were low and during the purification stages it was difficult to remove all traces of 
dicyclohexyl urea (DCU), simple treatment with water and filtration was insufficient, 
and attempts at recrystallisation as before failed to yield product. 
It was considered that the loss due to hydrolysis could be reduced in the 
original procedures by the use of silylated 6-APA/ 7 -ACA. A method was adapted from 
GlombitZa(202) which utilizes hexamethy1disilazan (bis-trimethylsflylacetamide) as a 
silating agent to dissolve the B-lactarn starting material in dichloromethane, with little of 
the undesired N-silation. This is then reacted with the acid chloride or mixed anhydride 
of the desired compound. This produced the meta and pam derivatives in higher yield 
and purity than the aqueous techniques. The cephalosporin compounds were 
successfully recrystallised from acetone and water, in an attempt to purify the penam 
compounds, conditions were found to separate and analyse the compounds by 
analytical and preparative HPLC (high perforinance liquid chromatography). The 
analysis revealed that small amounts of the B-lactam difunctionalised meta and para 
products were produced during the synthesis, identified by the longer retention times 
and by the integrated peak heights by NMR. This was further investigated and it was 
found that the double B-lactarn compound (Fig 3,4 (referred to as the Dimer) could be 
selectively prepared by removing the alkyl chloroformate and replacing the acid by the 
corresponding acid chloride and using the appropriate molar ratios. The pam dimer 
was tested for B-lactarnase activity. 
CH30COH2C 
-L 
H00 
0 
CH20COCH3 
02H 
Fig 32. The cephalosporin Timer' produced from 1,4 teraphthalic acid. 
These techniques were used to prepare the saturated alkyl and phenyl penam 
and cephem. derivatives as well as the cyclohexyl B-lactarn compounds used as 
substrates for the kinetic investigation of the B. cereus 13-lactamase enzymes I and 2. 
The nitrophenyl penicillin compounds unlike the saturated alkyl compounds were 
successfully recrystallised in the acid fonn from ether/ethyl acetate mixtures. 
The oitho carboxyphenyl and 2-carboxycyclohexyl acid derivatives were 
prepared by the method of Perron etal(221) This procedure utilises the cyclic anhydride 
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form of the acid starting material and triethylamine to forrn the corresponding salt of the 
B-lactarn products, this produced the penams and cephem compounds in good yield and 
quality. 
3.2 Attempted pfWarafion of a penam aldebyde. 
As pail of the investigation into the mechanism of action of the B-lactamase 
enzymes the aim was to synthesise aldehyde analogs of the nonnal penicillin substrate, 
replacing the C3 carboxylate function with an aldehydic group, with the hope that this 
would fonn a Schiffs base (Fig 3-ý with the Lys-234 residue, thereby confirming or 
otherwise the essential nature of this interaction, allowing an evaluation of the results 
presented by Ellerby (163) for the interaction of the C3-alcohol derivative of penicillin V 
(phenoxymethyl penicillin). 
4111, 
-.. -90 Nj /i --. 
- 0 -czzzo H2N 
Lys-234 
R 
N, s 
W 
-C 
Lys-234 
Fig 33.. Hypothetical possibility of a C3 aldehyde penicillin fonning a Schiffs base &. X 
with the active-site residue Lys-234 of B-lactamase 1. 
Ile second primary objective was to prepare a B-lactarn ring-opened aldehyde 
compound (Fig 34), again with the hope being that this would form a hemi-acetal with 
the active-site Ser-70 residue, and thereby act as a potent inhibitor and a possible 
active-site label suitable for three-dimensional X-ray studies. 
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0 HNJ 
NH ýCO2H 
&2 
d \\O 
+ 
- 
/1 
Ser-70 
R 
-... a 
0H 
NH -C02H 
ýH2 
ý-OH 
Ser-70 
Fig 34 Hypothetical possibility of a C7 aldehyde of penicillin fonning a hemiacetal 
with the active-site residue Ser-70 of B-lactamase 1. 
Two approaches were adopted to achieve these objectives. The first was to 
modify the existing structure by either the reduction of the acid group or the oxidation 
of the corresponding alcohol and the second was to couple an aldehyde group in the 
form of an acetal. which could later be deprotected. Two acetals were investigated, 
amino acetaldehydedimethyl(ethyl)acetal. These were coupled to the penicillin nucleus 
via amide fonnation at the position C7. 
The initial attempts to produce the C3 aldebyde ofpenicillin G were made using 
sodium borohydride to reduce the C3 carboxylate group. These early experiments were 
carried out in dimethy1formarnide under atmospheric conditions, using stoichometric 
quantities of the reagents and starting materials, reaction progress was followed using 
2,4 dinitrophenyl. hydrazine, no indication was given of any of the desired products. 
Changing the conditions, by lowering the temperature, carnOng out the reaction under 
nitrogen and changing the solvent also failed to reveal any evidence of an aldebyde. 
Inspection of the reaction liquors by N. M. R and I. R. revealed either unreacted starting 
material or a complex mixture of decomposed products. It was thought that the 
conditions could be too vigorous, and it was decided to try milder reducing conditions, 
the method of Zakharkin and Khorlina (222)was tried. This procedure uses the 
commercially available dfisobutylaluminium hydride (DEBAL) to reduce the esters of 
carboxylic acids into the corresponding aldehydes in high yield at -700C in toluene, 
hexane or ether as the solvent. It was reported by the authors that the solvent had a 
marked effect on the efficiency of reduction by up to 15%. It was decided to try the 
reduction on the methyl ester of penicillin G, prepared and purified by the method of 
Gensmantel, (211) using DIBAL as the reducing agent the reaction was unsuccessful. 
Following the reaction by HPLC produced results that indicated that the starting 
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material decomposed without the production of an aldehyde or an alcohol product. The 
solvent was changed from toluene to hexane and then ether, and even with careful 
control of the temperature fluctuations all failed to yield the desired product. 
An attempt was made to increase the reactivity of the carboxylate function of the 
substrate, by carrying out the reduction on the C3-acid chloride derivative of penicillin 
G. The procedure of Fujisawa and Sato (223) uses oxalyl chloride to prepare N, N- 
dimetbylchloromethylenammonium chloride, the iminium salt activates the carboxyfic 
acid which reacts with the weak reducing agent, lithium tii(tert-butoxy)aluminium 
hydride to achieve improved chemoselective reductions of acids into aldehydes. This 
again, after many attempts, failed to produce the desired aldehyde. Similar results were 
obtained using other reported mild chemoselective reducing agents, 9-boratabicyclo 
(3,3,1) nonane(224), thexylbromoborane-dimethyl sulphide (225). The conclusion from 
these experiments suggest that either the penicillin G molecule was unstable to reducing 
conditions, however mild, or that the aldehyde at the C3 position was extremely 
reactive. However, as an aldehyde was not detected by I. R., chemical spot testing or 
HPLC at any stage during these experiments, suggests that the first possibility was the 
most likely. 
The failure to directly modify the carboxylate group of the penam. nucleus at the 
C3 position lead to an attempt to couple aminoacetaldehyde alkyl acetal to the C7 B-lactarn 
carbonyl carbon of penicillin G (Fig 3-ý. 
0H 
CC >-CH2-8-ý 
s 
0 N, 
0', 
NH 
ýH2 02H 
ýH 
OR \ OR 
R= Methyl, Ethyl group 
Fig 35. Aminoacetaldehyde alkyl acetal coupled to the C7 B-lactam carbonyl 
carbon of penicillin G. 
The coupling the acetal to penicillin G was successful as seen by the changes in 
the infra-red and NMR spectra. ne procedure used to synthesise the ring opened C7 
compounds the same as that developed to prepare the B-lactarn ring opened propyl and 
benzyl amides. These compounds were prepared as potential competitive inhibitors of 
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the serine enzyme. The acetal was added in a 2: 1 ratio in ethyl acetate/ether, an 
immediate precipitate formed, the penam salt , which 
further reacts to produce the ring 
Opened compound. The product was recrystallised from acetone and gave an N. M. R 
spectra consistent with that of the ring opened C7 acetal of penicillin G. 
For the next step, the hydrolysis of the acetal to the aldehyde, the procedure of 
Beeby (226) was used initially. This procedure uses 2N hydrochloric acid, 1,4 dioxan, 
in a nitrogen atmosphere, at room temperature, to prepare the C4 aldehyde derivative 
of cephalothin from the corresponding diethyl acetal derivative in 45% yield. Attempts 
at using this procedure on the prepared penam acetal failed to produce the desired 
aldehyde. Modifying the conditions, using 0. IM trifluoro acetic acid, acetone, 
acetonitrile, dimethylfon-namide and tetrahydrofuran in place of 1,4 dioxan, and using 
the dimethyl acetal instead of the diethyl acetal and using the C3 methyl ester instead of 
the acid of the C7 acetal derivative failed to improve the conversion of acetal to 
aldehyde. Analysis of the reaction products was made by solvent extraction with ethyl 
acetate and ether, this recovered small quantities of the unreacted acetal. Following the 
reaction by TLC ( dichloromethanc/acetone) and IiPLC (acetonitfile/ water) failed to 
detect the presence of an aldehyde product, spot testing with 2,4 DNPH and treating 
the end reaction products with sodium bisulphite produced a similar lack of result. As 
with the attempts at directly producing the aldehyde by reducing the carboxylate group 
of penicillin G it is suspected that either the reaction conditions were inappropriate to 
deprotect the acetal or that the aldehyde, on production, reacted readily to give further 
breakdown products, which were not identified. 
The possibility that the failure to detect an aldehyde during the deprotection was 
due to the fon-nation of the hydrated forrn of the aldehyde was tested on a model 
system, for this the synthesis of benzylpenilloaldehyde was chosen, the procedure used 
was that of Harvard (227), and involves the condensation of phenyl acetal chloride with 
the respective amino acetal under Schotten-Bauman conditions, followed by the 
deprotection by suspending the acetal product in ether and adding UN HCI in 
saturated salt solution, this produced the hydrate, which gave a negative test with 2,4 
DNPH and sodium bisulphite. The hydrate was converted into the aldebyde by 
refluxing in toluene. The product benzylpenilloaldehyde crystallised on cooling and 
was recrystallised from chloroform and ether. This worked successfully for the 
dimethyl and diethyl acetal starting materials. An interesting feature of the NMR of this 
compound in d6 DMSO shows the aldehydic proton to be uncoupled, giving a sharp 
singlet at 9.4 6, which is considered to be unusual. When this procedure was adapted 
for use with the penam compounds the results were again unencouraging. Having 
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tested the procedure it became obvious that the conditions required to deprotect the 
penicillin aldehyde were too vigorous and would result in decomposition. 
The suspected reactive nature of the penicillin compound, under the conditions 
used to generate an aldehyde group, led to another search for a way to activate the acid 
group so that mild reducing conditions could be used. This led to the publication by 
Gottstein (206) which gave the conditions for producing penicillin aldehydes at the C3 
position. The results show that the highest yeild was obtained using penicllin V as the 
starting material ( 47%), and the lowest yeild was obtained using penicillin G( only 
6%). The low percentage yield of the aldehyde product from penicillin G may explain 
the lack of success from the earlier experiments using penicillin G as the substrateof 
our experiments. The process described by Gottstein involves the Raney nickel 
reduction of the thio acid derivative of the B-lactam, obtained from the reaction of 
sodium sulphide on the C3 mixed alkyloxy anhydride of the starting material (207). 
After several unsuccessful attempts to reproduce these literature experiments 
described by Gottstein, the conditions were studied more closely and the reaction 
intermediates analysed by I. R. and NMR, using the model compound, 
phenylacetamido-N-propanal to follow the reaction (Fig 36). 
0H0 
CH2-ý-ý-CH-& I 
>- 
&3 \H 
Fig 36. Phenylacetamido-N-propanal. 
C-1 
The starting material, the corresponding carboxylic acid, was prepared by a standard 
Schotten Bauman experiment and recrystalfised from water. The next stage of the 
synthesis was to produce the thio derivative, which gave a strong thiocarboxylate 
stretch in the IR spectrum at approximately 1540 cm- 1. This is followed by the 
reduction using Raney nickel and NN-diphenylethylenediamine as an aldehyde trapping 
agent, giving the intermediate (Fig 3 /ý: 
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Li 
Fig 3 7. 
C. ý 
This compound was isolated and recrystallised from ethyl acetate/ether, in 60% yield. 
Analysis by NMR (CDC13) gave the proton spectra consistent with that of the 
protected aldehyde intermediate. The f=1 stage was to deprotect the aldehyde, which 
was achieved by hydrolysis with p-toluenesulphonic acid, which results in the 
formation of a heavy precipitate that requires the addition of an excess of diethyl ether, 
reducing the volume by distillation to produce the aldehyde product. The fmal yield 
was very small < 10% of the inten-nediate and < 5% overall, no attempt was made to 
try and optimise the yield. As with the benzy1penilloaldehyde the NMR of the 
phenylacetamido-N-propanal show that the aldehyde proton is uncoupled. This 
compound together with benzy1penilloaldehyde were tested for inhibitory behaviour 
with the B-lactamase I enzyme, no inhibition was found, either competitive or time- 
dependent. 
Having tested the procedure the experiment was repeated using penicillin V as 
the substrate, but once again after exhaustive efforts the results were discouraging. 
From the analysis of the reaction intermediates as the reaction progressed, difficulties 
were encountered upon the addition of sodium sulphide to the mixed anhydride, which 
had the effect of readily opening the B-lactain ring, and at the nickel reduction stage, 
which caused decomposition. In the paper of Gottstein et a] (206) it is reported that "the 
extreme susceptibility of thio acids to hydrogenolysis by Raney nickel enables one to 
remove selectively the thiol group under such mild conditions as to forestall appreciable 
attack on the vulnerable sulphide sulphur atom in the penicillin nucleus. " This was not 
the finding of this work. 
In a final attempt to produce the aldehyde the oxidation of the C3-alcohol of 
penicillin V to the corresponding aldehyde was tried. The reduction of peniciffin V from 
the starting acid to the alcohol is achieved by using the procedure of Balsamo et a] (213) 
Sodium borohydride in tetrahydrofuran successfully reduces the mixed anhydride 
formed by penicillin V and alkyl (methyl, ethyl) chlorofon-nate at -I OOC. This confirms 
that in addition to using mild conditions, a more reactive form of the acid is required for 
the successful reductionwrithout damaging the B-lactarn ring. The earlier attempts made 
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on the acid using NaBfU, DIBAL and lithium tri(tert-butoxy)aluminium hydride were 
made on the the methyl ester, ring opened and ring closed, derivatives of penicillin G. 
This method produced the alcohol in 25% wAv yield, but again no attempt was made to 
optimise the conditions. For the oxidation step the procedure of Griffith eta] (214) was 
chosen. This was chosen because of the reported chemoselective behaviour in 
converting alcohols to aldehydes, in high yield of sensitive highly functionalised 
macromolecules. 
ýIbe procedure uses the ruthenium compound 'tetra-n-propylammonium 
perruthenate' (TPAP) in a synergistic combination with co-oxidant N-methy1morpholine 
N-oxide. Three procedures ( A, B and Q are given'(214) and each of these were tried, 
(with the exception that nitrogen was substituted for the recommended argon in 
procedures B and Q, but all failed to give an aldehyde product. Attempts at lowering the 
temperature to -I OOC and then gradually allowing the reaction mixture to adjust to room 
temperature produced the change in colour indicative of successful oxidation. ( TPAP is a 
dark green solid which produces a green solution which darkens as the reaction 
proceeds) After one hour the reaction mixture was passed through a silica column and 
washed initially with dichloromethane, which removed the dark green material, but by 
infra-red show no evidence of product. This was followed by eluting with ethyl acetate 
which washed from the column unreacted starting material, confin-ned by NMR. No 
further attempts were made to prepare the aldehyde product, despite the failure to isolate 
the desired product these early experiments are encouraging and offer potentially the best 
and most convenient way to generate aldehydes from penam compounds. 
3.3 The use of semi-prepqrative high perfon-nance liquid chromatogWhy to puri 
Mnam and cepbem compounds. 
The use of high performance liquid chromatography (HPLQ for the 
purification of highly expensive antibiotic materials is increasing rapidly. Over the last 
few years the basis for a quantitative understanding of semi and preparative HPLC has 
begun to emerge which gives a clearer picture of the mathematical relationships of 
BPLC separations under over-load conditio,, S(228). For our purposes it was imperative 
that mflligram and gram quantities of the prepared cephem and penam were obtained in 
a pure fon-n suitable for enzymatic study and the subsequent interpretation of the kinetic 
data, and the hydrolysis mechanism(s) of the B. cereus 5691H B-lactamase enzymes I 
and 2. 
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The use of analytical liquid chromatography for the analysis of antibiotics has 
been in existence since the mid- 1940's (229) but it was not until the mid 1970's that the 
use of BPLC to analyse mixtures of antibiotics became widely used (230)- Today a 
number of excellent reviews comprehensively cover the application of BPLC to the 
separation of penicillins and cephalosporins. (231) 
For our purposes the procedure of Cox and Snyder(228)was used to develop 
the conditions suitable for the separation of prepared carboxyphenyl cephalosporins. 
Cox and Snyder give a six stage plan to the systematic design of a procedure for 
preparative BPLC purification, the first four of these stages were adopted( Fig 39). 
Step 1. Step 2. 
Pfflimmary 
analytical Final analytical 
method development --P- separation 
(250x4 mm column) conditions (I -I OOpg) 
Step 4. T Step 3. 
Serni-preparative Overload analytical 
separation conditions ( 5-500 mg) (0.1- 25mg) 
, 
(250x 21 mm colurnn) ,iI 
Fig 38. Systematic approach to the method development leading to the C., 
separation of B-lactams by semi-preparative I]FLC. 
Initially, two instruments were used in establishing the conditions for efficient 
separations, an analytical column (250 x 4.6mm) and a semi-preparative column ( 250 
x 21.4mm ). Later as experience was gained in the separative technique, method 
development was carfied out using only the larger column, which could be adjusted to 
operate under analytical conditions. This had the advantage of not having to adjust the 
conditions, established using a smaller column when scaling up using different 
instrumentation. 
The use of phosphate and citrate buffers to separate the cephalosporin 
compounds was found to produce poor peak shape when higher loading levels were 
introduced, with unacceptable levels of 'tailing' or 'fronting' which hindered resolution 
and the efficiency of separation. This was solved by replacing the buffers with 
ammonium acetate, which was found to improve peak shape and which could be used 
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successfully in a variety of loading levels, it also had the advantage of being easily 
removed after separation to yield the pure compound. 
The column efficiency of the semi-preparative equipment was tested 
periodically by measuring the plate counts with 25pl injections of a standard solution 
2g benzene, 0.2g naphthalene in I 00ml methanol). I'lle results show no appreciable 
column damage from use over a two year period. 
The conditions for the separation of the 7B-carboxyphenyl derivatives were 
established using benzy] cephalosporin. Varying the ammonium acetate levels from 
2.0 - 0.1% w/v it was found that, for the analytical IIPLC, 0.1% ammonium acetate 
was sufficient, for the semi-preparative separation the most satisfactory results were 
obtained using a I% ammonium acetate mixture. Tbe sample was made from 0.5g of 
crude starting material in 2ml, of which 50- 1 00p I were injected onto the column. 
During the method development 'cuts' were taken from the large scale chromatograms 
as each peak apex eluted, the sample cuts were run analytically to ensure the 
consistency of the cbromatograms and homogeneity of the collected fraction. Peak 
identification was made by following the peak changes as a result of hydrolysis either 
by sodium hydroxide or enzyme hydrolysis. 
For the cephalosporin compounds two or three principal components were 
found. 
Table 5. Major p!!, ýk retention times( R) for the anal)jical (i) and semi -preparative (ii 
7B-carboxyphenyl cephaloýpoijn dedvatives. 
(i) Analytical. 
Compound Acetonitrfle tR WM) 
oitho-carboxyphenyl 15 2.60 7.20 
cephalosporin. 
meta-carboxyphenyl 20 2.80 3.20 4.60 
cephalosporin. 
par, +caiboxyphenyl 17 2.80 7.30 9.30 
cephalosporin. 
(ii) Semi-preparative. 
Compound Acetonitfile tR (mins) 
oitho-carboxyphenyl 25 4.80 11.40 
cephalosporin. 
meti-carboxyphenyl 20 5.20 7.40 9.30 
cephalosporin. 
par, +carboxyphenyl 18 4.0 11.40 14.10 
cephalosporin. 
Due to the presence of large quantifies of ammonium acetate the products, after 
being freeze dried, were found to be highly hygroscopic but this was overcome by re- 
injecting the isolated fractions and eluting with water only. The final products from the 
purification by BFLC were found to be the desired monomeric compounds and in the 
case of the meta and pxa derivatives, the dirneric compounds of the structure given 
below were also isolated. 
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These structures were confin-ned by NMR spectroscopy, which show the peak 
integrals and splitting patterns of the aromatic protons to be consistent with that of a 
dimeric compound. This was further confirmed by synthesizing the dimeric compound 
and comparing the BPLC trace and NMR. The overall purification obtained by this 
method was > 97% with the cephalosporin compounds. 
Attempts at purifying the corresponding mewand pam carboxyphenyl 
penicillins by this method were unsuccessful, producing poorly resolved 
chromatograms. It was necessary to develop a new conditions and the use of 0.1% v/v 
trifluoroacetic acid and acetonitrile. This produced well resolved chromatograms at the 
Wgher loading levels required for semi-preparative purposes. However, this method 
did have serious limitations. The low operating pH of the eluent caused product 
decomposition, which overcome by buffering the 'cuts' with sodium phosphate and 
storing at 0-5 OC prior to freeze-drying. The purification levels obtained by this process 
was less than that obtained with the cephalosporin compounds, at the level of > 94 %. 
For the oitho compounds (aromatic and cyclohexyl) the alternative synthetic 
method of Perron et al (22 1), using the cyclic anhydrides, produced highly pure 
compounds which could not be improved upon by subsequent HPLC chromatography 
and these compounds were used for the enzymic evaluation. 
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3.4 Background: Kinetic analysis. 
The two main effects achieved by enzyme catalysis are molecular recognition 
and rate enhancement. The increases in the rate of reaction brought about by the use of 
enzymes occurring under ambient conditions are often dramatic. This ability to promote 
reactions circumvents the use of high temperatures and pressures and has led to ever 
increasing industrial interest. However, evaluating the rate enhancements achieved by 
comparing to non-enzyme catalysed reactions is not a simple correlation. The 
"mechanism" by which the two reactions occur can be quite different. This simple fact 
is probably responsible for the speculation that it is the "mechanism" or "mode" of 
chemical catalysis which is responsible for the the large rate enhancements seen using 
enzymes and that the shape and electrical complimentarity of binding the substrate to 
the enzyme active-site which is responsible for specificity and recognition. 
Chemical catalysis alone is generally insufficient to explain the rate increases 
achieved by enzyme systems. Often it is the case that groups on both the substrate and 
enzyme, which are not directly involved in the process of bond breaking and making, 
that make important contributions to lowering the activation energy, promoting 
catalysis. 
The first step in enzyme catalysed reactions is the bringing together of the 
reacting species. An often quoted model for this process of proximity comes from a 
consideration of intramolecular reactions, which show rate enhancements, though 
varying over a wide range. 0 8 1) The bringing together of two molecules is 
accompanied by a negative change in entropy, resulting from the reduction in the 
volume of space available to the reacting molecules. This ordering is expressed as a 
loss in translational and rotational entropy. The closer the fit the greater the loss of 
entropy . 
(232) For model systems this difference between an intramolecular 
unimolecular reaction and an intennolecular birnolecular reaction has a maximum 
unfavourable value of 108 M at 25 Oc. 
A+B 
, &S/J K-Imol-I 
unfavourable rate 
A ------- B 
loose transition 
state 
- 40 
102 
A--B 
tight transition 
state 
-150 
108 
or equilibrium factor 
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However, this represents only the entropic difference, it takes no account of the 
effects of strain or solvation. (233) 
The stabilising influences of the enzyme can be separated into two distinct 
Darts, one involving the atoms undergoing change during the process of catalysis and 1- 
the other as the non-reacting parts of the two species. The interaction between the 
substrate and the enzyme of the non-reacting parts, the "binding energy", must reach a 
maximum at the transition-state and not at any intermediate state or the stabilisation will 
result in saturation conditions developing at low concentration of substrate and 
increasing the free energy of activation, resulting in less efficient catalysis. The 
lowering of the activation energy resulting from the favourable interaction between the 
non-reacting parts of the reacting species is often not expressed in the simple tenns of 
increased binding (Ks), but instead is used to compensate for the unfavourable energy 
changes by lowering the activation energy (kcat). 
The observed free energies of binding substrates to enzymes, expressed by the 
Kmapp(apparent) values are often less than the 'true' intrinsic binding energy since 
some is used to compensate for the necessary loss in entropy. Estimates of the intrinsic 
binding energies associated with small substituent changes in enzyme-substrate 
interactions can produce large increases when compared to solute-solvent systeMS(234). 
AA0 for the transfer from 
enzyme to water. (kJ mol- I)* 
-(CH2)- 14 
-OH 29 
* Values for kcat/Km relative to the hydrogen atom. 
AACit for the transfer from 
n-octanol to water. (kJ mol-l)** 
34 
-6.62 
** Values relative to the hydrogen atom. For the hydroxyl group this corresponds to the value when bound to 
an aliphatic compound. 
The transfer of solute between solvents provides a measure of the 
hydrophobicity, which for small groups gives rise to empirical relationships, such as 
the Hansch equation(235): 
IT = log p1po 
where P is the partition coefficient between n-octanol and water for ( R-X), the 
substituted compound and Po is the corresponding partition coefficient for ( H-X), the 
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reference compound, 7r is the Incremental Gibbs free energy of transfer for the 
substituent R. 
Comparing the tramfer of a solute to a solvent, to that of a solute to an enzyme 
provides some measure of the hydrophobicity of binding involving enzyme systems. It 
is more difficult to estimate the individual contributions of hydrogen bonding and salt 
linkages to the binding of a solute to the enzyme as the solute is exchanging the 
aqueous solvent shell for the binding site of the enzyme. Despite these problems 
estimates can be made by comparing the Michaelis-Menten second order rate constant 
(, kcaVKm) for a series of related compounds. In this thesis this approach is used to 
compare the contribution of a methylene group for a series of linear and branched 
aliphatic 6B-alkyl penicillins, testing for the existence of a hydrophobic binding site in 
the B-lactamase I and B-lactamase 2 enzyme of B. cereus. In a second series of 
compounds the 613 and 713 aryl carboxy penams and cephems were used to test for the 
contribution of a hydrogen bonded/coulombic interaction with the enzyme(s). This was 
further investigated by comparing the stereochemical cis and tians 613 and 713 carboxy 
cyclobexyl compounds. 
Studies involving the reaction of tyrosine and the deaminated form of 
aminoacyl-tRNA synthetase(236) showed that the loss of a salt linkage resulted in a 
change of binding energy of 18kJ/mol. With chymotrypsin the catalytically active 
conformation involves a salt bridge between the (x-NH3' group of Ile- 16 and the -C02- 
of Asp- 194. When this is removed by altering the pH, the stabilisation energy 
associated with the salt bridge is calculated to be 12.1 U/ Mol. (237) 
With penicillin and cephalosporin compounds containing charged functional 
groups in the C6/ C7 side group the enzyme kinetics were obtained over the pH-range 3- 
10. The pH-rate profiles obtained were used to obtain and expand the understanding of 
the essential amino acid residues required for activity of the B-lactamase enzymes of R 
cereus. Other penam and cephem compounds investigated include the C3 ester of 
penicillin G and the alcohol of penicillin V and the lactone of phenylacetylcephalosporin. 
These compounds are the non-charged counterparts of the normal C3/C4 carboxylate 
containing B-lactams. The interaction implicated for this group from previous kinetic and 
more recent x-my diffraction studies is a catalytically essential salt bridge formation with 
Lys-234 of the B-lactamase I enzyme. The removal of this interaction will allow an 
estimate to be made of its magnitude and importance to substrate recognition. 
It is perhaps not surprising that changes in pH have a large influence the rate of 
enzyme-catalysed reactions since the active-site(s) are composed of ionisable groups 
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which must be in the correct ionic state for optimal activity, maintaining conformation 
and the binding of the substrate. lbus, a study of the enzyme dependence of the 
Prototropic groups upon pH can yield important information conceming the groups 
essential for efficient catalysis, which may in turn be used to help "unravel" the 
mechanism of catalysis. However, caution has to be applied when interpreting the 
results of pH-rate studies, since the apparent pKa values obtained for a particular 
enzyme substrate reaction may not be for a variety of reasons the 'true' pKa. A simple 
example involves a change in the rate determHng step with pH, to produce a 'kinetic 
pKa', this can result in either an apparent upfield or downfield shift from the true pKa 
of a residue present in the active-site. 
Any interpretation is further complicated by the fact that the environment of the 
enzyme active-site is capable of perturbing the non-nal pKa values found for amino 
acid residues in water and can therefore lead to erroneous conclusions. However, this 
can be offset against other infort-nation, such as the primary sequence data of the 
enzyme concerned, x-ray data, particularly involving the active-site and the results 
obtained from mutagenesis experiments, where selected residues have been replaced 
and the effects on activity evaluated. 
3.5 pH-Dependence of the B-lactamase I and 2 enzMes of B. cereus. 
A pH-rate study reported by Waley (1975) (109) investigating the pH- 
dependence of B-lactamase I from B. cereus found that a plot of kcat and kcaMm 
against pH for the enzyme catalysed hydrolysis of penicillin G produced bell-shaped 
curves, both giving the same pKa values, 4.85 and 8.60. The value of Km for 
penicillin G being therefore pH-independent, indicating that the ionisations involved do 
not affect the substrate binding. These results indicated that the pK; Ys characterise 
groups on the free enzyme, suggested to be a lysine and a glutamic acid residue. 
However, the enzyme catalysed hydrolysis of ampicillin produced plots of kcat and 
kcaVKm against pH which differed. The plot of kcaVKrn giving values of 5.40 and 
8.60, while kcat versus pH produced values of 4.05 and 7.40. As both substrates gave 
an apparent pKa value of 8.60 for the plot of kcat/Km against pH, this was taken to 
signify that it represents a group on the free enzyme, since if the value had been a 
complex expression of ionisation and rate constants it would be expected to change 
with changing substrate. The situation is less clear for the lower pKa value which 
differs with the substrate, 4.85 with penicillin G and 5.40 for ampicillin. For penicillin 
G this value remains the same for both the kcat and kcaVKm pH-rate plots and 
therefore could be regarded as indicative of a pKa value pertaining to the free enzyme. 
With ampicill in, which gave the values of 4.05 and 5.40 for the pKa I value. The pKa 
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value shown by the kcat dependence may be explained by the effects of the side chain 
amino group on the enzyme-substrate complex, which at low pH will be protonated. 
However, this does not explain the higher value of 5.40 for the plot of the second order 
rate constant against pH. 
During the course of this work the kcaVKm pH-dependency for a range of 
penams and cephems were examined, the results have revealed that both pKa values 
vary considerably, not only for the penam derivatives but also the cephern compounds. 
It will be shown that the ionisations involved are more complex than originally 
suggested, comprising of a complex mixture of ionisations, and rate constants. 
Later work, again involving Waley (1983)(238) investigated the pH-dependence 
of the B-lactarnase 2 enzyme. The distinction between the two enzyme types is 
functional as well as structural and involves important differences in their specificities 
and inhibitor susceptibility. I'lie B-lactamase 2 enzyme being originally described as a 
'cephalosporinase', though penicillin enzymic rate constants are of the same order of 
magnitude. The essential difference of the class 2 enzyme is the requirement of a zinc 
ion co-factor for activity, the class I enzyme being a serine protease. The plot of kcat 
against pH for the hydrolysis of penicillin G by the zinc(H) enzyme differs from the 
bell-shaped curve seen for the class I enzyme, showing a tail on the alkaline side. This 
was interpreted as due to two ionic forms of the enzyme-substrate complex capable of 
giving products (Fig 39). 
XH3 
KI ý[ 
kl 
S+ EH2 
-X 
H2 > EH2 +p 
K2 
S, EH -- XH EH+ P 
K3 
S+E- 
,X 
Fig 39. Kinetic scheme for the B. cereus B-lactamase 2 enzyme. 
The ionisation constants for the enzyme substrate complexes are KI, 2,3. The ionic 
forms of the enzyme substrate complexes are shown by X, XH, XH2 and XH3. 
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The kcaVKm pH-dependency shows a non-nal bell-shaped curve and can be 
accounted for by three ionic fort-ris and two ionisations of which one is catalytically 
active. The values given by the plots are shown in table 14. X-ray evidence supports an 
earlier supposition that the ligands around the zinc(H) ion include three histidines, a 
cysteine and a possible water molecule. From the pH-rate profiles if either of the two 
observed pKa values refer to a metal bound water molecule then it would be the lower 
value of 5.50. 
Table 6. lonisation constants for the hydrolysis of be! y3jlpenicillin catalysed by 
B-lactamase 2. a 
-Ty pri-dependence of kcat 
pKI 
pK2 
pK3 
_TY pri-dependence of kaWKm 
pKI 
pK2 
Zn (H)-B-lactamase 2 
5.10 
8.00 
10.20 
5.60 
7.60 
a. From; Bicknell. R., Knott-Hunziker, V. & Waley. S. G. Biochem. J. 213,61-66 (1983) 
As with the B-lactamase I enzyme it was found that the kmVKm pH- 
8.40 
10.30 
5.50 
9.00 
dependency of benzy] penicillin was reproducible, but with the prepared compounds 
containing polar and charged functional groups the results show a pH-dependency 
more complex than that reported by Waley. 
3.6 Effects of surface cbarme, ionic strenZh and error analysis on the qporent 
pl&s of e! IKMe catalysed reacfions. 
Before discussing the pH-dependence of the compounds studied in this 
investigation it is necessary to consider control conditions under which the experiments 
were carried out. One of these controls involves the effects of ionic strength. 
The surface charge of an enzyme creates an ionic atmosphere or electrostatic 
field which may either stabilise or destabilise the charges of the partially buried and 
buried residues. This is particularly important for those residues involved in the 
Co ffl-ß-lactamase 2 
5.80 
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enzyme mechanism, either directly, acting as genefal acid/base catalysts or indirectly by 
maintaining the active conformation of the enzyme. These surface charges are affected 
by the ionic strength of the surrounding medium. These affects will be most noticeable 
at the extremes of pH and in a medium of low ionic strength, typically less than 0.15 
M. These deleterious effects can be offset by increasing the ionic strength of the 
operating conditions by adding potassium or sodium chloride. Today many of the in- 
vitro enzyme reactions are quoted as using a solution of IM ionic strength as the 
control conditions. However, many enzyme reactions studied as a function of pH are 
usually measured between pH 5-9, where few surface charge amino acids titrate, 
consequently lower ionic strengths, as low as 0.1 M can be used with confidence. (239) 
Previous work using B-lactamases I and 2 show and this work confirms, the 
B-lactamase enzymes demonstrate little variation associated with changes in ionic 
strength(109). Furthermore, recent work by Fink et al (184,185) following the 
conformational. states of the B-lactamase of B. cereus over the pH range 2-11 found 
that the enzyme remains folded between the pH values of 4- 10, beyond these limits the 
enzyme at first unfolds and then later refolds. The experiments of Fink were carried out 
in the absence of, and with added, potassium chloride. The mid-point for the transition 
in the absence of added salt (1=0.05) was pH 3 and pH 10.9, with added potassium 
chloride (I M) the transition began at pH 4.5 with the mid-point at pH 3.4. 
The kinetic studies during the investigations reported here were carried out without 
the addition of potassium chloride to the 0. IM buffers used, these conditions were 
decided upon at the outset of this work based upon earlier evidence. 009) The results of 
control experiments, in which potassium chloride was added to the buffer solutions and in 
which the buffer salts used at selected individual pH's are shown in table 92, which 
shows the effects of these changes are not reflected by the Michaelis-Menten parameters. 
During the course of the work, the evidence produced by Fink et al support this earlier 
decision. 
The "typical " bell-sbaped curve seen for many enzyme catalysed reactions may 
be the result of the formation of the incorrect ionic form of the enzyme required for 
optimal activity or the result of the denaturation of the enzyme. It is therefore necessary 
to test the time stability of the enzyme over the pH-range that is to be studied. For the 
B-lactamase enzymes this was done by incubating the enzyme at pH 3,5,7,9, and 10 at 
300C and then testing the activity at pH 7 using penicillin G as the substrate after 
various time intervals. The results of this experiment give the half-life values shown in 
table 15. 
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values inactivation of B-lactamase I at va! ying pH at 3 QC, tested 
again t pgnicillin G at 30PC and PH 7. 
pH k (hr I) t 1/2 (hr 
3.0 12.77 x 10-2 5.43 
5.0 1.92 x 10-2 36.10 
7.0 1.26 x 10-2 54.79 
9.0 2.04 x 10-2 33.95 
10.0 10.98 x 10-2 6.31 
The Michaelis-Menten parameters calculated for the substrates studied were 
obtained from single curve progression analysis, the conditions being used such that 
the average time profile was complete within one hour from the start of the reaction. At 
each pH the experiments were repeated and the average value taken. 
For B-lactamase 2 the average time profile for the substrates studied was more 
constant and was complete within ten to twenty minutes, this was possible because the 
kinetics observed were simple first order kinetics and the enzyme concentration could 
be easily adjusted to achieve reaction completion within the desired time. At least three 
concentrations were used for each reaction and the average result taken. 
The kinetic results were calculated from single curve progression analysis for 
both enzyme assays, rather than using the method of initial rates. The data was 
transferred from the Gilford 2600 single beam LJV spectrophotometer to a micro 
computer for analysis. The reactions using B-lactamase 2 did not display saturation 
kinetics but gave pseudo first order curves. The rate constants from these curves were 
calculated using an iterative non-linear least squares procedure, treating the initial and 
final absorbances as adjustable parameters. The experimental data was then compared 
with that calculated from the rate constants. 
The assays involving the B-lactamase I enzyme were generally found to show 
saturation behaviour. For many years the common linear transformations of the 
Michaelis-Menten equation ( Lineweaver-Burke, Eadie-Hofstee and Hanes) have been 
used to calculate the enzyme kinetic parameters kcat, Km and kcaVKm. All these plots 
have a tendency to distort the data, more recently the development of rectangular 
hyperbolae fitting routines for use by micro computers to calculate the kinetic data 
circumvents this problem. Expefimental errors will result in the distortion of the data 
which ever method of processing the results is selected. In these experiments the 
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equipment used and the procedures adopted are such that the errors are minimised. 
However, because such errors are inevitable, the experimental data was processed 
using linear transformations, and a curve fitting routine and the average result taken. 
The decision to use single curve progression analysis to obtain the Michaelis 
constants was made because a single enzyme-substrate reaction allows hundreds of 
data points to be generated and a single batch of substrate and enzyme avoids 
preparative experimental errors. It also has the advantage of avoiding the very time 
consuming method of initial rates, it avoids the errors involved in the initial slope 
determination and avoids the precise calculation of substrate concentrations. It also 
avoids using large quantities of substrate and enzyme making it cost effective, subject 
to less errors and generates many more data points than are possible by using initial 
rates. 
The major criticism of this method is that product inhibition may distort the 
results obtained. It was found that repeating substrate additions to an enzyme solution 
did not cause product inhibition. The use of initial rate experiments produced results 
which are in agreement with the results found using single curve progression analysis. 
The results from using the standard reagents cephaloridine and benzy] penicillin are in 
good agreement with literature values and the values supplied by the manufacturer of 
the enzymes. Finally, the use of progress curves to calculate the steady-state kinetic 
parameters of B-lactarrVB-lactamase reactions is used by many of the research groups 
involved in this area of work. (240) Therefore, while the use progression analysis to 
obtain kinetic results from enzyme assays is not generally used, for the reactions 
involving the B-lactamase enzymes this is a valid technique. 
3.7 Testing for a hydrophobic binding site in B-lactamase I and 2. 
One of the principal binding interactions available to enzymes is the hydrophobic 
interaction. In the first set of experiments the potential for a hydrophobic pocket 
existing in the B-lactarnase enzymes I and 2 was investigated. 
In their native state globular proteins generally have the hydrophobic residues on 
the inside away from the polar aqueous environment. Hydrocarbons dissolved in water 
have an ordered sheath of water molecules disrupting the hydrogen bonding network, 
this reduces the entropy of water and results in aggregation. To regain entropy the 
hydrophobic solute can be driven into a hydrophobic region, either a non-aqueous 
phase (octanol) or a protein. Octanol is often the chosen reference for estimating the 
magnitude of 'hydrophobicity', defined by the Hansch equation. For enzyme systems 
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the binding of most substrate molecules is less straight forward since it involves 
hYdrogen-bonding and electrostatic forces in addition to hydrophobic interactions. 
Allowing for these differences estimates can be made of the importance of the 
hydrophobic bonding in enzyme systems by comparing the apparent second order rate 
constants (kcaVKm) for a series of compounds. 
AAG* RT In kcaVKml 
kCat/I<M 2 
1. Sample compound 
2. Reference compound 
x 5.801 Ki mol- I 
The second order rate constant is used as this avoids any under estimation from 
comparing enzyme dissociation constants, since many enzymes utilise binding energy 
to lower the activation energy, rather than to give tighter binding. For instance the 
a-chymotrypsin serine protease has been shown to have an active-site containing a 
hydrophobic binding pocket that binds strongly to aromatic and branched chain 
aliphatic compounds. (241) 
3.8 Hydrophobic binding involving B. cereus 569/HB-lactamase 1. 
An earlier investigation involving a series of N-alkyl penicillins, and the 
B-lactamase of B. Rchenifbrmis 749/C found that there was no correlation between the 
length of the C6 alkyl chain and kcaVKm. This led to the conclusion that 
hydrophobicity of the C6 alkyl chains of penicillin is not a factor that is responsible for 
B-lactam resistance and that the major recognition features are located elsewhere on the 
substrate(242). 
When this work was repeated by Buckwell (199) with a series of N-alkyl 
cephalosporin derivatives and the B-lactamase I enzyme from B. CereUS (243) a linear 
correlation was reported with increasing chain length, with kmVKm increasing thirty 
fold from the acetyl to the lauryl derivative and was thought to provide evidence that a 
hydrophobic binding site existed within the active-site of this enzyme. This produces a 
value of 0.88 U mol- I for the incremental Gibbs Free energy of transfer per methylene. 
The same experiment with a series of alkyl penicillins produced a more complicated 
result, which shows an increase activity with increasing chain length, with a six fold 
increase in the value of kmVKm, from the methyl to the hexyl derivative (n=6) but 
thereafter a decrease, with increasing chain length. This produces a value for the 
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incremental Gibbs Free energy of transfer per methylene for the units n=0-4 of 1.40 
U mol- 1, thereafter an increase of 0.89 U mol- I. Luengo and Moreno (1987)(244) 
investigating the bioactivity for the same series of aliphatic penicillins (n=4- 10 
against S. aureus B-lactamase reported optimal activity was found with the octyl 
derivative. 
In view of these discrepancies the B-lactamase catalysed hydrolysis of N-alkyl 
penicillins, was reinvestigated and the results are shown in Table 13. A plot of kcaVKm 
against the 6B alkyl chain length (Fig 40) shows a linear relationship to the nonanoyl 
derivative. The calculated incremental Gibbs free energy changes of transfer ( AAGt) 
with increasing chain length are shown in table. 17 From this table, using the ethyl 
penicillin as the reference compound and plotting AAG$ against chain length (Fig. 41) 
shows that there is a four fold increase to the octyl derivative. This corresponds to a 
free energy of transfer per methylene unit of 0.62 U mol- 1. Interestingly, this is 
similar to the pattem of activity reported by Luengo and Moreno. (244) 
Table. 8 Ile incremental Gibbs Free EneM of tmnsfer of N-alkyl penicillins to the 
B-lactamase I egzMe from B. cereus. 
Penicillin 
Compound ýAGVU mol 
CH3CO - 
C2H50D 0 
C3H7CO 0.95 
C4H9OD 0.88 
C5HI ICD 1.78 
C6Hl3CD 3.14 
C7HI5()D - 
C8Hl7CD 3.58 
CgH190D - 
CloH21CO -5.36 
CI IH23CD - 
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Fig. 40. Plot of kcaVKm against alkyl chain length from the data shown in 
table 13. 
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n 
Fig. 41. Plot of AAGI against chain length from the data shown in table 8. 
When kaVKm for the non-acylated penicillin compound ( 6-APA)(243) is 
compared to kcaVKm for the first two N-acyl B-lactam compounds, the methyl and 
ethyl derivatives, an incremental free energy difference of 2.45 U mol- I is calculated 
for the methyl compound(243) and 5.9 7U mol for the ethyl compound, this 
correlates to 3W mol -I per methylene. 
These correlations for the penicillins and particularly the cephalosporins indicate 
that there is a hydrophobic recognition site, though weak, for N-alkyl B-lactams at the 
active-site of B. cereus 5691H B-lactamase 1. When the magnitude of the free energy of 
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transfer is compared to the values associated with the transfer of a methylene group 
from water to n-octanol of 2.86 M Mol- 1(181), or to micelles of 2.70 U Mol- 1(245) ý it is 
seen to be small and much smaller than the transfer of methylene groups to some 
enzymes which can be as high as 14 kJMOI - 1(246). Therefore, despite the free energy 
linear correlations observed, the magnitude of the values involved show that these 
values are not conu-nensurate with enzymes where hydrophobic binding is important. 
Considering the differences in the free energy of binding between 6-APA, which has a 
6B-amino group, and the methyl and ethyl penicillins, which have a 6B-amido group, 
acylation of 6APA, rather than being a purely hydrophobic interaction also results in a 
change in the extended hydrogen bonded network between the substrate and the 
enzyme, contributing to an increase in the binding energy. If the typical bond energy of 
a hydrogen bond is assumed to be 20 U mol- I then this could increase the binding of 
acyl groups to the enzyme by a maximum of 40-60 M mol- 1. However, the evaluation 
of the net energy of hydrogen bonding is difficult because the substrates are 
exchanging the aqueous solvent shell for the binding site of the enzyme. Therefore, 
though there is an increase in the incremental Gibbs Free energy resulting from 
acylation of the C6-B-amino group the size of the increase is not as large as expected. 
Since this work was completed detailed high resolution x-ray data has become 
available for a number of serine B-lactarnase I enzymes. For the Staphylococcus aumus 
B-lactamase, (149) the specificity profile shows a preference for substrates with 
stereochernically unhindered hydrophobic end groups on the C6B-side chain of the B- 
lactarn (247). At the active-site of there is a small hydrophobic gully formed by the side 
chains of Val- 103 and Ile-239, which from model building is in the correct region for 
forming favourable hydrophobic interactions with the substrate. 
This would in part explain why alkylated penicillins show the relatively large 
increase in the free energies of binding compared to 6-APA and would also explain the 
observation an optimum associated with a small chain length, since increasing chain 
length would eventually exceed the region of the hydrophobic gully and encounter 
destabilising forces. A leucine residue is conserved throughout the class A B-lactarnases 
and forms part of the bottom of the binding site where the B-lactam side chain is 
expected to lie(I 5 1). However, at this time a detailed high resolution spectrum is 
unavailable for the B. cereus enzyme and consequently an alternative binding 
mechanism may operate and this may in pail explain the conflicting evidence which this 
and other investigations have revealed. 
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3.9 Hydrophobic binding, involving B. cereus 569/HB-lactamase 2. 
Very little dependence in specificity based upon the length of the N-alkyl side 
chain of either cephalosporins, or penicillins was found with the zinc dependent 
B-lactamase 2 enzyme. For the cephalosporin compounds Buckwell 0 99) found that a 
linear relationship existed between the value of the second order rate constant and the 
increasing alkyl chain length, and that a plot of AAG$ against chain length gives a free 
energy change per methylene of 0.49 U mol- 1. Carrying out the same experiment using 
N-alkyl penicillins, produced results which are shown in Table 42. Calculating the 
incremental Gibbs free energy of tmnsfer shows that no correlation exists ( Table. 9 and 
Fig. 4Z. 
Table. 18 The incremental Gibbs free eneM of transfer of N-acyl penicillins to the 
B-lactamase 2 eqz yMe from B. cereus. 
Compound 
CH3CD 
C2H50D 
C3H7(D 
C4H9OD 
C5HI ICD 
C6Hj3CD 
C7HI50D 
C8HI70D 
CloH210D 
CI IH23()D 
Penicillin AAGI/kJ mol- I 
0 
-0.97 
-1.18 
-1.58 
-0.54 
-2.86 
-1.67 
-0.95 
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Fig. 42. Plot of AAGT against chain length from the data shown in table 9 for N- 
alW penicillins. 
Therefore, it is concluded that B-lactamase 2 has no strong recognition site for 
C6 linear hydrophobic side chains of B-lactarns. 
3.10 An investigation into the effects of introducing chain branching and possible 
steric interactions of penicillin and cepbalospofin defivatives with B. cereus 5691M- 
lactamase I&2. 
The next stage of the investigation was to test the dimensions of the active-site, 
by using isopropyl and teniary butyl penarn derivatives. The results of these 
experiments can be found in (Tables 13 and 42). The cephem analogs had been 
investigated previouSly(243). The data from these experiments are summarised in 
table. 10 and show some interesting results. 
n 
Table. 10 The second order rate constant (kcat/Km) for the enzMe catalysed 
hydrolyýis of the isopropyl and tertia! y bu! yl penam and cephem B-lactams. 
Compound 
Penicillins. B-lactamase 1. 
, kcaVKm (M -I s- 
1) 
B-lactamase 2. 
CH3(CH2)2 
(CH3)2CH 
(CH3)3C 
1.84 x 107 
1.35 x 107 
0.17 x 107 
2.35 x 105 
0.96 x 105 
0.52 x 105 
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The isopropyl 7B-alkyl side-chain has little effect upon the reactivity with 
B-lactamase 1, for the corresponding t-butylcephalosporin a 1,000 fold reduction was 
observed when compared to the propyl cephalosporin. For the B-lactamase 2 enzyme 
both substrates showed 'normal' activity. The difference in activity for t-butyl 
cephalosporin between the two enzymes of 2x 105 was interpreted as being indicative 
of steric hindrance, the special requirements of the t-butyl compound being greater than 
the space available at the active-site of the serine, but not the zinc-, dependent 
B-lactamase. 
However, with the 6B-branched alkyl penicillin derivatives, the results (Table 
10 show that rates of hydrolysis by B-lactamase I and B-lactamase 2 are not greatly 
affected by these substitutions. The largest difference was observed with the t-butyl 
penam, which was 10 fold less reactive than propyl penicillin, but this is thought to be 
not large in the context of steric inhibition. From these results it would seem, for the 
serine B-lactamase, that acylating the 6/7B side-cbain of the substrate results in 
enhanced specificity, but not substantial recognition for changes in hydrophobicity and 
branching. The large decrease recorded for the t-butyl cephalosporin, which is not seen 
for the penarn analog, highlights the differences in reactivity between the penams and 
cephems. 
3.11 Investigating the effects of introducing charged fundonal groups into the 
6/7B side- cbain. 
It has been shown that substituting a negatively charged group into the side chain 
of 7P)-substituted pheny1cephalosporins dramatically decreases the enzyme specificity 
with the B. cereus. B-lactamase I enzyme, (243) giving low values for kcaVKm. 
Pheny1cephalosporin is Ix 104 times more reactive than the 2-carboxyphenyl derivative. 
With B-lactamase 2 these charged functionalifies had correspondingly little effect. 
Comparing the effect on the activity of the various substitutions with the 
B-lactamasel enzyme shows there is a large difference in specificity, which is in 
contrast to the results obtained with the B-lactamase 2 enzyme, in which there is little 
dependence of kmVKm upon the nature of the substituent. In general, the effect shown 
with the serine enzyme decreases as the substituent is moved from the 4- to the 3- to the 
2- position. The 3- and 2- substituted derivatives are three to five-fold and twenty to a 
two-hundred fold less reactive than the analogous 4- isomer, respectively. 
Superimposed on the steric effects of the substituents is a further effect causing a 
reduction in specificity, which has been interpreted as an unfavourable charge 
interaction between the enzyme and the substrate. A similar investigation by Matagne et 
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al (248) compared the reactivity of cefotaxime and ceftazidime to that of cephaloridine 
and demonstrated the effects of steric interaction in the case of cefoL-Wme, which 
contains an oxime functional group in the 7B-side chain, resulting in a reduction in the 
specificity constant of 10- 1000 fold for the range of enzymes tested. When a 
carboxylate group was introduced onto the oxime giving ceftazidime, this further 
reduces the activity towards the class A B-lactamases, compared with cefotaxime, by an 
average of 100 fold, and by as much as 10,000 fold compared with cephaloridine. 
These apparent trends are also observable for the penicillins. Comparing the activities 
of carbenicillin and ticarcillin, both of which contain a carboxylate group in the 68-side 
chain, to that of benzy1penicillin show that relative activities are decreased by 10-100 
fold. 
A notable difference between the relative activities of the cephems and penams, 
to the various class A B-lactamases, is that while both B-lactarn types show a change in 
kat with the inclusion of sterically hindering B-side chains, particularly carboxylate 
groups, the penicillins remain 'good substrates'. Thus, the inclusion of a carboxylate 
group does not appear to significantly modify the rates of acylation and deacylation. 
The inclusion of Ent. cloacae P99, a class C B-lactamase shows that for both 
penicillins, and cephalosporins the rates of acYlation do not differ greatly from those of 
the class A enzymes, any differences being within a factor of 10. 
Interestingly, Matagne et a] noted that the results of their survey of the class A 
B-lactamases produced widely varying kinetic parameters and individual behaviour 
from which it is difficult to obtain useful information. There does not seem to be a clear 
relationship between the serine class A B-lactamases and the values of kcat and 
, kcaVKm. The consistency of the catalytic or binding properties of enzymes from 
different sources often leads to the prediction that the three dimensional structures and 
therefore the mechanism will be very similar. This has important implications when 
generalisations, are drawn using three dimensional x-ray structures, mutagenesis 
experiments and kinetic data of the enzymes of class A and class C to propose a 
'general mechanism' for serine enzyme hydrolysis. 
The poor activity of the 2-carboxyphenylcephalosporin would be consistent 
with the 7B- side group interacting with a negatively charged group at or near the 
catalytically essential serine residue. From the high resolution x-ray evidence of 
Herzberg andMoUlt(149) for the B-lactamase I enzyme from S-aureus PC] possible 
candidates could be the Glutarnic acid residue- 166 or Glutamic acid- 168, and both have 
been postulated as acting as a possible general base in either the acylation or deacylation 
process. The replacement of Glu- 166 residue by a glutamine residue by mutagenesis 
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resulted in a loss of enzyme activity-057,160,161) Similar results and conclusions were 
arrived at chemically by using water-soluble carbodiimides, with the B. cereus 
enzyme. (109) These observations are supported by the loss in enzyme activity at a pH 
below the apparent pKa of an acid group. 009) Mutagenesis of Glu- 168 converting it to 
Asp- 168 is reported to have correspondingly little effect upon activity. (I 57) Although it 
is not unambiguous that this group plays any mechanistic role with the class A 
enzymes, as its replacement by aspartic acid has little effect upon activity, amidation of 
the acid residue by the action of the bulky substituent Dnp-ethylenediamine results in 
the inactivation of the B-lactamase enzymes B. cereus and B. ficheniformis (class A 
enzymes), E cloacae P99 and Raeruginosa (class QJ1 58) This has lead to the 
speculation that the role of this residue, a conserved residue of the class A enzymes, is 
not invariant and is not catalytically essential, but instead is utilised to maintain the 
active confon-nation of the enzyme catalytic centre. The observed loss of activity with 
Dnp-ethylenediamine can be explained by steric hindrance, with the substrate being 
unable to reach the enzyme active-site. The conversion of Glu- 168 into a glutamine 
residue as in the case of Glu- 166 would help resolve this problem. 
Substitution of charged functional groups into the 7B-phenyl side chain of 
cephalosporins produced little change in the reactivity with B-lactamase 2, kcaVKm 
being largely independent of the substituent. This is similar to that found for the N- 
alkyl, B-lactarn derivatives. 
The zinc dependent enzyme can be inactivated by cbelating agents and by the 
action of water soluble carbodi-imides, which modify an essential carboxylate of the 
Glu-37 residue. 058) The role of this residue has been postulated to be that of a general 
acid/base. First acting as a general base, deprotonating a metal-associated water 
molecule and as a general acid by donating the abstracted water proton to the B-lactarn 
nitrogen. Unlike the B-lactamase I enzyme, there is no indication that an ionisable 
carboxylate group on the 7B-side chain of the cephalosporin substrate lowers activity 
due to the repulsion by a like charge at the active-site of the enzyme. 
Sutton eta](172)found from recent x-ray studies of the enzyme, that the Glu-37 
residue is somewhat distant (2.3nm) from the bound zinc to be involved 
mechanistically and proposed an active role for the Glu-212 residue at a distance of 
1.1 nm from Zn. Cryosolvent studies carried out by Bicknell and Waley (240) proposed 
a mechanism which involves a confon-national change of the enzyme during catalysis, 
which is in accordance with other reports on the Toppiness' of B-lactamase enzymes, 
this could bring the distant Glu-37 close enough to act as a general base. Active-site 
rnutagenesis experiments carried out by Lim et al 180) found that the 'essential' Glu-37 
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residue when replaced by Gln-37 did not in fact result in enzyme deactivation, they also 
report that the Glu-212 residue is also non-essential.. They did find that when His-28 
(ffis-28 is not one of the three zinc histidine ligands) is mutated this did result in a loss 
of enzyme activity and consequently is an essential residue that maybe involved in 
substrate recognition. Clearly this is a subject for debate and further investigation. 
The lack of specificity of B-lactamase 2 for a wide range of B-lactams regardless 
of the size and charge suggests a mechanism where nucleophilic attack takes place from 
the less hindered (x face, despite stereoeletronic control favouring the more hindered B 
face attack. Evidence for this comes from the metal ion stabilisafion and rate 
enhancement from copper (H) catalysed hydrolysis of benzylpenicillin(21 1), the 
catalysis originating from the enhanced basicity of the the B-lactarn nitrogen in the 
transition-state. 
The reaction mechanism of the B-lactamase 2 enzyme investigated by using 
ctyoenzymology (240) revealed a branched tdphasic mechartism involving burst 
kinetics, depicted by the scheme: 
E+S- 
Ks 
w- ES , 
k2 
>E+P 
k3 
ES2 
k4 
P- ES 3E+P 
The results of the study found ES I to be a non-covalent Michaelis complex, supported 
by no change occurring in the visible spectrum upon its formation, the complexes ES2 
and ES3 are accompanied by changes in the spectra. 
This then gives rise to four hypothetical mechanisms: 
The B-lactam 0 or N displaces water as a ligand and the zinc acts as an electrophillic 
catalyst, with Glu- 37 acting as a proton shuttle in the acylation. - deacylation steps. This 
mechanism is consistent with a four and five co-ordinate zinc (H) complexes and is similar 
to other zinc (H) containing hydrolases, particularly thermolysin(249) and carbonic 
anhydme(250) 
(ii) The B-lactarn does not coordinate to the zinc, but a metal-bound water molecule is 
activated by the coordination and attacks the B-lactarn. Involving a change in the 
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co-ordination geometry of five-four-five during catalysis. This would be consistent 
with the initial enzyme-substrate complex ES I- 
(iii) Both the water and the 13-lactam are attached to the zinc (H) ion, this would be 
observed at ES2 or ES3 instead at ES 1, leading to a six co-ordinate metal ion. The six 
co-ordinate transition-state leading to and from the tetrahedral intermediate while it may 
be favoured by the zinc, the binding to the enzyme itself may become less favoured, 
which would give high metal dissociation constants. 
(iv) The fourth possibility is that the metal co-ordinated thiol group of cysteine could be 
acting as a nucleophile. This was regarded as unlikely as the binding to the mew would 
reduce the nucleophilicity and attempts at modifying the thiol were unsuccessful due to 
the protection afforded by interaction with the metal ion. 
3.12 ne pH-rate analysis of B-lactamase I and 2. 
In view of the early results and the conflicting evidence produced by kinetic, 
mutagenesis and x-ray experiments, the next stage of the work was to focus attention 
upon the changes in activity of the enzyme-substrate reactions over the pH range 3- 10. 
Tbe aim was to clarify some of the experimental observations and produce a clearer 
picture of the hydrolytic mechanism of the B-lactarnase I and B-lactamase 2 enzymes. 
The following discussion will be based primarily on the changes in the 
observed activity with changing pH associated with the free enzyme and substrate 
(kmV]Km). Tbe data collected over the pH range 3- 10 for the compounds studied do 
not show smooth patterns of behaviour making analysis very difficult. Interpreting the 
pH dependences shown by the enzyme-substrate complex(es) (either kcat or Km) is 
even more difficult and requires substantially more data than that needed for the second 
order rate constant(25 1). However, during the following discussion changes in kat and 
Km will be used to support the arguments being presented, wherever possible. 
The assignment of pKa values from the calculated curves are based on the 
results shown in tables 14-61. A curve-fitting procedure, using a non-linear reduced 
chi squared algorithm'(252) was chosen to calculate the pKa values. This equation 
allows a curve to be generated which calculates the pKa values from the experimental 
data and also allow a curve to be generated from assumed pKa values, which can then 
be compared to the experimental data. 
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3.13 The ffl-dqpýndent behaviour of the B-lactamase I egKMe from B. cercus 
569, seen1with -Ldiffeýrent6kBanLd7Bfunctioilaliýsed enamsandIce 
hems. L-- LýL-L_ __R L- 
The simplest kinetic scheme that explains the kaVKm pH dependency reported 
by Waley(I 09) for the reaction of B-lactamase I with penicillin G (benzyl penicillin) 
involves three forrns of the enzyme, differing in charge by unity with the 
interconversions, characterised by the respective pKa values relating to the free enzyme. 
This gives correspondingly three charged forms of the enzyme-substrate complex, 
linked by two ionisations. Assuming fast proton transfer reactions and that only the 
intermediate forrn of the enzyme (EHS) leads to product, the variation of kaWKm 
icil 
Kel 
EH 
Ke2 
E 
kcat 
(app) = 
Km 
(x Ks 
s- EH2S 
Kesl= (xKel 
Ks 1 kp 
S EHS w EH 'P 
KeS2-'ý (x Ke2/ 
p Ks 
+s 
-dL- ES 
kp /Ks 
I+ (H +/ Kel) + (Ke2 
with pH gives the apparent pKa values for the free enzyme Ke, and Ke2, a potential 
problem arises from the fact that these equations make no allowance for the ionisations 
of the substrate. However this would generate a rate expression cumbersome to deal 
with and therefore the analysis will be limited to the ionisations involving the enzyme 
only, except in those cases where those involving the substrate are considered 
relevant. Waleys(109) analysis generated pKa values of 4.85 and 8.60 using 
benzylpenicillin and 5.40 and 8.60 using ampicillin as the substrate. 
'Ibis work gave the pKa values 4.91±0.06 and 8.80±0.08 (Figs. 43), the results 
are shown in table 14. Replotting the data published by Waley 0 09) using 
Leatherbarrow's reduced chi squared algorithm, produced pKa values of 4.82±0.1 and 
8.72±0.05 for kcav]Km. Despite the similarities between the two sets of data it was 
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interesting to see that there was an increase in activity going from pH 4 to pH 3, the 
original data did not go below pH 4. This was repeated to establish if this was real effect 
or an experimental artifact, it was found that the increase in activity with decreasing pH 
was reproducible ( Table. ]-ý. 
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3.60 
3.20 
2.80 
2.40 
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C> 2.00 
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Fýgure 43 A plot of kcat/Km against pH for benzyl penicillin with B-lactamase 
1, at 30 OC. The line shows the bestfit curve through the experimental data. 
This could suggest that the protonated forrn of the substrate is a better substrate 
for the enzyme at low pH, this would give two forrns of the enzyme substrate complex 
giving products, instead of one: 
EH RCO2H EH +P 
RCO2H 
EH2 EH -ma- E 'w 
RCO2- 
k3 
EH RCO2- 
u- EH +P 
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Figure 44. A plot of kcat against pH for benzyl penicillin with B-lactamase 1, at 
30 OC. 
The pH-rate profile for the hydrolysis of benzy1cephalosporin catalysed by B- 
lactarnase I (Fig. 4-ý which was selected as a reference compound for the cephalosporin 
derivatives analogous to penicillin G produces the pKa values of 4.36±0.01 and 
8.80±0.1( Table 28). These values are consistent with those calculated for penicillin 
G, though pKa I is slightly different. The value of the second order rate constant for the 
cephalosporin derivative over the pH range 3- 10 is 100 fold less than those of penicillin 
G, which is consistent with the original classification of B-lactamase I as a 
tpenicillinase' enzyme. It was interesting to observe that benzy1cephalosporin also 
shows a levelling off of activity at low pH ( Fig. 45) 
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Figure 45 A plot of kcaVKm against pH for benzyl cephalosporin with 6- 
lactamase 1, calculated at 30 OC. 
10-1 
8.80 
8.40 
8.00 
7.60 
7.20 
6.80 
6.40 
6.00 
5.60 
lkdc 
5.20 
4.80 
4.40 
4.00 
3.60 
Figure 46. A plot of k-cat against pH for benzyl cephalosporin with PI-lactarnase 
1, calculated at 30 OC. 
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Similar results to these have recently been reported by Knapp and Pratt(253) for 
the pH dependence shown by penicillin G with the E coli RTEM-2 wild type 13- 
lactamase. The results show kcaVKm activity at low pH does not approach zero. In this 
case the activity at low pH was explained by different protonated forms of the enzyme 
remain active, which is fitted to scheme shown below, rather than the protonated form 
of the substrate becoming a better substrate at low pH as discussed above. 
-. a EH2 ----, -EH --E Kal Ka2 
(kCat7Kn) a2 (kCat/l, ýjn) EH 
T 
The data was fitted to the following equafion; 
(kcavl<m) EH2 [H'] 2+ (kcat/Krn) EH Kal [H+] 
kcat/Km = 
Kal Ka2 + Kal [H'] + IH'] 
2 
which gave the pKa values of 6.18±0.25 and 7.59±0.17. 
Plotting the pH-rate dependence of kmt for the standard penicillin and cephalosporin 
(Figs. 44 and 46) shows that kcat varies in a similar manner with benzyl penicillin as 
kmt/Km but giving pKa values of 5.3±0.02 and 8.75±0.06. For benzy] cephalosporin 
the values of kmt although showing similar evidence of a bell-shaped profile, the wider 
variation of the data made it difficult to calculate accurate pKa values. This implies that 
the Km for benzyl penicillin is pH-independent. Both compounds show similar 
magnitudes of Km (10-5 M) while the kcat values of the two compounds differ by 
103-104, so that the difference in specificity between benzy1penicillin and 
benzy1cephalosporin is due to either the rates of acylation (k2) or deacylation (k3). 
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3.14 The pH-rate profiles of with B-lactamase I. 
The results (Tables 29 - 31)show that plotting kcaVKM against pH for the 
01tho, meta and para isomers produces bell-shaped curves (Figs. 47 - 49) with the 
following pKa values: 
Commund. pKal pKa2 pH Wtimum 
benzy] cephalosporin. 4.36±0.01 8.80±0.1 6.0-7.5 
3-nitrophenyl 6.54±0.01 8.60±0.10 7.5 
cephalosporin. 
4-rfitrophenyl 7.53±0.03 8.16±0.20 8.0 
cephalosporin. 
2-nitrophenyl 5.96±0.02 9.25±0.01 7.0 
cephalospofin. 
I 
Figure 47 A plot of kcat/Km against pH for 4-nitrophenyl cephalosporin with 
B-lactamase 1, at 30 OC. 
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Figure 48. A plot of kcaVKm against pH for 3-nitrophenyl cephalosporin with 
B-lactarnase 1, at 30 OC. 
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Figure 49. A plot of kmVKm against pH for 2-nitrophenyl cephalosporin with 
13-lactamase 1, at 30 OC. 
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Figure 50. A plot of kcat against pH for 4-nitrophenyl cephalosporin with P). - 
lactamase 1, at 30 OC. 
Comparing the pKa values of the meta and para compounds with the reference 
compound, benzylcephalospori-n, shows that, allowing for error, that the higher pKa2 
value remains reasonably constant, while the respective lower pKa I values show greater 
variability. The pH-profiles ( Fig47and48) of both compounds are very'sharp'with 
a single optimum value, unlike the reference compound which shows a optimal activity 
over several pH values. A similarity which both compounds share with that of the 
reference compound, is the leveling off or even a 'relative increase' in activity as the pH 
changes from 3 to 4. 
For the 78-4-nitrophenyl compound inspection of the kcat and Km values 
( Table 31) shows that kcat produces evidence of a bell-shaped curve when plotted 
against pH (Fig. 50) and the pKa values 7.3 1 ±0. I and 8.78±0.1. Unlike the reference 
compound which shows pH-independent behaviour for the Krn parameter the values 
for the para nitro derivative appear at first to decrease with increasing pH, which then 
later increase, passing through a minimum at pH 7.0 - 8.0, though in the absence of 
more detailed studies it could, allowing for error, be equally argued as showing pH 
independence. Despite this uncertainty the values of Km appear to inversely change 
with kcat. T'herefore, the pH-dependent specificity could be associated with substrate 
binding, which is increased at high and low pH. Superimposed on this are the relative 
changes in kcat and Km between pH 3-4. While A-cat shows an apparent increase, Km 
shows evidence of a decrease, which could suggest an increase in transition-state 
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binding and decreased substrate binding. Inspection of the kcat and Km dependencY of 
the 7B-3-nitrophenyl isomer (Table 30) shows that while kcat remains constant over 
the pH range 4-9, the values of Krn appear to show a similar pattern of behaviour seen 
for the para isomer, though which could within experimental error could also be 
argued as pH-independent. 
The 7B-2-nitrophenyl isomer unlike the meta and pam derivatives appears to 
-I- snow a broad bell-shaped curve when kcaVYm is plotted against pH (Fig. 49). 
Unfortunately, this compound when tested using B-lactamase I did not show saturation 
kinetics under the conditions used and as a consequence it was not possible to obtain 
the individual values for kcat and Km. From the table of values (Table 29) the oitho 
isomer is 100 fold less reactive than either the meta or the Pam isomer, therefore it 
would seem that placing the nitro group oitho to the amide linkage results in poorer 
activity, whether this reflects a steric or a charge interaction or a combination of the 
two factors was not possible to evaluate. In an attempt to further resolve this question 
and the interplay of these two factors the next phase of the work was to replace the 
nitro group with a carboxylate group, which carries a fon-nal ionisable group rather 
than the canonical charge of a nitro group. 
3.15 The pH- rate profiles of 7 B-2,3,4-carbonRhenylcepbalospoiins with 
B-lactamase 1. 
The results of the pH-rate profiles of the 2,3,4-carboxyphenyl cephalosporins 
with B-lactamase I are shown in tables 32-34. The plots of kcat/Km against pH (Figs 
51-5_ý all show the remarkable behaviour of increased reactivity at low pH together 
with the 'normal' bell-shaped profile around neutral pH. Three ionisations are required 
to explain these observations, although it was possible to obtain three apparent pKa 
values, because of the errors involved, they are indicative rather than absolute. 
However, the important point is the high activity observed at low pH, which has not 
been seen previously. 
ComMund. pKal pKa2 pKa3 
2-Carboxyphenyl 4.85±0.02 5.76±0.10 
cephalosporin. 
3-Carboxyphenyl 3.92±0.10 5.84±0.01 
cephalosporin. 
4-Carboxyphenyl 4.48±0.20 6.08±0.10 
cephalosporin. 
7.68±0.01 
7.64±0.01 
8.62±0.20 
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Figure 51. A plot of kcaVKm against pH for 2-carboxyphenyl cephalosporin 
with B-lactamase I, at 30 OC. 
Figure 52. A plot of kcaVKm against pH for 3-carboxyphenyl cephalosporin 
with B-lactamase 1, at 30 OC. 
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Figure 53. A plot of kcaVKm against pH for 4-carboxyphenyl cephalosporin 
with B-lactamase 1, at 30 OC. 
The k: aVKm values are 3- 10 fold greater at pH 3 than at ambient pH. These 
were unanticipated and surprising results. To confin-n these observations and to show 
that they were not due to any physical changes of the enzyme, several repeat runs were 
made for each compound and in the case of the 4-carboxyphenyl compound initial rates 
measurements were made (Table 3-ý the results were in accordance with the single 
curve analysis. In addition to these experiments further controls were made to test if the 
increasing activity could be attributed to either the buffer being used or the ionic 
strength of the reaction medium, but again the results obtained found that changing the 
buffer or the ionic strength produced very little effect. This matches the work of Ellerby 
etal (163)who found that an ionic strength of 1=0.5M was sufficient to give uniform 
results over the same pH range involving different buffers. The B-lactamase enzymes 
do not appear to be sensitive to changes in pH or ionic strength over the pH range 4- 
10. (109,184-5,254) 
Therefore, these results could indicate that at pH's around the pKa of the 
substrate carboxylate group increased activity is observed, even though as the pH is 
lowered and approaches the pKa of a possible active acid group in the enzyme (Glu- 
166), lower activity would be expected from the protonation of this residue. The pH-rate 
profiles demand at least two active enzyme-substrate complexes, EHS, the traditional 
intermediate to explain the bell-shaped curve and EH2S or the kinetic equivalent EFISH to 
explain activity at low pH. Below pH 5 it is anticipated that the carboxyl group on the C7 
side chain will become protonated and the undissociated acid may be a better substrate 
than that with the negatively charged carboxylate. A common assumption in the literature 
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has been that the low pKa of about 4.80 is due to the protonation of the catalytically 
active Glu- 166. The pKa of the carboxyl group at C3/C4 of the substrate is around 2-3. 
If only EnzCOý- and B-lactam- C7CO2- were the only active forrns the rate should fall off 
dramatically at low pH. This is not observed. The following complexes are therefore 
possibly active. 
i. Enz C02H. B-lactam C7CO2- / C3C02- EH2S 
I Enz C02-- B-lactam C7CO2H/ C3C02- EHSH 
iii. Enz C02-- B-lactam C7CO2- ý C3CO2H EHSH 
iv. Enz C02H. B-lactam C7CO2H / C3C02- EH2SH 
v. Enz C02H. B-lactam C7CO2- / C3C02H EH2SH 
vi. Enz C02H. B-lactam C7CO2H / C3C02H EH2SH2 
Complexes iji and iii are kinetically indistinguishable as are the complexes iv and v. 
The total scheme is presented as follows: 
EH2 
pKel 
EH 
pKe2 
+ S, -- 
Ks 
aI SH 
k, 
"2 -- EH2 2 lb'EH2 
pKs I pKes I 
S2 
SH -, 
-pKeS2 
SH 
k2 
EH2SH -> EH2 
k3 
EHSH > EH 
pKS2 pKeS3 
KS3 
S EHS 
pKeS4 
pKS4 
Li ---lo- 
ES 
k4 
> EH 
p 
p 
p 
+ 
+ 
It is important to appreciate that the literal interpretation of the data in terms of pKa! s is 
not without difficulty. This work has already shown that the low pKa obtained from 
plots of kcaVKm against pH is not substrate independent and is therefore not due to a 
simple ionisation of an enzyme catalytic group. 
The observed increase in activity could be rationalised as the removal of an 
unfavourable coulombic interaction between the 7B acid group of the B-lactam and an 
acid group at the active-site of the enzyme. If this were the case then as the carboxylate 
group is moved around the aromatic ring it would be reasonable to expect that one or 
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more of the compounds would display a 'normal' pH-rate profile as the interaction 
between the groups is reduced, it is therefore surprising that all three compounds show 
increasing activity at low pH. Comparing the enzyme specificity of the three isomers 
produces a further complication, from the values of kmvy\m the descending order of 
activity is meta> pam> oilho. The meta compound is approximately twice as reactive 
as the paiaisomer and 100 fold more reactive than the oilho compound over the pH 
range 3- 10. Furthen-nore, when the activity of the isomers is compared to 7B-benzyl 
CePhalosporin at ambient pH the reference compound is at least twice as reactive, while 
at pH 3 the memand pamcompounds show the higher activity. 'ne oithocompound 
by contrast remains 10 fold less reactive at low pH, thus there would seem to be a 
balance between the steric and coulornbic intemction of these compounds within the 
active-site of the enzyme. 
Attempting to interpret the pH response of the individual Michaelis parameters 
, kcat and Km. is complicated when the deviation for error is included, despite this the 
results appear to show that for the 7B-4-carboxyphenyl compound ( Tables 33-3-ý kcat 
to be pH-independent, while Krn shows higher values at high pH and correspondingly 
lower values at low pH when compared to the ambient pH(Fig 54). 
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Figure 54. A plot of Km agahist pH for 4-carboxyphenyl cephalosporin with B- 
lactamase 1, at 30 OC. 
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This is in contrast to the changes in Km values shown by the reference 
compound, which appear pH-independent and the pam nitrophenyl compound which 
shows a possible increase in the value of Km at low pH. This could mean that if the 
PKa change of 4.48 shown by kmVKm represents the protonation of the substrate, 
then the increase in specificity comes from apparent decreased substrate binding 
(Km)aPP. 
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Figure 55. A plot of kcaVKm against pH for 4-carboxyphenyl cephalosporin 
Timer' with B-lactamase 1, at 30 OC 
Interestingly, at high pH the value of (Km)app also increases, with the result that 
decreased activity may be attributable to tighter binding of the substrate. The 7B-3- 
carboxyphenyl compound ( Table 33) displays a similar behaviour to the Pamisomer, 
with kcat remaining independent of pH while Km shows lower values of Km at the 
low pH and higher values at high pH. For the 7B-2-carboxyphenyl cephalosporin 
compound (Table 32) the value of kcat steadily decreases with increasing pH while 
Km demonstrates behaviour similar to the nitropbenyl cephalosporin derivatives, 
showing a higher value (I 00-fold increase) in Km at pH 4 and at pH 9( 6-fold 
increase) compared to the value at pH 7. Therefore, it would appear that replacing a 
nitro functional group of the 7B-phenyl side chain with a carboxylate group results in 
two types of behaviour, one involving a decrease in the value of Km as the pH 
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decreases and one involving an increase in Km at higher pH, which when combined 
with kcat these produce the higher specificities seen at low pH. 
The dimeric compound of the paia carboxylate derivative when tested for 
activity with B-lactamase I( Table 3ýover the pH range 3-9 produced data through 
which a curve, fitting two pKa values, 4.17±0.20 and 5.75±0.30, could be fitted 
(Fig-55). These values are similar to the pKal and pKa2 values calculated for the 
carboxypheny] cephalosporins, but in this case the lower pKa value is associated with 
increasing activity, while the converse holds for the dimer. The relative values of the 
second order nate constants of the 4-carboxyphenyl cephalosporin derivative and the 
dimer show that the dimer is only 10 fold less reactive towards B-lactamase 1. This is a 
surprising result considering the size of the substrate, it was expected that the B- 
lactamase I enzyme would not hydrolyse this compound. 
3.16 The pH- rate profiles of 6B-4-nitLophenyl and 4- formylphnenyl _ penicillins with 
B-lactamase 1. 
Repeating these experiments with 6B-4-nitrophenyl, 4-fon-nylphenyl and 2,3,4 
carboxyphenyl penicillins, produced some interesting and contrasting results. ( Tables 
16-20). Plotting kmt/Km against pH for the 4-nitro and forrnylphenyl derivatives (Fig 
56 and 57) produce plots with the following pKa values: 
Compound. pKal pKa2 pH Mtimum 
4-nitrophenyl 5.80±0.2 8.97±0.1 7.0 
penicillin. 
4-fonnylphenyl 5.77±0.1 9.00±0.2 8.0 
peniciffin. 
benzyl penicillin. 4.91±0.06 8.80±0.08 6.0-8.0 
The pH-rate profiles of the two functionalised penam derivatives are similar to 
those of the nitro cephem compounds and show that these compounds have optimal 
activity over a narrow pH range, typified by profiles that are 'sharp' in appearance, 
unlike the benzyl compound which has a broader range where optimal activity is 
observed. While the higher pKa remains fairly constant the lower pKa values of the 
two substituted derivatives show greater variation with the values of 5.77 and 5.80. 
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Figure 56 A plot of kaVKm against pH for 4-nitrophenyl penicillin with B- 
lactamase 1, at 30 OC. 
Figure 57. A plot of kmVKm against pH for 4-fonnylphenyl penicillin with B- 
lactamase 1, at 30 OC. 
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Figure 58. A plot of kcat against pH for 4-nitrophenyl penicillin with 
B-lactamase 1, at 30 OC. 
However, unlike the cephalosporin and penicillin reference compounds these 
derivatives do not show the levelling off in activity as the pH decreases below pH4. 
Plotting the value of kcat for the 4-nitrophenyl penicillin compound produces a bell- 
shaped curve (Fig, 58) with the pKa values 4.22±0.1. Comparing the individual 
Michaelis constants of the 4-nitrophenyl derivative illustrates some important points. 
4-nitrophenyl pgnicillin. 
pKal pKa2 pH optimum 
kcat/Km 5.80±0.2 8.97±0.1 7.0 
kat 4.22±0.1 5.90±0.1 5.0 
From these values the optimum pH value involving 'pKa' changes of the enzyme- 
substrate complex take place at pH 5.0, while the 'ionisations' involving free enzyme 
and substrate have the optimum at pH 7.0. Furthennore, the pKa values obtained by 
plotting kmt against pH differ markedly from those values obtained from plotting 
kcaVKm against pH. This could be evidence of a confon-national change taking place 
upon binding the substrate, this idea of 'floppiness' has been previously invoked to 
explain thejuxtapositioning of potential active-site residues required during hydrolysis. 
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Comparing the individual Michaelis constants of the fonnylphenyl delfivative, the 
value of the pH optimum again changes and like the 4-nitrophenyl compound the pKa2 
value obtained by plotting kcat against pH does not agree with the value obtained from 
Plotting kmt/Km against pH. The pKa I values however do not change significantly 
when the Michaelis parameter kcat is plotted against pH. 
4-fonnvi)henvl pýýnicillin. 
vKa I pKa2 RH Wtimum 
kcat/Km 5.77±0.1 9.00±0.2 8.0 
kat 5.19±0.2 8.17±0.05 6.0-7.0 
Taken together, these results may indicate either a change in the rate 
deten-nining step and therefore a 'kinetic pKa', or a confon-national change which 
results in a change in the micro environments of the key active-site residues and 
changes in the observed pKa! s. A third possibility involves a compensation 
phenomenon, in that the introduction of a functional group into the 6B-side chain 
results in a change in the intrinsic reactivity which may then offset the true pKa by 
being more or less sensitive to a change in an active-site residue at its pKa. It may also 
be that some of the compounds do produce a pH rate profile showing the pKa of the 
Glu- 166 residue while others show a change in the rate of acylation or deacylation 
steps, preceding the ionisation of this residue and therefore fail to reflect it's ionisation. 
Similarly, the values shown for pKa2 for these compounds may also be characteristic 
of a change in the rate determining step rather than by the ionisation of a catalytically 
essential residue. This may then explain the changes seen not only from comparing the 
pKa values obtained from the kcaVKm verses pH profiles of the 6B-nitrophenyl and 
formylphenyl compounds and that of the reference compound (66-benzylpenicillin), 
but also the pKa changes obtained from examination of the kcat pH-rate profiles. 
Hou and Pool e(2-54,255) have investigated the effects of substrate side chain 
structure, ionic strength and temperature on the activity of S. aureus B-lactamase and 
found that changes in activity with changing ionic strength were small, but the effect of 
changing pH was conspicuous. Ile effects of changing pH for the B-lactamase 
hydrolysis of ampicillin and penicillin G show that pH has a significant effect on Km, 
with decreased aff"ty shown by ampicillin providing evidence that the positively 
charged side chain amino group is responsible for the decreased affinity. The maximum 
activity, shown by vmax, occurs at slightly different pH optima for the two 
compounds, this was further explored by Hou and Poole, who found that the optimum 
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B-lactamase activity for a series of B-lactarn substrates varied in accordance with the 6B- 
side chain. These results were considered to indicate that different enzyme substrate 
complexes may be formed depending upon the nature of the substrate side chain. 
3.17 ne DH- rate profiles of 6B- 2,3,4-carboxyphenyl penicil I ins with B-lactamase 1. 
Replacing the 6B-benzyl penicillin side chain with 2,3,4-carboxyphenyl groups 
as with the cephalosporin analogs also produced some unusual results. ( Tables 18-261 
Plotting kcaVKm against pH for the meta and Pam carboxypbenyl penicillins gave two 
pKa values (Fig. 59 and 60). 
4-Catbonýphenyj 
penicillin. - pKal pKa2 pH gptimu 
kcaVKm 7.24±0.20 8.70±0.10 8.0 
3-CarboUpheny J1 
penicilli 
kaVKm 6.23±0.3 7.69±0.3 7.0 
2-CatbonTbenyl 
pgdcilhn. 
kcaVKm 4.90±0.3 3.0-4.0 
For the oitho isomer (Table 18) it was only possible to calculate a single pKa value, 
though the data do suggest evidence of two further values around pKa 6.0 and pKa 
7.5, (Fig 61) but to substantiate these values requires further detailed work. 
152 
Figure 59, A plot of kmVKm against pH for 4-carboxyphenyl penicillin with B- 
lactarnase 1, at 30 OC. 
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Figure 60. A plot of kcaVKm against pH for 3-carboxyphenyl penicillin with 
13-lactamase 1, at 30 OC. 
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Fýgure 61. A plot of kcaVKm against pH for 2-carboxyphenyl penicillin with Pf- 
lactamase 1, at 30 OC. 
Figure 62. A plot of kcat against pH for 3-carboxyphenyl penicillin with B- 
lactamase 1, at 30 OC. 
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The oitho compound shows an unmistakable increase in activity with 
decreasing pH compared to the ambient pH, as seen with the cephalosporin 
compounds. Therefore, as the carboxylate is moved around the aromatic ring a change 
in the pH-rate profile occurs which becomes more pronounced as the functionality 
moves through ottho>meta>para The cephalosporin analogs also show similar pKa 
values and enhanced activity at low pH. It is interesting to note that for the meta isomer 
higher activity is seen at pH 3 and 4 than at pH 5. 
Comparing the pKa values calculated for the penam and cephem B-lactams 
studied, in pailicular the cephalosporin carboxylate compounds, shows that the pKa 
value of 6.0±0.2 is highly consistent. Knapp et al(253) studying the effects of 
cy-steine/serine mutagenesis of the RTEM- I B-lactarnase published a pH-rate profile 
(, kcaVKm) of benzyl penicillin with the RTEM-2 B-lactarnase, which produced a curve 
giving the two pKa values 6.18±0.25 and 7.59±0.17. This was fitted to the scheme: 
EH EH -E 2 Kal Ka2 
(kcavKm) El2 (kcavl<in) EH 
ir 
This scheme was also supported from the B-lactamase activity with benzyl 
penicillin and borate inhibition, which defined two enzyme dissociations with the pKa 
values 6.0 and 7.5, assigned to the residues Glu- 166 and Lys-234. The assignment of 
the pKa value 7.5 to Lys-234 and not to Lys-73 was made on the evidence of the 
enzyme reactivity with methanesulphonyl floride. The methanesulphonyl fluoride 
reactivity differs from the B-lactamase activity of the borate complex in that it remains 
high throughout the alkaline pH region, and it is therefore clear that considerable 
reactivity remains with EH2 and the the catalytic apparatus of the enzyme is still 
significantly intact at this ionisation. The pKa of Lys- 73 has been previously assigned 
to be greater than 9. (256) This residue has been suggested as a component of the 
'catalytic triad' ( Ser-70, Glu- 166 and Lys-73) not only by the reaction towards neutral 
agents but also by the three dimensional evidence of x-ray studies on related 8- 
lactamases. 
The pKa value assigned to Glu- 166 in the free enzyme, 6.0, suggests a 
carboxylic group whose dissociation is retarded either by a hydrophobic environment or 
by a hydrogen bonded network. However, as the values of pKal and PKa2 shown in 
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the above scheme relate to the free enzyme, which on the binding of specific substrates 
may change. The conformational flexibility of the class A B-lactamases has been 
previously reported, MoeWS(151) suggested that the (fl) loop containing the Glu-166 
residue would need to be flexible to place it closer to the active-site serine during 
catalysis. This pKa value is in marked contrast to the observations of Waley(109) who 
calculated that the pKal value of the B. cereus class A B-lactamase to be 4.8 and 
Anderson et al (257) who calculated the pKa I value of the Saureus PC] class A 
13-lactamase to be considerably lower than 6.0. This may reflect the differences in the 
specific active-site environments of the enzymes, or it may be indicative of the different 
confori-nations of the free enzymes, the PCI and Rcereus may prefer an open 91 loop 
conformation while the RTEM-2 enzyme prefers a closed conformation. 
In this investigation of the active-site mechanism of the B. cereus B-lactamase, 
the cephem and penam, substrates studied produced results which agree with both the 
evidence produced by Waley( 109) and the work of Knapp et al(253). Benzyl penicillin 
and benzy]. cephalosporin produce pH-rate profiles which give pKa values in agreement 
with the findings of Waley, while the 6B and 7B-carboxyphenyl B-lactams produce pKa 
values in agreement with those reported by Knapp. However, unlike Knapp our initial 
assessment of the change in reactivity seen at low pH could be accountable by the 
protonated form of the substrate rather than that of the enzyme. A possible explanation 
(other than advocating that the class A B-lactamases have non-identical active-site 
conformations) for this different behaviour is that the B-lactamase enzymes are capable 
of the binding individual 13-lactams into the active-site differently and so the apparent 
pKa! s obtained reflect a combination of more than one set of catalytically essential 
residues of the free enzyme. For example with B. cereusB-lactamase the absence of a 
613-713 side-chain charged functionality on the substrate may result in the ionisation of 
Lys-73 being predominant, giving a pKa value of 8.80, as reported for benzyl 
penicillin by Waley( 1 ()9), while introducing a carboxylate group into the aromatic ring 
of the side chain orientates the substrate in the enzyme active-site such that it makes it 
sensitive to the ionisation of Lys-234, thereby producing an apparent pKa value of 
7.50. The pKa of the Glu- 166 residue has been reported to be 4.80 by Waley and 6.0 
by Pratt et a] but since both these pKa values have been observed during this work it 
could mean that one of the values is a 'kinetic pKa' while the other value represents the 
true pKa of the glutamic acid residue, or perhaps both values represent different pKSs 
of the Glu- 166 residue, one in which the environment has been disrupted and one not. 
Ilis is supported by the work of Adachi et al(258) who through active-site 
mutagenesis produced mutant strains of the RTEM- I B-lactamase, substituting Ala- 
166, Asp- 166, Gln- 166 and Asn- 166 for the Glu- 166 residue. All the mutant strains 
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accumulated a covalent complex with benzylpeniciflin coffesponding to a stable acyl- 
enzyme intermediate, but only the Asp- 166 mutant displayed slow hydrolysis of this 
complex, the stability of the enzyme-substrate complexes is believed to be sufficient for 
crystallographic purposes. This indicates that the role of Glu- 166 is to act as a specific 
catalyst in the deacylation step only, the carboxylate group is not-essential for substrate 
recognition or for acylation. It was also found that the Glu- 166 residue plays an 
important role in the folding of the protein, and the possibility remains that the folded 
state of the mutant proteins do not resemble that of the wild type enzyme. If Glu- 166 is 
involved only in the deacylation process this leaves the question as to what machinery 
is responsible for the acylation process, candidates include Ser- 130 (153)and Lys-73 
(149). Therefore it would appear that the enhanced activity seen at low pH could be due 
to one or a combination of either the protonation of an active-site residue of the enzyme 
or of the substrate at positions C3 and of the 6B-side chain phenyl group. 
In this work only the meta carboxyphenyl penicillin compound demonstrated 
saturation behaviour throughout the pH profile allowing for detailed analysis. The para 
isomer gave saturation kinetics only between pH 5-8 and the oitho isomer did not 
display saturation kinetics. The results for the meta compound (Table 19) show that Km 
is pH-independent and plotting kmt against pH (Fig. 62) produces a bell-shaped curve 
with an optimum at pH 7.0 and two pKa values, 6.48±0.2 and 8.16±0.3. The higher 
values given by kmt compared to kcat/Km may be indicative of the same enzyme 
residues but in disturbed environments in the enzyme-substrate complex, as a result of 
substrate binding. 
Evidence for the B-lactamase I enzyme of B. cereus 569/H displaying a 'kinetic 
pKa' in the acid region of the pH-rate profile comes from the observation that while the 
high pKa value remains reasonably constant the low pKa value shows greater 
variability, as demonstrated in the following table: 
Comppund low pKa NO pKa 
Benzyl penicillin. 
4-ForTnylphenyl penicillin. 
4-Nitrophenyl penicillin. 
3-Carboxyphenyl penicillin. 
4-Carboxyphenyl penicillin. 
4.91±0.06 
5.77±0.10 
5.80±0.20 
6.23±0.25 
7.19±0.15 
8.80±0.08 
9.00±0.20 
8.97±0.10 
7.69±0.30 
8.70±0.10 
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Compound low pKa high pKa 
Benzyl ceohalosporin. 4.36±0.01 
2-Carboxyphenyl cephalosporin. 5.76±0.10 
3-Carboxyphenyl cephalosporin. 5.84±0.01 
2-Nitrophenyl cephalosporin. 5.96±0.02 
4-Carboxyphenyl cephalosporin. 6.08±0.10 
3-Nitrophenyl cephalosporin. 6.54±0.01 
4-Nitrophenyl cephalosporin. 7.53±0.03 
8.80±0.10 
7.68±0.01 
7.64±0.01 
9.25±0.10 
8.62±0.20 
8.60±0.10 
8.16±0.20 
The use of pre-steady state techniques and cryoenzymology to investigate the 
serine enzyme hydrolysis mechanism of the B-lactamases has demonstrated that the 
mechanism proceeds via an acyl-enzyme inten-nediate, the simplest scheme depicting 
this sequence being: 
k-, k2 k3 
E+S : ýý ES > EA >E +P 
kl 
where ES is an enzyme-substrate complex and EA is an acyl-enzyme intermediate and 
P is the product. Anderson et al (257) using dansyl cephalosporin as the substrate to 
study the pre-steady state pH rate behaviour with the Saureus PC] class A B- 
lactamase, found that acylation was rate deterniining and that acylation and deacylation 
were pH invariant at low pH but decrease proportionately at higher pH. The following 
scheme was proposed: 
Ks, 
EH2 +S F-H2S 1. pKel= 4.4 
3- 
2- pKe2= 7.7 
Ks ]k-2 3- pKesl< 4.4 
EH +S -' EHS EHS' EH +P 4- pKeS2-'-2 7.7 '2 k3 
2- 4- 5- 2- 5- pKeS'22-- 7.5,7.8 
KS2 
Ks, >Ks=KS2 E+S ES ES' E 
k2> k-2--z%k3 
This scheme implies that the rate is limited by the chemical processes of acylation. and 
deacylation, both these steps requiring an enzymic functional group with a pKa around 
7.70 in the protonated form, and therefore that the acyl-transfer reactions are general 
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acid catalysed. A general base is also required to activate the active-site nucleophile 
during acylation and the hydroxyl group of water during deacylation, for this function 
the residue must have a conjugate acid/base of around pKa 4.0, likely to be a 
carboxylate group. The non-perturbation of this pKa by the substrate implies that the 
substrate C4-carboxylate group and the carboxylate group of the protein are not closely 
associated. In contrast Pratt eta] (259) investigating the accumulation of an acyl-enzyme 
with S. aureus PC] and dansyl penicillin concluded that the rate determining step at 
saturation of S-type penicillins is deacylation. In earlier work canied out by Waley et al 
(240) investigating the pre-steady state kinetics B-lactamase I from Bxereus56941 with 
7B-(2,4-dinitrophenylamino) deacetoxycephalosporin and cephalosporin C it was 
found that acylation was rate determining in both cases. Fisher (260)concluded that for 
good substrates with the class A B-lactamases acylation is rate determining. In later 
work Waley et al(261) reported that B. cereus 569/li 13-lactamase with penicillin G and 
penicillin V the rate constants for acylation and deacylation were high and of the same 
order of magnitude, and that the dependence on pH of the two processes was similar 
on the alkaline side. These high values and similar dependence on pH are indicative that 
the same enzyme residues participate in the catalysis of both acylation and deacylation. 
The high value of acylation suggests the concentrations of E, S and ES at equilibdum 
may not be in the same proportions and therefore for good substrates the hydrolysis by 
B-lactamase I is partially diffusion controlled. Similar results were reported for the 
B-lactamase PCI of S. aureus. 
ýFhese contrasting results suggest the distinction between penicillins and 
cephalosporins, and between 'good' and 'bad' substrates can generally be made on the 
basis of the changes in the rates of acylation. Consequently, as the work in this 
investigation demonstrates, as the substrates are modified it is possible to observe a 
change in the rate-deten-nining step of acylation or deacylation, furthen-nore, it can be 
speculated that the same groups involved in acylation need not be the same as those 
involved in deacylation. In fact it is easier to understand if they are not, since the 
general base would be in the wrong place to perform both functions of deacYlating the 
serine residue and the hydroxyl group of the incoming water molecule, especially if the 
action of ring opening the B-lactarn involves a twisting action rather than a stretching 
motion. The twist would place the acyl-enzyme ester involving Ser-70 away from the 
general base that deprotonated the serine and therefore the incoming water must 
approach and be activated by a base located elsewhere in the active-site. If, as 
suggested by Waley(19-7) that the Glu- 166 residue is responsible for both catalytic steps 
this also would entail conformational movement of the active-site residues changing the 
location of the acid residue from the position seen in the crystal structures of the class A 
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enzymes. It is possible that either of these confon-national changes could be partially 
rate detennining. 
Thus, the pH rate profiles of the compounds studied could show a change from 
acylation to enzyme substrate formation implicating a different general base, involving 
an uPfield shift of the lower pKa from 4.91 to around 6.0. Kinetically, this can be 
demonstrated by re-considering the scheme: 
k-, k2 k3 
E+S- 
---»- 
ES W, EA >E +P 
kl 
accepting the assumption that a change in the rate deten-nining step involves the rate of 
acylation then if it is assumed that kI is pH- independent and k2 is pH-dependent, then 
k, k2 Ka 
kcaVKm = x 
k-, + k2 Ka + [H+j 
This can be illustrated as; 
kcaVKm = 
kcat 
Km 
I- & 2- 
kcav'Km kI Ka 
[H+l 
'true' pKa for a less reactive substrate 
k, k2 Ka 
kcat/Km 
k-I 
x 
Ka + [H+j 
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-17 ph 'true' pKa 
At the break, for good substrates where k2ý: k- 1, the pH is still below the true pKa and 
k, Ka 
kcaVKm = 
[W] 
since H+ >> Ka then 
k2 
x 
Ka Kapp = Ka x 
k2 + k-i 
_, + 
k2 [H+l k2 
Therefore, a change in the rate limiting step can only occur when k- I ý! k2. 
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3.18 The reaction of 7/6B-carboLcycycjoheUl cohaloýpgfins and mnicillins with R 
cereus 5691H B-lactamase euýMes I- 
In an attempt to investigate further the enhanced reactivity shown at low pH by 
A- - the charged OB arylcarboxylate side chain containing penam and cephem compounds 
a series of stereochernical cis'tians 2-carboxy cyclohexyl penicillin and cephalosporin 
derivatives were prepared ( b. and c. ), the 2- cyclohexyl carboxylate compounds were 
selected because the corresponding oithocarboxyphenyl derivatives show the largest 
change in behaviour associated with changing pH. The underivatised cyclohexyl group 
(a. ) allowed for the evaluation of the cis and tmns isomers and for the changes in 
reactivity due to changing an aromatic side chain group for a saturated cycloalkyl. 
group. 
RCONH RCONH 'I-, 
s 
S CH3 -7 62 
x T. 
513 
5 
72 
0/)ýj 
4 3 CH 30 CH20COCH3 
0 o"I H 2H 
02 
(R) 
B-lactam 
7 
a. 
B-Lwtam 
C02H 
B-Lactam 
ýý-02H 
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The results of the pH-rate studies involving the B. cereus 5691H 13-lactamase I 
enzyme and the penarn compounds are shown in tables 21-23 and the cephern 
compounds in tables 38-40. Plotting the second order rate constant kcaVKm against 
pH (Figs 63-68) for these compounds produced the pKa values shown below: 
Compound pKal pKa2 pKa3 pH Mtimum 
Cyclohexyl peniciflin. 5.05±0.1 9.10±0.2 6.0-7.0 
ci&2-Carboxycyclohexyl 4.10±0.2 7.40±0.3 3.0 
perficillin. 
hans-2-Carboxycyclohexyl 4.20±0.2 5.80±0.2 5.0 
penicillin. 
Cyclohexyl cephalosporin. 3.32±0.3 9.46±0.3 5.0-8.5 
ciswMarboxycyclohexyl 3.20±0.2 4.65±0.3 6.70±0.3 4.0-6.0 
cephalosporin. 
tmns-2-Carboxycyclohexyl 6.80±0.2 9.05±0.2 8.0 
cephalosporin. 
Comparing thekcaVKm activity of the reference cyclohexyl compounds to 
those of benzyl penicillin and benzyl cepbalosporin, show that there is, allowing for 
error, reasonable agreement between the calculated pKa values for the penicillin 
compounds, while for the cepbalosporin compounds greater deviation exists. 
Compgund pKal vKa2 pH Mtimum 
Cyclohexyl peniciffin. 5.05±0.1 9.10±0.2 6.0-7.0 
Benzylpenicfllin. 4.91±0.06 8.80±0.08 6.0-8.0 
Cyclohexyl cephalosporin. 3.32±0.3 9.46±0.3 5.0-8.5 
Benzylcepbalosporin. 4.36±0.1 8.80±0.1 7.0-8.0 
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Figuie 63. A plot of kmVKm against pH for cyclohexyl penicillin with B- 
lactamase 1, at 30 OC. 
Figure 64. A plot of kcat/Km against pH for 2-cis-carboxycyclohexyl penicillin 
with B-lactamase 1, at 30 OC. 
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Figure 65 A plot of kcaVKm against pH for 2-trans-carboxycyclohexyl 
penicillin with B-lactamase 1, at 30 OC. 
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Figure 66. A plot of kcat/Km against pH for cyclohexyl cephalosporin with 13ý 
lactamase 1, at 30 OC. 
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Figure 67 A plot of kcaVKm against pH for 2-cis-carboxycyclobexyl 
cepbalosporin with B-lactamase 1, at 30 OC. 
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Figure 68. A plot of k-caVKm against pH for 2-trans-carboxycyclohexyl 
cephalosporin with B-lactamase 1, at 30 OC 
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The cephalosporin derivatives are much poorer substrates for B-lactamase I 
than are the coffesponding penicillin compounds. If, the decrease in reactivity shown 
by the lower value of 3.32 reflects the pKa of an ionisable acid, the most likely would 
be the C4 acid group on the dihydrothiazine ring of the cephalosporin compound. For it 
to be an acid group of the enzyme would require a substantial shift from the 'normal' 
observed pKa value, though this can not be discounted. If this were the case, it would 
be in direct contrast to the results shown by benzylpenicillin, where evidence exists that 
the protonation of the corresponding acid group of the heterocyclic thiazolidine ring 
increases specificity. Altematively, the value obtained for the cyclohexyl compound 
could be further evidence of a kinetic pKa. To resolve this uncertainty more data points 
are required. 
The pH-rate plots of the individual values of kcat and Km of the two penicillin 
reference compounds ( cyclohexylpenicillin and benzyl penicillin ) (Fig. 44 and69170) 
show that for cyclohexylpenicillin Km appears to pass through a pH minimum at pH 6, 
though the values ( Table 21) which deviate only by a factor of two over the pH range 3 
- 9, could also be described as independent of the changes in pH. The value of kat on 
the other hand appears to pass through a maximum at pH 7.0-8.0. This can be 
compared with those of benzyl penicillin, for which the kcat dependence gave the 
values 5.30±0.02 and 8.75±0.06, and Km to be pH-independent. In both cases there 
is insufficient information to analyse any further and substantially more data is required 
before an accurate assessment can be made. Inspection of the individual Michaelis- 
Menten parameters of the cephalosporin reference compounds ( Tables 28 and 38) show 
that both kat and Km for the cyclohexyl derivative remain constant over the pH-range 
3-9 until pH 3 when the value of Km increases seven fold. The benzy] cephalosporin 
derivative displays pH-independent behaviour for the Km parameter while the value of 
kat appears to pass through a maximum at pH 8.0. 
The values of the second order rate constants of the respective reference 
compounds show that the cyclohexyl compounds are less reactive than the 
corresponding aryl compounds. Therefore, replacing the benzene ring by a saturated 
six membered ring reduces the enzyme specificity. For the penicillin derivatives this 
appears to be due to an increase in Km of the cyclohexyl compound, the value of k= 
is equivalent for both substrate types. For the cephalosporin compounds both kmt and 
Km are reduced for the cyclohexyl derivative, with the largest difference, by a factor of 
10 being a decrease in the value of kat. 
Comparing the plots of the second order rate constant against pH (Figs 64 and 
65) of the cis and tr&is isomers of 2-carboxycyclohexyl penicillin show that they 
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display very different behaviour, which is further complicated by the ttans isomer 
being a diastereorneric mixture. There is a notable difference between the two 
compounds, the cis compound displaying the higher activity, particularly at low pH 
where the difference is a hundred fold. 
The lower pKa values of 4.10 and 4.20, which are lower than that calculated 
for the reference compound, could be indicative that at the ionisation of the side chain 
acid group of the substrate affects activity. Evidence that it could be the pKa of the 
substrate comes from the behaviour at low pH of the cis1trans compounds, the cis 
derivative displays increasing activity going from pH4 to pH3. This could mean that 
the acid group of the 6B side chain when in the cis position interacts unfavourably with 
the active-site of the enzyme and as the pKa of the carboxylate group is reached this 
destabilising interaction is removed and produces enhanced activity. This is also seen 
with the oitho aryl-carboxylate compound. The tmns isomer does not display this 
behaviour, instead the activity decreases frorn pH 5 to pH3. Therefore, for the tmm 
derivative the ionisation of the side chain carboxylate does not effect the enzyme 
specificity indicating an absence an interaction with the enzyme. Again this is seen by 
the pam aryl carboxylate compound. 
Comparing the individual parameters of kcat and Km for the cis compound 
(Fig 71 and 72) shows that pH-dependence of Km displays offly one apparent pKa 
value of 6.58±0.1. Plotting kcat against pH, though based on a few data points appears 
to produce a pH profile from which two pKa values, 6.30±0.1 and 8.02±0.1, can be 
derived. These values differ from those found by plotting the second order rate 
constant and may reflect the changes in pKa values as a result of substrate binding 
since kcat values depict changes taking place in the enzyme substrate complex. 
Optimum activity is seen at pH 7 for kcat but for the second order rate constant 
optimum activity is seen at pH 3. There was insufficient data to assess the tmns 
compound, which did not display saturation kinetics for the pH values 8- 10. Though 
the results do indicate that Km passes through a minimum around pH 5, while kcat 
passes through a potential maximum at pH 6. 
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Figure 69 A plot of Km against pH for cyclohexyl penicillin with B-lactamase 
1, at 30 OC. 
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Figure 70. A plot of kcat against pH for cyclohexyl penicillin with B-lactamase 
1, at 30 OC. 
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Figure 71. A plot of Km against pH for 2-cis-carboxycyclohexyl penicillin with 
B-lactamase 1, at 30 OC. 
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Figure 72. A plot of kcat against pH for 2-cis-carboxycyclohexyl penicillin 
with B-lactainase 1, at 30 OC. 
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Ibe data obtained for the cislirans 2-carboxycyclohexyl cephalosporin isomers 
unlike the penicillin derivatives display little behaviour in common, or to that of the 
reference compound, 7B-cyclohexyl cephalosporin. Saturation kinetics, in contrast to 
the benzy] derivative, were not observed with the cyclohexyl isomers, though higher 
reactivity (kcaVKm) was seen with both the isomers. The kmVKm against pH plot 
(Fig 68) of the tmns isomer produces a bell-shaped curve with maximum activity at 
pH8, with the pKa values 6.80±0.2 and 9.05±0.2. The cis compound, by contrast 
, produced a pH-rate profile (Fig 67) giving some evidence of three pKa values with 
the maximum activity seen at pH4, producing the pKa values of 3.20±0.2,4.65±0.3 
and 6.70±0.3, these values represents no more than an indication, more data is 
required to establish the validity of this interpretation. Despite these reservations the 
lack of similarity of these results suggest that a different mechanism or rate detennining 
step controls the hydrolysis of these compounds, re-enforcing the idea of enzyme 
recognition and kinetic pKa's. 
The lower pKa value of 3.20 shown by the cis derivative could be indicative of 
the protonafion of the 7B-side chain carboxylate, which in the case of the cephalosporin 
compound results in lower activity, whilst for the corresponding penicillin derivative 
protonation of the side group carboxylate enhances enzyme activity. Alternatively, the 
reduced activity may reflect the protonation of the carboxylate group of the 
dihydrothiazine ring, and the loss of a salt bridge fon-nation with the Lys-234 residue. 
However the benzy]. penicillin derivative shows evidence of enhanced reactivity for the 
same process. T'he transcompound, similar to the penicillin isomer, does not show any 
effect on rate resulting from a protonation/deprotonation step occurring with a pKa 
value around 3.20. However, it does show an upfield shift of the lower pKa I value 
compared to the value of the reference compound, while the higher pKa value remains 
unchanged. This is similar to the behaviour shown by the non-ionisable aryl penicillin 
compounds, which were explained in ten-ns of providing the possibility of a kinetic 
pKa. 
Finally, the absence of a pKa value in the region 8.50-9.50 for the cis 
cyclohexyl isomer questions the assigning of this value to the pKa change of a basic 
lysine residue, either Lys-73, a proposed general acid of the active-site or Lys-234 
which has been implicated in substrate binding. The iorfisation of these residues has 
been proposed to account for the loss in activity at high pH. The cis compound has 
the highest pKa value of only 6.70, this then must question the proposed 'essential 
roles' of either of these residues. Knapp et a/ (253) investigating the effects of the 
mutagenesis of (Ser-70-4Cys) have shown that the reaction of benzyl penicillin with 
with the RTEM 2 B-lactamase has a pKa I value of 6.18 which could be either that of 
Glu- 166 or Lys-234. Therefore, perhaps what is shown here is the effects of 
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differential binding which results in a change in sensitivity to the pKa of different 
groups within the enzyme active-site. Though it must also be remembered that these are 
poor substrates for the B-lactamase I enzyme. 
3.19 The pH-rate profile of the C3-alcohol of penicillin V and ester of penicillin G 
and the C4-lactone of beDZ3L] cephalospofin with B. cereus 5691H 13-lactamase 
es 1. 
Having investigated the complex behaviour shown by the penams and cepbems 
containing charged functional groups in the 6/7 B side-chains, the focus of attention 
was changed to the carboxylate function at position C3/4. It was decided to modify the 
substrates by altering the functionality at these positions to produce substrates with no 
ionisable groups and monitor the effects on reactivity over the pH range 3- 10. The 
lactarn compounds made were an alcohol (A. ), an ester (B. ) and a lactone (C. ). 
A. 
B. 
C. 
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The starting materials for these compounds were phenoxymethyl penicillin, 
benzyl penicillin and benzyl cephalosporin, these were chosen for their high activities 
with the 13-jactamase I enzyme. The alcohol compound is also the potential precursor to 
s 
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producing an aldehyde at the C3 position of a penicillin B-lactam. It was believed that 
the aldehyde compound would act as a potential inhibitor and provide an active-site 
label of the serine enzyme. 
One of the primary assumptions of the interactions between 13-lactams and class 
A and C B-lactamases, is that between the C3/4 carboxylate group of the substrate with 
an active-site lysine group, in the case of the B. cereus 5691H B-lactamase enzyme I 
this has been identified as the Lys-234 residue. This assumed essential interaction is 
used in all the model building studies using three dimensional X-ray information of the 
protein active-site. Model building is used because as yet none of the X-ray studies 
reported have been able to trap an intact substrate molecule or a good competitive 
inhibitor in the active-site. It was hoped that the aldebyde substrate would form a 
Sch. iffs base with the lysine residue, confin-ning this interaction and provide an active- 
site label. 
The results of the experiments on the substrates in which the C3/4 carboxylate 
of the B-lactarn is replaced by non-ionisable groups are shown in tables 24-27 and 41. 
Plotting the second order rate constant (kmVKm) for B. cereus, 569/H B-lactamase I at 
30 oC and ionic strength 0.2 M against pH ( Figs 73- 76) produced the pKa values: 
Compound pKal pKa2 pKa3 pH gptimum 
C3-Alcohol. *5.10±0.20 9.40±0.30 
**5.20±0.20 9.70±0.30 
**4.70±0.20 8.10±0.20 9.40±0.20 
C3- Methyl Ester. 5.80±0.10 9.46±0.10 
Benzylcephalosporin. 4.36±0.10 8.80±0.10 
C4-Lactone. ***4.84±0.20 9.20±0.10 
* 1% v/v dioxan-waterat 300C vvith anionic strength of 0.2M.. 
** 20% v/v methanol-water with an ionic strength of 0.2M. 
*** I% v/v (1,4 dioxari/acetoniHe- water(40: 60)). 
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Figure 73. A plot of kcaVKm agahist pH for the C3 alcohol of perkillin V 
solubilised in 1% v/Iv 1,4 dioxan, at 30 OC. 
Figure 74. A plot of kcat/Km against pH for the C3 alcohol of penicillin V 
solubilised in 20% v/v methanol with B-lactamase 1, at 30 OC. 
174 
To study the enzyme hydrolysis reaction it was found that the alcohol was fully 
solubilised by using I% v/v 1,4 di oxan. The decision not to use methanol as a co- 
solvent was made to avoid the potential methanolysis side reaction, this could have the 
effect of complicating the reaction kinetics. Under our chosen conditions saturation 
kinetics was not observed and the data was analysed by single curve progression 
analysis, consequently the discussion will be limited to the second order rate constant 
kCaVKrn 
- From our data (Tables 25,26) two pKa values were obtained, 5.10 and 9.40, 
the C3-alcohol shows a bell-shaped pH-rate profile ( Fig 73). There are two important 
observations to make. Firstly, there is undoubtedly a basic group on the enzyme which 
needs to be in its protonated form for maximum activity. This group has a pKa of 9.40. 
It is often assumed that the high pKa observed in B-lactamase I catalysed hydrolysis of 
B-lactarn antibiotics is due to Lys-234 interacting with the C3 carboxylate group. This 
work shows that there is still a catalytically important group of high pKa even when the 
C3 carboxylate is replaced by the neutral bydroxymethyl group. It seems extremely 
unlikely that this ionisable group represents Lys-234 interacting with the C3 alcohol. 
The C3 alcohol is a good substrate ( kcaVKm 10 5 M- I s- 1) and therefore we conclude 
that the ionisable group of pKa 9.40 is serving a function other than interacting with the 
C3 carboxylate of penicillins. - 
The second important observation from the pH-rate profile ( Fig 7-ý is that, 
unlike the other substrates, the rate does fall off as expected at low pH. At pH3 
kcaVKm. is smaller than that at pH 4. This indicates that the levelling off of the rate at 
low pH observed for substrates with an ionisable group at C3 may be due to its 
conversion to an undissociated carboxylic acid. 
Shortly after this work had been completed, Ellerby etal(163) published the 
results of a study investigating the effects of mutagenesis on the B. fichenifbimis class 
A B-lactamase involving changes of the Lys-234 residue, as part of the study they 
investigated the reaction of the C3 methyl alcohol of phenoxymethyl penicillin 
( Penicillin V) with the wild type and mutated enzymes, but over a narrower pH range, 
4-9, than that used in this study. The role of the lysine 234 residue has long been 
advocated in the mechanism of the catalytic action of the class A and class C serine 
enzymes by providing an electrostatic binding site for the C3/4 carboxylate of the B- 
lactarn substrates, this fundamental assumption was tested by Ellethy et al(163) by 
changing the lysine 234 group for glutamic acid and alanine. These mutations caused 
pKa perturbations of the ionisable groups responsible for the pH dependence of the 
free and bound enzyme. As might be expected the mutations resulted in decreased 
substrate recognition, reflected by changes in the value of Km at neutral and higher pH. 
At low pH Km remains essentially the same for the two mutant enzymes as for the wild 
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type enzyme. The changes in the value of kcat for the mutant strains also indicate 
changes in the transition-state stabilisation as well as the ground state binding. 
Lys-234 is a highly conserved residue of the serine B-lactamases and was 
proposed as taking part in electrostatic bonding with the substrate carboxylate group by 
Knox (163) based upon analogous catalytic mechanisms of the cell wall peptidases. 
Later, with the arrival of detailed x-ray results the side chain of Lys-234 was found to 
be protruding into the active-site cavity close to the serine residue, model building 
showed the side chain amino group to be ideally positioned to stabilise the substrate via 
coulombic interaction. 
The hydrolysis of the C3-alcohol of penicillin V as a function of pH was 
reported to give, with the wild type enzyme B. fichenifoanis, a pH-rate profile with two 
pKa values, 4.89 and 8.30. Unusually, it was the basic forrn of both catalytic groups 
which caused activity. The mutant enzymes with the alcohol substrate produced the 
'non-nal' bell-shaped curves with pKa values of 4.90 and 8.40 and 5.20 and 10.0 for 
K234E and K234A substitution, respectively. 
The published results show Km to have increased I 0-fold for the alcohol 
compared to the C3-acid substrate with the wild type enzyme, for the mutant enzymes 
Km is shown to have risen slightly. The value of kcat of the alcohol substrate with the 
wild type enzyme reduces 15-fold, while for the mutants a small increase is seen when 
compared to acid substrate. The pH dependence shown by the alcohol substrate with 
the wild type enzyme, show an increase in activity with increasing pH and is matched 
by a corresponding decrease in the value of Km. This was interpreted as improved 
binding of the alcohol compound above the pKa of the Lys-234 residue and therefore 
more than one ionisation state of the enzyme is capable of catalysing the hydrolysis 
reaction. The bell-shaped profiles shown by the mutant enzymes support this view and 
show clearly that residue 234 is not the only catalytically essential residue with an 
ionisation value composing pKa2. 
With this difference in results between our experiments and the published 
experiments the pH dependence of the alcohol was repeated, this time using the 
conditions of Ellerby et a]. The results of this experiment (Table 27) produced data 
through which two or three pKa values could be deten-nined when plotted against pH. 
(Fig. 74) It is interesting to note that the pH optimum value was obtained at pH 9.0, 
which matches the published data. Using I %v/v dioxan the kmVKm optimum value is 
obtained at pH 7.0. When two pKas are calculated from the results in 20% v/v 
methanol values 5.20 and 9.70 are obtained and produces a profile similar to that 
176 
Obtained from the original experiment carried out in 1,4 dioxan (Fig 73). Calculating 
three pKa values produces a curve of greater similar to that reported by Ellerby eta/ 
with the calculated values 4.70,8.10 and 9.40. The first two pKa values agree with the 
values calculated from the published data, but extending the pH rate profile to pH 
11.30 shows that a third value exists associated with a decrease in activity with 
increasing pH. 
When the C3 methyl ester of benzyl penicillin was tested as a substrate over the 
PH range 3.0- 10.0 ( Table 24) this produced a curve with the pKa values 5.80 and 9.46 
(Fig 75). Comparing the higher pKa2 value obtained using the alcohol and ester 
derivatives as substrates to that of the corresponding acid compounds suggests that by 
removing the C3 carboxylate group from the substrate that activity depends upon an 
ionisation of an essential group of the enzyme between pH 9.0 and 10.0. The lower 
value of pKa2 seen for the C3 acid compounds, between pH 8.0 and 9.0 is presumably 
either a 'kinetic pKa' or some other complex behaviour, such as alternative binding or a 
change in the hydrolytic mechanism. 
For a cephalosporin derivative the C4 carboxylate group was lactonised by 
cyclising the C3 side chain to the C4 acid group using the method of Cocker eta](215) 
Unlike the modified penicillin compounds saturation kinetics were observed, which 
show Km to be pH-independent andkcat to produce a profile matching the second 
order rate constant. The compound was solubilised in a mixture of I% v/v 1,4 
dioxan/acetonitrfle-water. The data obtained (Table 41 ) with the B-lactamase I enzyme 
was used in the curve fitting routine calculating two values (Fig 76). Unusually high 
reactivity of the lactone substrate was seen at pH 7.0, this was tested by repeating the 
experiment between the pH values 6.0 and 8.0, the results show consistency with the 
original data (Table 41). 
The pKa values calculated show that the values are in agreement with those obtained 
with the penicillin alcohol compound and therefore a similar argument as used for the 
alcohol compound pertains and leads to the conclusion that the often quoted essential 
role of Lys-234 in substrate binding is not in fact supported by the results of these 
experiments. This can be further demonstrated by comparing the ratio of the second 
order rate constants (kmt/Km) to that of the hydroxide ion catalysed hydrolysis of the 
modified penicillin and cephalosporin compounds to the ratios obtained for the 
corresponding acid derivatives. The hydroxide ion catalysed hydrolysis is used to 
detennine the chemical reactivity and the effects of structural changes involving B- 
lactarris antibiotics. The magnitude of these effects will depend upon the nature of the 
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Figure 75. A reproduced plot of kcaVKm against pH for the C3 methyl ester of 
penicillin G with B-lactamase 1, at 30 OC. 
Figure 76. A plot of kcaVKm against pH for the C4 lactone of benzy] 
cephalosporin solubilised in I% v/v 1,4 dioxan with B-lactamase 1, calculated at 30 
0C. 
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nucleophile, and the rate determining step. Despite these problems of direct comparison 
the hydroxide ion catalysed hydrolysis will be used as an index of reactivity and to help 
interpret the effects of substrate changes on the molecular interaction of modified 
substrates with the active-sites of the B-lactamase enzymes. 
The alkaline and enzyme hydrolysis at pH 7.0 of the methyl ester of penicillin 
G and the lactone of benzyl cephalosporin has been previously investigated. (269) It Was 
found that the rate of hydroxide-ion catalysed hydrolysis is increased when the 
carboxylate groups at positions C3 and C4 of penicillins and cephalosporins are 
replaced by an ester and lactone group, the value of the second order rate constant is 
16-130 fold greater than that of the corresponding acids, the alcohol by contrast is 
bydrolysed at a comparable rate to the acid (Table 11). 
Table IL The effect of the carboLcyjategroup on the chemical and B-lactamase I 
activi1y of penam and cephem compounds at pH 7.0 
Substmte kOH/M-Idm3s-I B-lactamase I kcaVKm/M-Is-I 
Benzy] penicillin. 1.54xlO-I 4.35xlO7 (4.17xlo7)a. 
Benzyl penicillin 
methyl ester. 2.49 6.29x 103 (7.03x 103) 
Benzyl penicillin 
methyl alcohol. 3.10xlO-l 4.59xI05 
Benzylcephalosporin. 8.90xIO-2 IAOA04 (0.60x 104) 
Benzy1cephalosporin 
lactone. 11.60 l. 38xlO5 (3.23xlo5) 
a. From Laws, A. L. &Page, M. l. J Chem. Soc. PERKIN TRANS. 11(1989)1577-81. 
Raflo 
2.82xI08 
2.53xlo3 
1.48xI06 
1.57xI05 
1.1 9X 104 
The enhanced reactivity shown by the ester and lactone is due to them being more 
electron withdrawing than carboxylate groups making the B-lactam carbonyl carbon 
more susceptible to nucleophillic attack. 
Comparing the enzyme activity of these compounds shows that placing an 
alcohol group at the C3 position produces a B-lactam that retains substantial enzyme 
activity, which is lost when replaced by a methyl ester, despite the fact that the ester 
compound is 8 times more chemically reactive than the alcohol. Lactonising the 
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cephalosporin compound has vety little effect on relative activity as both chemical and 
enzyme activity are enhanced relative to the acid. This has been interpreted(269) as 
showing that either the interaction of the C4 carboxylate function of cephalosporins 
with Lys-234 is not a primary recognition site or that changing the acid function into a 
lactone contributes a similar binding energy in the enzyme active-site. It was calculated 
that the two oxygen atoms of the lactone carry considerable negative charge, with a 
dipole moment in the order of 4.60 D and therefore is capable of intetacting with the 
positive charge of the lysine residue. For the methyl ester the loss of activity is ascribed 
to the conformational flexibility of the ester group preventing interaction with the 
enzyme lysine group. 
From these studies it is apparent that the charged groups likely to be directly 
involved in catalysis are Lys-234, Lys-73 and Glu-166, assuming pKal to be either a 
kinetic pKa or that of Glu- 166. The pH dependencies of kcaVKm in these studies have 
shown that pKa2 is not due entirely, if at all, to the ionisation of the Lys-234 residue. 
If the higher pKa value is due to Lys-73 and Lys-234 then as one is removed the other 
remains, such a scheme is proposed by Knapp and Pratt: (253) 
H02C -Glu- 166 :: t-, 
02C 
V- 
Ser-70-OH - 
pKa 1 6.0 
Ser-70-Ofi 
H 'd- 113N 3N+ -Lys-73 '-' W- 
-dL- -a'- 
0c P2C f2 02C 
Ser-70-OH -'-w- Ser-70-OH Ser-70-0 
1 N+ HN 13 2 
pKa3 >9 
H N+ -Lys-234 
H N+ - HN'H 3 -, w- 3 ---w- 
2 v- 2N 
pKa2 7.5 
pKa4 >9 
-. M- H2N ------ u- 
H2N 
These pKa values were derived from the results of experiments carried out on the 
RTEM2 wild type 8-lactamase with benzyl penicillin as the substrate and inhibition 
studies with boric acid and methanesulphonyl fluoride. The reaction of the wild type 
enzyme with benzy] penicillin produces pKa values 6.18 and 7.59, the higher 
corresponds to the dissociation of Lys-234 rather than Lys-73, the lower value reflects 
the pKa assigned to Glu- 166 which suggests that the acid group dissociation has been 
retarded by a hydrophobic environment, lack of hydrogen bonding interaction or 
unfavourable electrostatic interactions. 17herefore with the Bxereus enzyme, if the 
three dimensional an-angement of the active-site residues is comparable the pKa2 value 
evaluated for alcohol, ester and lactone may provide evidence with the RTEM2 enzyme 
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of the ionisation of Lys-73. Some of the 6/7 B side chain carboxylate B-lactams also 
show some evidence of this, while others reflect the ionisation of the Lys-234 residue. 
Alternatively, pKa2 may be due to the ionisation of a residue outside the active- 
site, two possible candidates are Tyr- 105 and Lys- I 11, both of which are conserved 
residues (270). Tyr- 105 is located near the active-site and has a slightly higher pKa 
value than lysine and which is consistent with the pKa values found by Ellerbys 
investigation, and the higher pKa values seen during this work. If tyrosine is 
responsible for loss of activity with increasing pH then its function would most likely 
be maintaining the correct conformational state for catalysis. A sin-fflar role has been 
postulated for the Tyr-248 residue of carboxypeptidase. (27 1) However, the possibility 
that the residue could also act as a potential general base during catalysis remains, such 
a role has been suggested for the Tyr- 150 residue of the Citrobacterfreundiiclass C& 
lactarnase by 0 fner et al (153). 
3.20 The pH dependence of the B-lactamase 2-enz3gne from B. cereus 5691H seen 
with different 6B and 7B functionalised penams and cephems. 
G-Lactamase 2 from B. cereus 5691H differs from B-lactamase I in that it 
requires a zinc (111) ion as a co-factor. Sabath and Finland(262) (1968) concluded that a 
number of metal ions would be capable of competing with the zinc (H) ion with the 
following afflinities Hg+2 > Cd+2 > Zn+2 > Ni+2, but until 1974 only zinc had been 
known to activate the B-lactamase 2 enzyme. In 19 74 Davis et al (167) found that the 
substitution with CO+2 +2 +2 fj , Cd+2' Mn and Hg onned stable metal complexes with the 
enzyme, retaining sigrifficant activity. It was also found that the enzyme bound more 
than one mole of the metal ion co- factor per mole of enzyme. Activity against benzy] 
penicillin was associated with only one of these sites, that of the highest affmity, 
though the maximum hydrolysis rate was observed when the zinc (H) concentration 
was higher than that required for a single immobilised metal ion. The second binding 
site appeared to have a low stability constant. Using cephalosporin C as a substrate it 
was speculated that the excess Zn+2 could be used to bind to the cephalosporin giving a 
substrate with a higher affinity for the enzyme, thereby requiring a molar excess of zinc 
ion for maximum activity. 
Further infon-nation of the enzymes primary binding site was provided by 
Baldwin et a](168) using NMR techniques. They found that the metal binding site has 
as ligands, the enzymes only cysteine residue and three of the enzymes histidine 
residues. 
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As part of the examination of the enzyme active-site of B-lactarnase 2 the 
possibility of the involvement of a carboxylic residue as a general acid/base was 
investigated by Little et al (1986)(169) using a water soluble carbodi-imide (I -ethyl-3- 
(3-dilnethylarninopropyl)carbodi-imide) and a coloured nucleophile ( N-(2,4 
dinitrophenyl)etbylenediamine). The enzyme was deactivated and the coloured label 
was found to be attached to glutamic acid-37 which was suggested to be an essential 
active-site located residue. By analogy with other Zn+2 containing hydrolases (147) 
particularly thermolysin(263) and carbonic anhydrase (264) a mechanism was proposed 
implicating the Glu-37 residue as a general acid/base. The later work of Bicknell and 
Waley (238,240,265) combining pre-steady state kinetics and cryoenzymology to 
investigate the changes in co-ordination geometry of enzyme substrate complexes re- 
enforced this mechanism. 
In 1987 Phillips etal(145) reported the first detailed crystallographic image of 
the B. cereus 5691H B-lactamase 2 enzyme, confin-ning that the metal co factor ligands, 
of the primary binding site were the histidine residues 86,88 and 2 10 and the cysteine 
residue 168 and that the glutamic acid residue 37 was located 'near' the active-site in a 
shallow depression 2.3nm away. In the same year Sutton et al (172) published further 
X-ray data of the B-lactamase 2 enzyme, in which it was concluded that the Glu-37 
residue originally proposed was to distant to be directly implicated with the enzyme 
active-site. As an alternative candidate the considerably closer Glu-212 residue was 
suggested, lying at a distance of 1. Inm to the enzyme metal ion. Although this does 
not change fundamentally the mechanism suggested by Waley, doubts were beginning 
to emerge about the residues involved in the hydrolysis steps. 
'Ibese doubts were fully recognised by 1989 when the mutagenesis work of 
Lim and Pýne(180), involving changes of the glutamic acid residues 37 and 212 
demonstrated them to be non-essential for enzyme activity. It was concluded that the 
earlier deactivation seen by the combined action of a water soluble carbodi-imide and a 
nucleophile was one of steric hindrance. However, it was found that mutagenesis 
changing histidine 28 to an asparagine residue resulted in reduced enzyme activity 
towards ampicillin. and cepbalosporin C, particularly the cephalosporin compound 
which retained only 10% of the original activity of the wild type enzyme. It was 
concluded that this residue was important but not essential to enzyme activity and its 
role may be in substrate recognition. 
The pH dependence of the B. cereus 569M B-lactamase 2 enzyme unlike that 
of the f3-lactamase I enzyme has not been extensively studied and consequently the data 
available is limited. Tbe enzyme was odginally desciibed as a 'cephalosporinase' 
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though it has in fact similar rates of hydrolysis with penams and cephems. The most 
notable investigation was published by WaleýX238), who investigated the pH-rate 
activity of the enzyme with benzyl penicillin as the substrate over the pH range 5- 10 
and identified two ionisations. The pKa values obtained from the k2VKm pH- 
dependence of benzy] penicillin with the wild type zinc enzyme and the cobalt 
containing enzyme gave the following values: 
Co(II) enzyme Zn(H) enzyme 
pKal 5.50 5.60 
pKa2 9.00 7.60 
Re-plotting the original data for the cobalt enzyme and calculating the curve of best fit 
using Leatherbaffow's reduced chi squared fitting procedure gave a curve in good 
agreement with the original work and a good correlation of the calculated pKa values, 
5.40 and 9.0 1. As with the serine enzyme the reproducibility of published reference 
data was a used as a confidence test for the programs used to calculate the pKa values 
from our own experimental data. 
The pH-dependence of the observed kcaVKm was fitted to the equation(238) 
kcaVKm/ I+ 
[H+j 
+- 
K2 
K, [H+l 
The fitting the observed experimental data and the resultant curve requires three 
ionic forms of the enzyme and substrate linked by two ionisations. It was concluded 
that the role of the zinc was to either interact with the B-lactam oxygen or to provide, as 
a nucleophilic group, a metal bound water molecule and that if either of the observed 
pKSs refers to a metal co-ordinated water molecule then it would be the lower value 
5.60. 
The author found that using benzyl penicillin and the wild type zinc(H) enzyme, 
B. cereus 5691H B-Lactamase 2 (Table 43)gave the following pKa values: 
_pKal pKa2 pH 
gpýtimum BenUlpenicillin. 
5.96±0.30 8.23±0.20 7.0-8.0 
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Under the conditions used for canying out these experiments saturation kinetics were 
generally not observed. 
3.21 The pH-rate LeMonse of 6B-substituted penicillins with B. cereus 5691H 
13-lactamase 2. 
The results of plotting AcaVKrn ( Tables 43-50) against pH of 6B-subsfituted 
penam. compounds (Figs 77-84) produced the following pKa values: 
ComMund pKal pKa2 pH Mtimum 
Benzyl penicillin. 5.96±0.30 8.23±0.20 7.0-8.0 
4-nitrophenyl- 
penicillin. 7.38±0.10 8.60±0.10 8.0 
3-nitrophenyl- 
penicillin. 8.07±0.30 9.44±0.30 9.0 
2-nitrophenyl- 
penicillin. 5.71±0.10 9.24±0.20 6.50-8.50 
4-fon-nylphenyl- 
penicillin. 6.45±0.10 8.51±0.05 7.50 
4-Carboxyphenyl- 
penicillin. 7.91±0.10 8.73±0.10 8.0 
3-Carboxyphenyl- 
penicillin. 7.00±0.20 8.60±0.10 4.0-8.0 
2-Carboxyphenyl- 
penicillin. 4.60±0.20 4.0 
From this data while the value of pKa2 remains reasonably constant around 
8.4±0.2, excepting oilho and meta nitrophenyl derivatives which show a higher value 
around 9.3±0.1. The value of pKa I is more variable and with two of the compounds 
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Figure 77. A plot of kcaVKm against pH for benzyl penicillin witb B-lactamase 
2, at 30 OC. 
Figure 78. A plot of kcaVKm against pH for 4-fonnylphenyl penicillin with P., - 
lactamase 2, at 30 OC. 
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Figure 79. A plot of kcaVKm against pH for 2-nitrophenyl penicillin with B- 
lactamase 2, at 30 OC. 
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Figure 80. A plot of kmVKm against pH for 3-nitrophenyl penicillin with B- 
lactamase 2, at 30 OC. 
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( 3-carboxy and 2-carboxy phenyl derivatives) there is some evidence of three pKa 
values, but in the absence of detailed data this remains speculative - 
The para fonnylphenyl derivative produces a plot and pKa values (Fig. 7ý 
similar to those for the reference compound, and it would appear that placing and 
aldehydic function at the 4 position of the aromatic ring does not affect the enzyme. 
However, it is interesting to note that the value of the second order rate constant at the 
optimum PH is 2-fold higher than that for benzyl penicillin. 
Comparing the plots for the nitrophenyl penicillins (Fig. 79-81) the oithocompound 
produces evidence of a broad bell-shaped curve while the meta compound shows a 
sharper pH-rate profile with the optimum value at pH 9.0 and with a levelling off of 
activity at low pH. The para nitrophenyl compound for which data was obtained at the 
lower pH values of 4 and 3 shows a sharp pH rate profile with optimal activity seen at 
pH 8. It is interesting to note that for the 4-nitrophenyl compound saturation kinetics 
were observed at pH4 (Table 4 ý, this was not seen with any of the other B_ 
lacL-uns studied. 
Figure 81. A plot of kcaVKm against pH for 4-nitrophenyl penicillin with B- 
lactamase 2, at 30 OC. 
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Figure 82. A plot of kcat/Krn against pH for 4-carboxyphenyl penicillin with 8- 
lactamase 2, at 30 OC. 
Figure 83. A plot of kcaVKm against pH for 3-carboxyphenyl penicillin with 
13-lactarnase 2, at 30 OC. 
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Figure 84. A plot of kcat/Km against pH for 2-carboxyphenyl penicillin with 
B-lactamase 2, at 30 OC. 
When the o, m, p-carboxyphenyl penicillin derivatives were investigated for 
activity against B-lactamase 2 over the pH range 3- 10 (Tables 48-50), similar 
behaviour to that with B-lactamase I enzyme was observed. The pam carboxylate 
compound produced a typical bell shaped profile (Fig, 82) while the mem compound 
produced a profile which produced some evidence of an increase in reactivity at low pH 
(Fig. 83) and for the oilho compound the observed pH- rate activity was highest at low 
-TT pH, producing a curve with a single pKa value (Fig, 84). These patterns of behaviour 
are similar to those found earlier for the serine enzyme with the penicillin and 
cepbalosporin carboxylate derivatives and support the idea that this reflects a pKa 
change of 6B-side chain carboxylate of the substrate. Thus, for the B-lactamase 2 
enzyme as with the serine enzyme the conjugate acid form of the B-lactam appears to 
have higher enzyme activity than the conjugate base in the order; oitho > meta> pwa 
3.22 The reaction of 7B-carbonThenyl cephalosporins with B. cereus 5691H B- 
lactamase 2. 
The results (Tables 55-57) of the pH-rate profiles of the corresponding 7B- 
carboxyphenyl cephalosporins ( Fig 85-88) show some evidence of three pKa values, 
with the pam compound showing a possible fourth pKa transition in the acid pH 
range. However, to confirm these observations more data is required. 
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Figure 85 A plot of A-caVKrn against pH for benzy] cephalosporin with B- 
lactamase 2, at 30 OC. 
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Figure 86. A plot of kcaVKm against pH for 4-carboxyphenyl cephalosporin with B- 
lactamase 2, at 30 OC. 
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Fýgure 87 A plot of kcaVKm against pH for 3-carboxyphenyl cephalosporin 
with B-lactamase 2, at 30 OC. 
Figure 88. A plot of kmVKm against pH for 2-carboxyphenyl cephalosporin with B- 
lactamase 2, at 30 OC. 
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Compgund nKa I pKa2 pKa3 pKa4 
Benzyl cephalosporin. 
4-Carboxyphenyl- 
ceplialosporin. 
3-Carboxyphenyl- 
cepMospoiin.. 
4.15±0.2 5.65±0.1 
6.90±0.2 
7.20±0.08 
6.90±0.2 
8.60±0.2 
8.65±0.1 
8.60±0.09 
2-Carboxyphenyl- 
cephalosporin.. 5.40±0.2 7.09±0.1 8.52±0.2 
The values of pKa3 (or possibly pKa2) and pKa4 are, allowing for error, in 
reasonable agreement with some of those shown by the penicillin compounds and 
therefore could suggest pKa changes associated with the enzyme. The difference 
between the two substrate types occurs in the acid pH region, where the cephalosporins 
show a possible second bell-shaped curve with the pKa values 4.0 and 5.4±0.2, 
which was not seen with any of the other compounds. If the pKa of the 7B-side chain 
carboxylate is assumed to be between 4 and 5 then it is difficult to explain the increased 
activity by the conjugate acid being more reactive than the ionised fon-n. Below pH 4 
the activity decreases with an apparent pKa value of 4.0, but as the profiles are 
incomplete and the decrease in activity seen could be the beginning of a trend, the true 
pKa could be below the value shown, or indeed could be experimental error. If it is real 
then it could reflect either the protonation of a carboxylate group of the enzyme or the 
carboxylate group of the substrate. Ilerefore, it is clear that further detailed work is 
required with these compounds. 
Comparing the B-lactamase 2 pH-rate profiles for the two reference 
compounds, benzyl penicillin and benzy] cephalosporin (Figs 77 and 85), shows that 
while both compounds produce bell-shaped curves with two pKa values and have 
similar values for pKa2, the respective pKa I values differ markedly, 5.96 for benzyl 
penicillin (Fig 77) and 6.90 for benzyl cephalosporin (Fig 85). It is unlikely that either 
pKa reflects the protonation of the basic fon-n of the substrate, and therefore both 
reflect a change in the enzyme. 
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Ile pH-rate profile of nitrocefin which contains a non-ionisable 7B-side chain 
with B. cereus 5691H 13-lactamase 2. (266) produces a typical bell-shaped curve with 
pKa values 5.50±0.08 and 8.45±0.05. 
CH2 CONH q 
Nitrocefin 
02N 
Cfi=CH 0 N02 - : D> - 
Although the higher pKa is in reasonable agreement with the values found in 
this investigation the lower pKa value differs from that shown by benzyl 
cephalosporin, it is clear that pKa I is substrate dependent and does not represent a 
simple ionisation of the same group within the enzyme. This is supported by the 
mutagenesis work of Lim and P&ne(180) which showed substrate selectivity resulting 
from changes of the His-28 residue. 
If the fraction of free base (f[b) is used to represent the active forrn of either 
substrate or enzyme required for optimal activity it can be calculated from the following 
scheme: 
ICT I 
E 
KEH 
SH S 
KSH 
_., 
Ks k3 
-, 
ES >E+P 
If E- and S- are required for optimum activity ( S- refers to the O-carboxylate ) 
then a plot of log kcaVKm against pH in the acid region below the pKa of EH and SH 
will produce a slope of gradient 2. At higher pH as the pKa of each species is 
approached then the observed slope should change from 2 through I to zero. Assuming 
the pKa I values of 5.96 and 6.90 for benzyl penicillin and benzy] cephalosporin 
respectively the plots of kcaVKm against pH ( Fig 89 and 90) gave values of 0.36 and 
0.24 respectively, less than that predicted based on the assumption that S- and E- are 
the only active forms of the substnate and enzyme. 
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Fig. 89. A log plot of the second order rate constant (kcaVKm) against pH for benzyl 
penicillin assuming the pKa value 5.96. 
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Fig. 90. A log plot of the second order rate constant (kcaVKm) against pH for benzyl 
cephalosporin assuming the pKa value 6.90. 
Despite the decline in activity being much less than expected the pH-rate plots 
of the penarn and cephern substrates studied fall into two main categories, those 
compounds which show a decline in activity with decreasing pH, which includes the 
compounds containing a non-ionisable B-side chain group, and those compounds 
which show an increase in activity, these are the compounds containing a charged 
functional group in the side chain. 
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The consistency of the pKa2 values 8.40±0.2 shown by the substrates could be 
indicative of the ionisation of the metal co-ordinated cysteine residue, which results in a 
change in the co-ordination geometry, and the loss of enzyme activity. However, it has 
been shown that changes in the charge tmnsfer band of the cobalt (R) B-lactamase 2 
enzyme are consistent with the strengthening of the metal-sulphur bond rather than a 
weakening(266). The pKa transition 6.0-6.5 shown by some substrates could reflect 
the ionisation of either a metal bound water molecule as originally proposed by Waley 
or possibly a histidine residue. Similarly the pKa change around 7.0 could reflect the 
ionisation of a histidine residue. The proposal of two different pKss for the same 
residue is rationalised on the basis that three catalytically essential histidines are metal 
bound and the ionisation of which, as with the cysteine residue, will result in a change 
in enzyme activity, and it has also been shown by mutagenesis, that the none-metal co- 
ordinated histidine-28 residue is important for enzyme activity, (180) this will have a 
different pKa to the metal bound histidines. It could also be that one of the observed 
pK; Ys reflects the effects of ionisation of a group or groups involved catalytically, 
perhaps as a general acid/base which , as pointed out by Lim and P&ne(I 
80), have yet 
to be identified. 
The use of cryosolvents by Bicknell etal(1985)(266) to study the reaction of the 
zinc metalloenzyme PP-lactamase 2 using nitrocefin as the substrate found an initial 
'burst' followed by a slower hydrolysis rate. The burst was found to be larger than the 
enzyme concentration and was explained by the existence of a branched reaction 
pathway with the enzyme-substrate complexes ES 1, ES2 and ES3: 
Ks k2 
fa- ES, E+S- W- > E+ P 
k3 
ES2 
k4 0, ES3 k5 
P E+ P 
These complexes with nitrocefin were suggested to be, by their instability to 
acid, non-covalent Michaelis complexes. The environment of the bound substrate in the 
Michaelis complex ES, was accompanied by little change in the visible spectrum, in 
ES3 the environment shown by the chromophore resembled that of the substrate, while 
ES2 the change in ? urnax to a longer wavelength suggested that the substrate has 
become more "tucked in". For the cobalt (H) enzyme a slightly different sequence was 
proposed involving only two intermediate complexes: 
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Ks k2 
E+S ES, o- E+P 
ýk3 
ES2 
k4 
P E+ P 
The formation of ES, is considered to be consistent with a strengthening of the 
cysteine-cobalt bond, as seen by the change in the charge transfer band, reflecting a 
general tightening of the metal ion co-ordination sphere, with the cysteine ligand not 
being replaced during catalysis. Whether this situation is the same for the wild type zinc 
(III) enzyme, which binds the cysteine ligand more loosely than the cobalt (H) ion, is 
not known. 
The spectral infori-nation of the zinc and cobalt B-lactamase 2 enzymes has some 
similarity to the metallo enzyme cobalt carbonic anbydrase B. At high pH both enzyme 
types show characteristically well shaped peaks at 620nm and 640nm in the absorption 
and circular dichroism spectrum, and show pentacoordinate Co(H) complexes. (267) In 
carbonic anhydrase B the ligands surrounding the Co(H) ion include three histidines, 
two of which are in a I-Iis-X-His sequence and a water molecule. (268) The ligands of 
the B-lactamase 2 enzyme also include a fbs-X-His sequence as well as a cysteine, the 
presence of a metal co-ordinated water molecule as the fifth ligand, though yet to be 
proved, may be reasonably expected. 
Changes in the co-ordination geometry during catalysis of the hydrolysis of 
benzyl penicillin by the Co(H) B-lactamase enzyme was observed by following the 
spectral changes taking place at 425-700nm, using stopped flow spectroscopy. (265) A 
change in the ligand coordination going from four in the initial Michaelis complex ESI 
to five in the later complexes of the branched reaction pathway was identified. Thus, 
for the scheme involving the Co(H) metallo enzyme; 
kcat = (k2+ k3) k4/ (k3+ 
k4) 
and 
kcaVKm = (k2+k3) / YS 
These conditions have been shown to occur at 30C over the pH-range 6- 10, 
and at temperatures ranging between 3 and 30 OC at pH 6, with benzy] penicillin as the 
substrate. Under these conditions the spectral data show that the accumulation of ES I 
precedes ES2 and that the magnitudes of the rate constants follow the order k2 > k3 > 
k4. Steady state pH studies involving the cobalt enzyme(238)which use benzyl 
penicillin as the substrate have also been reported to follow a branched pathway. 
196 
S+ EH2 
- XH2 
kl 
EH2 +p 
K, k 
S+ EH -- XH EH +P 
K2 
S+ Ex 
Two of the species present differ in their proton state XH and XH2, the breakdown of 
XF12 to product being faster than that of EH (kl>k2). The pKa of the equilibrium 
between XH2 and XH is 8.30. At pH 6 XH2 will be in large excess over XH with the 
predominant intermediate being ES2. Considering the relative rates of breakdown of the 
inten-nediates to products at pH 6 from these schemes involving the cobalt (H) enzyme 
means the enzyme will be present as ES2 and XF12, but ES I breaks down faster than 
ES2, while XH2 breaks down faster than Mi. It then becomes easy to see that when 
the pH range studied is extended from 6- 10 to 3- 10, taken together with a greater 
variability of the substrates, that the binding could differ due to steric and protonation 
changes involving the 6/7B side-chain groups of the substrate with those of the enzyme 
and consequently there could be a change in order of magnitude of the kinetic 
parameters k2, k3 and k4. Therefore, as with the B-lactamase I enzyme the observed 
pKa changes seen for the B-lactamase 2 enzyme may include one or more 'kinetic 
pKa's'. 
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3.23 ne reaction of 7/6B-carboxycycloheLcyj cephalospofins and penicillins with R 
us ,, 91H B-lactamase 2 egZMe. 
Saturation kinetics were not observed with the 2-carboxycyclohexyl B-lactam 
derivatives with the 13-lactamase 2 enzyme. Plots of pH against kcaVKrn for the 
penicillin compounds (Figs 91-93) produced the following pKa values: 
Compound pKal pKa2 -pH gptimum 
Benzylpenicfllin. 5.96±0.30 8.23±0.20 7.0-8.0 
Cyclohexylpenicfllin. 6.20±0.30 7.92±0.20 7.0 
ci&2-Carboxycyclohexyl 4.41±0.20 4.0-8.0 
penicillin. 
aans-2-Carboxycyclohexyl 5.20±0.20 8.91±0.20 5.0 
penicillin. 
2-Carboxyphenyl- 4.60±0.20 4.0 
penicilhn. 
The results of the pH-studies of these compounds are listed in the tables 51-53. 
Comparing the pH-rate profile of reference cyclohexyl compound (Fig. 91) to that of 
benzyl penicillin ( Fig 7ý show that, allowing for error, similar results are obtained. 
These compounds have similar rates of hydrolysis with the Zn (H) enzyme. 
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Fýgure 91. A plot of kcaVKm against pH for cyclohexyl penicillin with B- 
lactamase 2, at 30 OC. 
Figure 92. A plot of kcaVKm against pH for 2-cis-carboxycyclobexyl penicillin 
with B-lactamase 2, at 30 OC. 
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Figure 93. A plot of kcat/Krn against pH for 2- tians-carboxy cyclohexyl 
penicillin with B-lactamase 2, at 30 OC. 
For the tians 2-carboxycyclohexyl isomer plotting the second order rate 
constant ( Table 53) against pH produces a curve of best fit calculating two pKa values 
(Fig 93). For the cis derivative ( Fig 92) only one pKa value could be calculated, 4.6. 
This is a similar result to the oilho carboxyphenyl penicillin derivative, which has the 
pKa value 4.4 1. As with the 6B- oitho carboxy aryl penicillin compound high activity 
was observed at low pH, but because of a rapid non-enzyme but acid catalysed 
hydrolysis rate, the lowest pH from which results could be obtained were pH4 and 
pH5 for the cis and trxis compounds respectively. Attempts at using initial rate 
analysis instead of single curve progression analysis at low pH were also unsuccessful. 
Thus, in the case of the penicillin derivatives substituting a cyclo hexyl ring for a 
benzene ring has little effect upon the hydrolysis rate. However, when an acid group in 
the 2 position is introduced, higher mtes of activity are seen. This is the first reported 
observation of this kind, the B-lactamase 2 enzyme is noted for the impartiality it 
displays for changes at the 6/7B position of penam and cephem compounds. 
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For the corresponding cephalosporin compounds ( Tables 58-60) plotting 
, kcaVKm against pH ( Figs 94-96) gave the following pKa values. 
ComDou d pKa I pKa2 pKa3 pH qptimu 
Ben2ylcephalosporin. 6.90±0.2 8.60±0.2 8.0 
Cyclohexylcephalosporin. 4.90±0.2 9.60±0.2 6.0-9.0 
ci&2-Carboxycyclohexyl 5.14±0.3 8.88±0.3 5.0 and 8.0 
cephalosporin. 
tmns-2-Carboxycyclohexyl 4.66±0.2 8.40±0.3 6.0-8.0 
cephalosporin. 
2-Carboxyphenyl- 5.40±0.2 7.09±0.1 8.52±0.2 4.0-8.0 
cephalosporin. 
From these plots the tmns isomer like the underivatised cyclohexyl reference 
compound shows decreasing activity with decreasing pH, while the cis isomer shows 
evidence of an increase in activity, though as with the oithocarboxyphenyl 
cephalosporin derivative the values obtained could, as with the penicillin derivatives, 
within experimental error, show pH-independent behaviour. Unfortunately, it was only 
possible with the cis cephalosporin isomer to go down to pH5, consequently a detailed 
analysis and the assigning of a true pKa value is difficult. Below this pH the acid 
catalysed hydrolysis rate prevented accurate determination of the enzyme hydrolysis 
rate. 
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Fýgure 94. A plot of kc-at/Krn against pH for cyclohexyl cephalosporin with B- 
lactamase 2, at 30 OC. 
Figure 95 A plot of kcaVKm against pH for 2- ciscarboxy cyclohexyl 
cephalosporin with B-lactamase 2, at 30 OC. 
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Figure 96. A plot of kcaVKm against pH for 2-tmns-carboxycyclohexyl 
cephalosporin witb B-lactamase 2, at 30 OC. 
Despite these problems a notable difference between the behaviour of the trans 
isomers is observable. The penicillin compound shows an increase in activity with 
decreasing pH, while the corresponding cephalosporin compound produces simple 
bell-shaped curve. Thus, there would appear to be a substantially different binding 
mode for penicillins, and cephalosporins, this in itself is not unusual since it has been 
known for a long time that B-lactamases are better enzymes for certain types of 
substrates, with B-lactamase 2 originally described as a cephalosporinase enzyme, but it 
has not before been narrowed down to small changes of the cephem and penarn 
nucleus. An alternative explanation is that two different mechanisms exist which are 
triggered by changes in the structure of the substrate. Examining the pKa I values for 
the B-lactamase 2 hydrolysis of the 2-carboxycyclohexyl B-lactams (Table IZ show 
that two predominant values emerge 4.4±0.2 and 5.2±0.2. For pKa2 a single value of 
8.6±0.3 emerges: 
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Table 12. Sbowing a comp! qiison of p Ka I and pKa2 values dedved from the 6- 
lactamase 2 hydrol ysis of 2-carbou-c y-clobeUl penicillins and cepbalospgrins. 
Compound pKal pKa2 
ci&2-Carboxycyclohexyl 4.41±0.20 
penicillin. 
tmns-2-Carboxycyclohexyl 5.20±0.20 8.91±0.20 
penicillin. 
oitho-Carboxyphenyl- 4.60±0.20 
penicillin. 
ci&2-Carboxycyclohexyl 5.14±0.3 8.88±0.3 
cephalosporin. 
hans-2-Carboxycyclohexyl 4.66±0.2 8.40±0.3 
ceptolospofin. 
oitho-Carboxyphenyl- 5.40±0.2 (7.09±0.1) 8.52±0.2 
cephalosporin. 
The changes in substrate reactivity with, B-lactamase 2, as a result of 
substituting a cyclohexyl ring for a benzene ring are minimal. The two unfunctionalised 
reference compounds have similar values for the second order rate constant kcaVKm. 
Both the carboxy cyclohexyl compounds are slightly less reactive than the 
corresponding aryl compound at the pH optimums, but the difference is not large. 
Therefore, the 13-lactamase 2 enzyme again demonstrates no special recognition for a 
benzene ring and leads to the conclusion that the active-site lacks a strong hydrophobic 
pocket. The high activity at low pH shown by the cephalosporin cis 
carboxycyclohexyl isomer and the cis and trans carboxycyclohexyl isomers of 
penicillin provides information about the possible interaction of the substrate with the 
active-site of the enzyme. It will be interesting to see what these interactions, whether 
physical or kinetic, will be as further information about the enzyme mechanism of f3- 
lactamase 2 becomes known. 
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3.24 The PH-rate profile of the C3-alcohol of penicillin V and ester of penicillin G 
and the C4-lactone of begzy] cephalospotin with B. cereus 5691H B-lactamase 2 
Mne. 
Neither the cephalosporin lactone (A. ), the penicillin alcohol (B. ) or the 
penicillin methyl ester (C. ) are good substrates for the B-lactamase 2 enzyme. For the 
penicillin derivatives it was not possible to assess the pH dependencies, only for the 
lactone was a pH-rate profile obtained (Fig. 97) The results ( Table 61) show that the 
enzyme activity is poor, with a maximum for the second order rate constant of 10 1- 102 1 
for the corresponding acid derivative the value of kcaVKm is of the order 105. This is a 
particularly interesting result in view of the generally poor recognition of other 
structural changes in the substrate by the zinc (H) metallo enzyme. (243,269. ) as the 
results of this work show. The pKa values calculated from plotting kcat/Km against 
pH agree with those found with the benzyl cephalospofin. 
Compound vKa2 pKa3 pH gptimum 
Benzylcephalospofin. 6.90±0.2 8.60±0.2 8.0 
Lactone of benzy] 6.80±0.2 8.40±0.2 8.0 
cephalosporin. 
cephalosporin solubilised in I% v/lv 1,4 dioxan with B-lactamase 2, at 30 OC. 
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Figure 97. A plot of kcaVKm against pH for the C4 lactone of benzyl 
Considering the the low value of the second order rate constant shown by the 
lactone derivative and the absence of significant activity shown by the penicillin 
compounds indicates the importance of the acid group to enzyme activity. The obvious 
conclusion is that the carboxylate group is essential in substrate recognition and 
binding. 
From the models attempting to explain the mechanism of action of the B-lactamase 
2 enzyme the orientation of the B-lactam. is such that the carbonyl carbon of the four 
membered ring is foremost to the metal ion, the metal ion subsequently activates either 
the B-lactam. or the attacking water molecule and stabilises the tetrahedral inten-nediate, 
with Glu- 37 acting as a possible general base. However, as Lim and P6ne(I 80) have 
shown through the mutagenesis of the Glu-37 residue this hypothesis is incorrect. If 
instead the substrate is bound to the metal ion by the carboxylate group this would 
explain the loss of activity when the carboxylate group is removed and would also 
explain why substrate changes involving the 6/7B-side chain have little effect upon 
enzyme activity since the side chain would be pointing away from the metal ion. If the 
carbonyl carbon of the B-lactam was nearest to the metal ion this would also mean that the 
adjacent side chain group is forced into an already crowded area close to the metal. 
Support for this idea comes from the studies of the copper (H) catalysed hydroxide ion 
catalysed hydrolysis of penicillins. (21 1) The results of the work found that the penicillin 
formed a bidentate ligand to the metal ion, which stabilised the transition-state by 58.1 
KJ. mol-1 at 300C. 
0-x 
Nu: 11 
AýI 
0 
Further it was found that estefification of the carboxylate group reduced the rate 
of copper (111) catalysed hydrolysis and was rationalised by the loss of co-ordination of 
the carboxylate group. The main objection to this proposal is the expectation that simple 
carboxylate salts and also the product would inhibit the enzyme unless the enzyme 
requires a specific bidentate ligand and the hydrolysis of the B-lactam, disrupts the 
binding eliminating the product. 
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Tables. 
Table 13. 
Sigma B-Lactamase I catalysed hydrolysis of N-acyl penicillins at 300CpH 7. 
RCONH 
S CH3 
0// 
N ICH3 
C02H 
The following results were obtained by Ti ffenz' single curve progression, and by initial 
rates. 
IB= Lineweaver-Burke plot. EH= Eadie-Hofstee plot. H= Hanes plot. 
R Program Km(10-5W kcat /§- I kcat/Km(107W-Is-I 
C6H5CH2 
Single Curve Progression. 
H 1.04 5656 5.42 
EH 10.30 6883 6.69 
LB 1.24 6062 4.89 
Initial Rates. 
LB 11.40 3630 3.18 
EH 5.72 3146 5.50 
H 9.20 3867 5.10 
R Program Km(10-5W kcat A- I kcat/KM(107W-IS-1 
CH3CH2 
Single Curve Progression. 
LB 17.16 2095 1.22 
LB 12.97 2079 1.60 
LB 15.46 2166 1.40 
Avemge. 15.20±2.23 2113±34 1.41±0.19 
EH 15.38 2057 1.34 
H 13.93 2116 1.52 
H 19.44 2129 1.10 
H 17.07 2214 1.30 
H 19.69 2203 1.12 
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H 17.13 1755 1.02 
A vemge. 17.45±3.52 2083±328 1.21±0.31 
Initial Rates 
LB 16.80 1887 1.12 
LB 18.31 2059 1.12 
Avemge. 17.56±0.76 1973±86 1.12±0.01 
EH 16.00 1887 1.18 
EH 15.30 2037 1.33 
Average. 15.77±0.23 1962±75 1.260.08 
R Program Km(lO-5W kcat /s- I kcat/Km(107W-Is-I 
CH3(CH2)2 
Single Curve Progression. 
EH 7.50 1518 2.10 
EH 7.33 1489 2.03 
EH 8.15 1547 1.90 
EH 6.93 1693 2.44 
Aveqge. 7.48±0.67 1562±73 2.18±0.28 
LB 10.88 1956 1.80 
LB 9.99 1637 1.64 
Average. 10.44±0.44 1797±159 1.72±0.08 
H 9.80 1726 1.76 
H 7.74 1531 1.98 
H 9.60 1871 1.95 
Avetage. 9.05±1.31 1709±178 1.90±0.14 
Initial Rates. 
LB 11.92 1626 1.36 
LB 8.08 1725 2.17 
A verage. 10.00±1.92 1676±50 1.77±0.4 
EH 11.30 1623 1.44 
EH 10.30 1790 1.74 
A vetage. 10.80±0.5 1707±83 1.59±0.15 
R Program KM(10-5)A4 kcat A- 1 kcat/KM(107W-IS-1 
CH3(CH2)3 
Single Curve Progression. 
LB 16.49 1163 0.71 
LB 12.92 1717 1.33 
LB 18.70 1597 0.85 
LB 12.39 2224 1.80 
Average. 15.13±3.6 1675±550 1.17±0.46 
EH 14.27 1065 0.75 
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10.71 1009 0.94 
Initial Rates. 
EH 19.50 1676 0.86 
EH 17.90 1897 1.06 
Average. 18.70±0.8 1787±111 0.96±0.1 
LB 19.14 1803 0.94 
R Program KM(10-5W kcat A- I kcat/Km(107N-Is-I 
CH3(CH2)4 
Single Curve Progression. 
LB 14.31 3260 2.28 
LB 15.07 3230 2.14 
LB 12.38 3316 2.68 
Ave q ge. 13.92±1.15 3269±47 2.37±0.23 
H 11.34 3185 2.81 
H 15.46 3577 2.31 
H 12.07 2996 2.48 
Avetage. 12.96±2.5 3253±324 2.53±0.28 
EH 9.97 2781 2.79 
EH 8.89 2133 2.40 
EH 9.30 2210 2.38 
Average. 9.39±0.58 2375±406 2.52±0.27 
Initial Rates. 
LB 17.34 2787 1.60 
EH 15.90 2817 1.77 
EH 14.30 2963 2.07 
A verage. 15.10±0.8 2890±73 1.92±0.15 
R Program Km(IO-5W kcat A- I kcat/KM(107W-IS-1 
CH3(CH2)5 
Single Curve Progression. 
LB 6.12 2545 4.16 
LB 6.72 3056 4.55 
LB 9.20 2990 3.25 
LB 7.45 2726 3.66 
LB 7.44 3004 4.15 
A ver. dge- 7.39±1.81 2253±803 3.95±0.6 
H 6.29 2530 4.02 
H 6.48 2957 4.56 
H 5.85 2481 4.24 
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H 4.99 2860 5.73 
H 7.51 2697 3.59 
A veraga 6.22±1.23 2705±224 4.23±1.5 
EH 6.21 2847 4.58 
EH 5.10 2310 4.55 
EH 5.81 2428 4.18 
EH 5.57 2813 5.05 
EH 6.49 2547 3.93 
A verc iga 5.84±0.65 2589±279 4.46±0.59 
InitiW Rates. 
LB 7.59 3311 4.36 
LB 5.86 3211 5.40 
A vercWe. 6.73±0.86 3261±50 4.88±0.52 
EH 6.42 3119 4.86 
H 7.05 3223 4.57 
R Program Km(10-5ýM kcat A- I kcat/Km(107W-ls-I 
CH3(CH2)7 
Single Curve Progression. 
LB 4.53 1948 4.30 
LB 4.21 1861 4.42 
LB 5.34 2590 4.85 
LB 4.33 2433 5.61 
A verage. 4.60±0.74 2208±347 4.80±0.81 
EH 3.66 1782 4.86 
EH 3.75 2314 6.18 
EH 4.06 2384 5.87 
EH 3.50 1752 5.01 
Aveqge. 3.74±0.32 2058±306 5.48±0.7 
H 3.47 1826 5.27 
H 4.68 1864 3.99 
H 3.47 2403 6.93 
H 4.66 2435 5.22 
Average. 4.07±0.6 2132±306 5.35±1.58 
R Program KM(10-5W kcat A- I kcat/Km(107W-Is-I 
CH3(CH2)9 
Single Curve Progression. 
LB 21.50 278 0.13 
H 44.60 562 0.13 
EH 19.40 432 0.22 
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Program Km(10-5W 
Cl'-(CH2)10 1113 
Single Curve Progression. 
LB 25.26 
EH 15.85 
H 36.86 
Single Curve Progression. 
EH 13.20 
LB 35.61 
H 31.48 
R Program Km(10-5W 
(CH3)2CHCH2 
Single Curve Progression. 
H 37.03 
H 35.62 
Aveqge. 36.33±. 07 
LB 21.08 
EH 21.50 
Initial Rates. 
LB 19.36 
EH 15.60 
R Program KM(10-5W 
(CH3)CCH2 
Single Curve Progression. 
H 112.97 
H 115.84 
A veWe. 114.41±1.43 
Initial Rates. 
LB 82.60 
EH 84.90 
kcat A- I kcat/KM(107N-IS-1 
378 0.15 
306 0.19 
433 0.12 
232 0.18 
10 
le, -7 0.12 365 0.12 
kcat A- I kcat/Km(107)/M-IS-1 
7365 1.99 
5479 1.54 
6422±943 1.77±0.22 
1657 0.79 
1916 0.89 
5333 2.75 
5200 3.33 
kcat A- kcat/Km(107M-ls-I 
12711 1.13 
18981 1.64 
15846±3135 1.39±0.26 
11256 1.36 
11400 1.34 
21 1 
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Table 14. 
Poilon Down B-lactamase I catalysed hydrolysis of Penicillin G over the pH 
range 3- 10 at 30 PC. Data from single curve progression. 
PHCH2C0NH S CH3 
0, 
N ''CH3 
C-02H 
pH Km (10-5N kcat (10 2)/s- I kcat/ Km (10 7N-is-I 
3.01 7.57 7.14 0.94 
7.20 7.10 0.98 
7.48 7.13 0.95 
Average 7.42±0.2 7.12±0.02 0.96±0.02 
4.00 9.12 5.81 0.64 
9.54 5.86 0.61 
9.34 5.84 0.63 
Aver-age 9.33±0.2 5.84±0.03 0.63±0.02 
5.04 5.56 12.48 2.24 
5.04 12.36 2.45 
4.01 11.79 2.94 
3.68 10.88 2.95 
Average 4.57±1.0 11.88±1.0 2.65±0.4 
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Table 14. fcot7t.. ) 
-Iry pri ym (10-5W 6t (10 2ys-l kcat/Km (10 7ýM-ls-l 
5.98 4.06 15.95 3.93 
3.92 16.12 4.12 
4.29 16.34 3.81 
Average 4.09±0.2 16.14±0.2 3.95±0.2 
7.00 4.76 20.76 4.36 
4.99 20.35 4.08 
4.52 20.03 4.43 
Average 4.76±0.25 20.38±0.38 4.29±0.15 
8.10 4.12 16.15 3.92 
3.72 15.97 4.29 
3.29 15.61 4.74 
Average 3.71±0.41 16.24±0.65 4.32±0.4 
9.04 80.64 7.29 0.90 
54.68 5.65 1.03 
67.00 6.40 0.96 
Average 67.44±13.2 6.45±0.8 0.96±0.05 
10.00 44.50 3.76 0.08 
22.07 2.53 0.11 
27.59 2.80 0.10 
Average 31.39±13.1 3.03±0.8 0.096±0.01 
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Table 15. 
Porlon Down B-lactamase I catalysed hydrolysis of Penicillin G over the PH 
range 3-4 at 30 PC. Data from single curve progression. 
PHCH2C0NH 
-rS 
CH3 
j 
,/N 
ICH3 
C-02H 
-111 P-n Km (10-5N 6t (10 2ys-l 6t/ Km (10 7W-IS-1 
3.01 6.26 778 1.24 
4.72 807 1.71 
3.50 6.66 733 1.10 
4.08 6.57 533 0.81 
8.28 757 0.91 
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Table 16. 
Porton Down B-lactamase I catalysed hydrolysis of C6-4-nitropheqyl 
Mnicillin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
02N 
0 CC 
ýCO2H 
-111 Km (10-5W kcat (102ys-I kcat/Km(107W-IS-1 PUL 
3.01 22.02 2.71 0.12 
28.87 3.32 0.11 
Average 25.45±3.42 3.02±0.3 0.12±0.01 
4.00 30.98 11.66 0.37 
18.83 7.68 0.41 
28.87 9.24 0.32 
Average 26.23±7.5 9.53±2.13 0.37±0.04 
5.04 50.77 39.67 0.78 
54.86 43.93 0.80 
Average 52.82±2.0 41.80±2.0 0.79±0.01 
6.00 5.15 12.20 2.37 
12.65 19.67 1.55 
Average 8.90±3.75 15.94±3.75 1.96±0.41 
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Table 16 (cont.. ) 
pH Km (10-5M kmt (102WI kmt/Km(107W-is-i 
7.00 2.88 9.53 3.31 
3.24 9.81 3.03 
2.39 7.03 2.94 
1.92 6.05 3.16 
Average 2.61±0.7 8.11±2.1 3.11±0.2 
8.00 5.39 11.12 2.07 
3.18 12.50 3.93 
7.84 16.28 2.08 
Average 5.47±2.3 13.30±2.98 2.69±1.24 
9.00 3.12 6.22 1.99 
2.73 2.63 0.96 
Average 2.93±0.19 4.43±1.8 1.48±0.52 
kobs(lo-3)/S-l [Eol 10-8/M , Cat/y, m (107W-IS-1 
k 
10.00 9.29 4.00 0.02 
216 
Table 17 
Porton Down B-lactamase I catalysed hydrolysis of C6-4-fon-nylphe 11 BY 
pgnicillin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
\ýc-e-ý ý 
HZs1. 
-10 
Ni 
CO2H 
pH Km (10-5W 6t (10 2ys-I kmt / Km (10 7W- I S-1 
4.00 - - 0.04 
5.00 13.89 3.11 0.22 
15.68 3.33 0.21 
Average 14.79±1.0 3.22±0.1 0.22±0.01 
6.02 40.00 15.74 0.39 
24.63 11.08 0.45 
Average 32.32±7.68 13.41±2.33 0.42±0.03 
7.10 23.70 13.20 0.56 
20.99 12.46 0.59 
Average 22.35±1.35 12.83±0.37 0.58±0.02 
8.04 10.58 9.28 0.88 
9.79 9.00 0.92 
Average 10.19±0.39 9.14±0.14 0.90±0.04 
9.00 11.20 3.13 0.28 
3.60 2.31 0.65 
Average 7.40±3.8 2.72±0.41 0.47±0.19 
10.00 9.40 2.10 0.22 
7.30 1.80 0.24 
Average 8.35±1.0 1.95±0.15 0.23±0.01 
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Table 18. 
Porton Down B-lactamase I catalysed hydrolysis of C6-2-carbonphen3j 
pýnicillin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0 
0 8-N 
s 
'100 
/, -N 11 C02- M+ 0ý/ 
_C02- M+ 
M'= HN+(C2H5)3 
pH k(obs) (10 - 3)/s -I (Eo) (I OW kmt / Km (10 7)A4- s- 
3.00 21.47 1.13 1.90 
4.00 30.06 1.13 2.66 
12.70 0.57 2.25 
5.40 0.28 1.93 
Average 2.28±0.38 
5.00 5.95 1.59 0.37 
5.37 1.41 0.38 
Average 0.38±0.01 
6.00 3.70 1.41 0.27 
7.00 0.24 0.04 0.59 
6.13 1.41 0.44 
5.94 1.41 0.42 
Average 0.48±0.11 
8.00 0.68 1.41 0.05 
0.43 0.71 0.06 
Average 0.06±0.01 
9.00 0.64 74.50 0.001 
10.00 0.68 74.45 0.001 
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Table 19. 
Porton Down B-lactamase I catalysed hydrolysis of C6-3-carbonmhenyl 
pgnicillin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0 
ý_H 
N 91 
il 1,10 [+0 CN 11 M+ 2- 049- -- 
_CO2- M+ 
Na+ 
pH ]Km (10-5)M kmt (10 2ys-I 6t/ Km (10 7N-IS-1 
3.01 3.90 0.44 0.11 
4.00 6.00 0.65 0.11 
5.04 11.97 0.71 0.06 
9.78 0.64 0.06 
Average 10.88±1.1 0.68±0.04 0.06±0.01 
5.98 7.20 1.00 0.14 
2.77 0.50 0.18 
5.95 0.66 0.11 
Average 5.31±2.6 0.72±0.28 0.14±0.04 
7.00 7.90 2.71 0.34 
3.21 1.75 0.54 
Average 5.56±2.34 2.23±0.48 0.44±0.1 
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-TY pn 
8.10 
Average 
9.04 
Average 
10.00 
Average 
Km (10-5W 
7.24 
12.26 
5.56 
8.35±3.91 
4.10 
8.81 
6.46±2.35 
5.30 
6.40 
5.85±0.55 
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kL-at (10 2ys-i kmt/Kým (10 7W-is-i 
1.73 0.24 
2.41 0.20 
1.08 0.19 
1.74±0.68 0.21±0.03 
1.52 0.37 
1.87 0.21 
1.70±0.18 0.29±0.08 
1.20 0.23 
1.22 0.19 
1.21±0.01 0.21±0.02 
Table 20. 
Potion Down B-lactamase I catalysed hydrolysis of C6-4-carbonwhenyl 
Mnicillin over the pH ranp,, e 3- 10 at 30 PC. Data from single curve progression. 
0 
M+ 02C 
ý-N 
s 
'1144 
; 17N 
11 
0 
_CO2- M+ 
M' = HN+(C2H5)3 Na+ 
-'r 
T 
pri kj(obs)(10-3)/S-l (Eo)(10-9W kmt/Km (10 
7W-Is-I 
3.00 0.70 5.33 0.012 
4.00 1.78 6.39 0.03 
2.51 5.33 0.05 
Average 0.04±0.01 
pH Km (10-5W kcat (10 2ys-I kcat / ym (10 7W- I s- I 
5.04 5.18 2.81 0.54 
7.69 1.96 0.26 
6.01 1.88 0.31 
Average 6.29±1.4 2.22±0.6 0.37±0.1 
5.98 48.65 39.25 0.81 
39.01 29.41 0.75 
41.26 31.01 0.75 
Average 42.97±5.68 33.22±6.03 0.77±0.04 
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Table 20. (cont.. 
-111 PH fn (10-5W K kmt (10 2ys-l kmt/ Km (10 
7W-IS-1 
7.00 18.91 18.41 0.97 
13.42 17.88 1.33 
26.82 26.82 1.01 
Average 19.72±7.1 21.04±5.78 1-10±0-13 
8.10 6.32 16.42 2.50 
6.51 16.70 2.57 
Average 6.42±0.1 16.56±0.14 2.54±0.03 
k(obs)(10-3)/S-l (Eo)(10-9N kcat/Km (10 7W-ls-l 
9.04 3.72 2.13 0.17 
4.36 4.26 0.10 
Average 0.14±0.03 
10.00 0.88 5.33 0.02 
6.70 4.26 0.016 
Average 0.018±0.002 
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Table 2 1. 
Porton Down B-lactarnase I catalvsed hvdrolvsis of C6 cvclohexv] venicillin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
ý-N 
I\ >'1000 
0//EN"/ 
M+ = Na+ 
C02- M 
pH yfn (10-5W kcat (10 2ys-l 6t/Km (10 7W-is-i 
3.00 13.91 10.07 0.72 
4.00 10.76 9.05 0.84 
5.00 10.04 14.07 1.40 
6.02 5.14 13.57 2.64 
7.10 8.72 20.56 2.36 
8.04 8.99 18.06 2.00 
9.00 9. 14.57 1.46 
10.00 - - 0.04 
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Table 22. 
Porton Down B-lactamase I catalysed hydrolysis of C7 ciscarboLcy cycloheL(Yl 
penicillin over the pH ranp,, e 3- 10 at 30 PC. Data from single curve progression. 
0H 
C02- M+ 
0 
_C02- M+ 
M+ = HN+(C2H5)3 
_TV Km (10-5>M pn 
3.03 3.79 
2.08 
2.21 
Average 2.69±1.1 
4.00 6.99 
Data 1 6.20 
6.68 
Average 6.62±0.42 
4.00 6.49 
Data 2 6.10 
6.40 
Aver-age 6.33±0.16 
kcat (10 2ys-I kmt / Km (10 7W-is-I 
9.07 
8.68 
8.69 
8.81±0.26 
17.40 
17.01 
17.23 
17.21±0.19 
14.86 
14.71 
14.77 
14.78±0.08 
2.40 
4.17 
3.93 
3.50±1.1 
2.49 
2.74 
2.58 
2.60±0.14 
2.29 
2.41 
2.31 
2.34±0.08 
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Table 22. (cont. ) 
pH 
5.04 
Average 
6.00 
Average 
7.00 
Average 
8.10 
Average 
9.04 
Aver-age 
10.00 
Average 
y, m (10-5M kcat(lo2ys-I Jýcat/Kfn(107W-is-1 
8.80 12.24 1.39 
11.40 14.26 1.25 
9.90 13.58 1.37 
10.03±1.23 13.36±1.12 1.34±0.11 
13.91 23.93 1.72 
13.52 23.96 1.77 
15.94 25.15 1.58 
14.46±1.48 24.35±0.8 1.69±0.08 
87.32 51.50 0.59 
63.70 41.55 0.65 
64.45 44.30 0.69 
58.98±28.34 45.78±7.2 0.64±0.06 
61.46 16.15 0.26 
51.18 19.41 0.38 
56.32±5.14 17-78±1.63 0.32±0.06 
k(obs) ( 10 -4)/s -I (Eo) (10- ION 6t / Km (10 7W-i s-i 
4.57 9.93 0.046 
9.40 19.90 0.047 
0.0465±0.001 
4.07 9.93 0.041 
7.56 19.90 0.038 
0.039±0.001 
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Table 23. 
Porton Down B-lactamase I catalysed hydrolysis of C6 trans-2-carbon 
cycloheUl penicillin over the pH range 3-10 at 30 PC. Data from single curve 
progression. 
02- M+ 
H 
C-N 14.1 s 
0 '1000 
01 
CO2-M+ 
M-'- = HIN ýý2t'5)3 
pH Km (10-5W 
3.00 159.47 
4.00 34.52 
5.00 28.72 
20.10 
Average 24.41±4.31 
6.02 248.46 
99.34 
Average 173.90±74.56 
7.10 290.00 
94.04 
Average 192.02±97.98 
k(obs) (10-4)/S- I 
8.04 8.34 
9.00 2.51 
10.00 10.23 
I<mt (10 2ys-l kcat / Km (10 7W- I s-I 
8.85 0.06 
5.78 0.17 
10.58 0.37 
8.83 0.44 
9.71±0.87 0.410.03 
31.42 0.13 
14.84 0.15 
23.13±8.29 0.14±0.01 
19.14 0.07 
7.87 0.08 
13.51±5.63 0.08±0.01 
(Eo) (10-9»4 k, cat / yrn ( 10 7»4- 1 s- 1 
2.13 0.040 
5.33 0.005 
533.0 0.0002 
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Table 24. 
Porton Down B-lactarnase I catalvsed hvdrolvsis of C3 methvIester of 
pgnicillin G over the pH range 3-9 at 30 PC. Data from single curve progression. 
PHCH2CONH 
S 
\ýA 
CH3 
-7 
N--, / ICH 3 
0 
// 
I 
C02CH3 
exp value = estimated value from the experimental data. est value = matched theoretical 
curve. 
pH k(Obs) (10-4)/s- I (Eo) (10-7N kmt/ yým (10 3W-Is-I 
4.00 exD value 1.20 1.02 1.20 
est value 0.61 0.60 
5.30 exp value 2.06 1.02 2.02 
est value 2.29 2.24 
5.80 exp value 4.13 1.02 4.05 
est value 4.33 4.25 
6.35 exp value 5.25 1.02 5.15 
est value 5.39 5.29 
6.81 exp value 2.69 0.51 5.29 
est value 2.78 5.47 
7.01 exp value 6.42 1.02 6.29 
est value 6.80 6.67 
7.85 exp value 6.42 1.02 6.29 
est value 7.04 6.90 
9.20 exp value 4.18 1.02 4.10 
est value 5.19 5.08 
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Table 25. 
Porton Down B-lactamase I catalysed hydrolysis of Q HydrolmeLhyl 
pýýnicillin V, solubilised in I% v/v 1A dioxan, over the pH range 3- 10 at 30 PC. Data 
from single curve progression. 
PHCH2C0NH S CH3 
OIZ 
N" ICH3 
CH20H 
-11 PFI k(obs) (10 -4)/s -1 (Eo) (10-8M kalt / ym (10 5ýM- 1 s- 1 Std. Err. (10-5) 
3.00 0.86 18.00 0.005 0.20 
0.25 9.00 0.003 0.15 
Average 0.004+ 
4.00 64.50 7.10 0.91 6.05 
5.00 131.83 7.10 1.86 29.17 
65.50 3.60 1.82 13.82 
Average 1.84 
6.00 268.33 7.10 3.78 30.67 
119.83 3.60 3.33 15.76 
Average 3.56 
7.00 286.67 7.10 4.04 41.23 
185.00 3.60 5.14 19.86 
Average 4.59 
8.00 265.00 7.10 3.73 48.83 
86.50 3.60 2.40 24.00 
Average 3.07 
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Table 25. (cont.. ) 
_TY k(obs) ( 10 -4)/s -1 pri (Eo) (10-8M kcat/ Km (10 5ýM-Is-1 Std. Err. (10-5) 
9.00 236.43 7.10 3.33 20.08 
140.40 3.60 3.90 18.65 
Average 3.62 
9.56 95.20 20.30 0.47 0.50 
89.26 20.30 0.44 0.48 
Average 0.46 
9.96 97.30 60.90 0.16 19.00 
86.67 60.90 0.14 14.86 
Average 0.15 
10.51 65.80 102.00 0.06 11.56 
11.30 30.70 162.00 0.02 2.06 
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Table 26 
Table of the results for the Porton Down B-lactamase I catalysed hydrolysis of Q 
HydroMethyl rom single curve penicillin at pH 10 .01 and 30 PC. Data fi 
prog-ressions. 
PhocH2CONH S CH3 
0, ZI 
N-- ''CH3 
CH2OH 
pH k(obs) (10-3)/S- I (Eo) (10-8M kmt/ Km (10 5W-is-I 
10.01 exp value 2.06 20.30 0.10 
est value 2.10 0.10 
10.01 exp value 5.25 40.60 0.13 
est value 5.38 0.13 
10.01 exp value 7.22 60.90 0.12 
est value 7.37 0.12 
10.01 exp value 11.55 101.50 0.11 
est value 11.28 101.50 0.11 
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Table 2 7. 
Porton Down B-lactamase I catalysed hydrolysis of Q Hydrolmethyl 
Mnicillin V over the pH mnve 3- 10 at 30 PC solubilised in 20% v/v methanol. Data 
from single curve progression. 
PHCH2C0NH S CH3 
OIZ 
N- '' ICH3 
CH20H 
pH k(obs) ( 10 - 3)/s -I (Eo) (I 0-8M kcat/ Km (10 5W-Is-I Std. Err. (10-5) 
3.20 3.01 11.80 0.26 4.0 
4.00 7.60 11.80 0.64 5.09 
5.00 14.46 11.80 1.23 32.84 
5.51 16.13 11.80 1.37 27.56 
17.08 11.80 1.45 30.65 
Average 1.41±0.04 
6.00 20-00 11.80 1.70 40.41 
6.48 19.35 11.80 1.64 38.60 
19.23 11.80 1.63 36.97 
Average 1.64±0.01 
7.00 28.28 11.80 2.40 47.91 
7.50 19.68 11.80 1.67 34.75 
8.00 17.88 11.80 1.52 27.46 
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Table2Z(cont.. ) 
Pn k(obs) (1 () -4)/s -1 (Eo) _IT (10-8M kcat / Kln ( 10 5ýM- 1 s-1 Std. Err. (10-5) 
8.53 28.40 11.80 2.41 30.42 
34.10 11.80 2.89 28.56 
Average 2.65±0.24 
9.56 13.46 11.80 1.14 10.01 
12.18 11.80 1.03 14.77 
Average 1.09±0.05 
9.96 6.42 11.80 0.54 3.00 
2.70 11.80 0.23 8.12 
Average 0.39±0.16 
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Table 28. 
Porton Down B-lactamase I catalvsed bvdrolvsis C7 benzvl ce-phalosr)ofin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
ýI D>-CH N 2 \, 
ý 
s 
-EN 04ýý CH20COCH3 
pH Km (10-5W kcat /s-1 kmt/ Km (10 5W-is-I 
3.01 6.70 0.49 0.070 
7.58 0.47 0.060 
Average 7.10±0.4 0.48±0.01 0.065±0.01 
4.00 4.59 0.43 0.090 
3.38 0.42 0.120 
1.75 0.85 0.050 
Average 3.52±1.77 0.57±0.28 0.086±0.034 
5.04 5.66 0.80 0.140 
8.61 0.96 0.110 
Average 7.14±1.47 0.88±0.08 0.125±0.02 
6.00 8.00 1.27 0.160 
8.19 0.72 0.090 
3.39 0.46 0.140 
Average 6.53±3.14 0.82±0.45 0.130±0.04 
7.00 4.57 0.62 0.130 
3.50 0.52 0.150 
Aver-age 4.04±0.54 0.57±0.05 0.140±0.01 
8.00 5.16 0.67 0.130 
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Table 28. (con t.. ) 
-TT I<in (10-5M pri 
9.00 8.29 
3.11 
4.25 
Average 5.22±3.07 
kobs(lo-4)/s-I 
10.00 1.878 
kcat /s-1 kmt/Kfn (10 5W-is-i 
0.42 0.050 
0.31 0.090 
0.33 0.070 
0.35±0.07 0.070±0.02 
[Eol 10-6/M kcat / Km (I 05W- I s- 1 
1.07 0.002 
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Table 29. 
Potion Down B-lactamase I catalysed hydrolysis of C7 2-nitrophenyl 
gMhaloMorin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
s 
02 ET--Jr N 
CH20COCH3 
02H 
-'r T -7M P-n k(obs) (10-5)ls- I (Eo) (10 
3.00 1. exp value 2.24 
4.00 1. exp value 2.90 
5.00 1. exp value 6.42 
2. est value 7.05 
6.00 1. exp value 7.22 
2. est value 7.87 
7.00 1. exp value 8.25 
2. est value 9.22 
8.00 1. exp value 7.70 
2. est value 8.69 
9.00 1. exp value 6.08 
2. est value 6.14 
10.00 1. exp value 2.41 
2. est value 2.49 
6.58 
6.58 
6.58 
6.58 
6.58 
6.58 
6.58 
6.58 
kmt / Km (10 2W- I s-I 
0.34* 
0.44* 
0.97 
1.07 
1.10 
1.20 
1.25 
1.40 
1.17 
1.32 
0.90 
0.90 
0.40 
0.40 
* Values calculated from the lineafised logarithak plot of time Vs. absorbance data. 
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Table 30. 
Porton Down B-lactamase I catalysed hydrolysis of C7 3-nitrophenyl cephalospolin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
0 ý- I N\s 
02N N r02H 
CH20COCH3 
-iry pri Km (10-6W 6t (10-2ys-l kmt/ Km (10 4W-ls-l 
3.01 2.36 5.11 2.17 
4.00 5.28 12.90 2.44 
5.90 10.15 1.72 
Average 5.59±0.31 11.53±1.37 2.08±0.36 
5.04 1.83 7.69 4.20 
3.30 9.41 2.85 
Average 2.57±0.73 8.55±0.86 3.53±0.67 
6.00 3.16 12.97 4.1 
7.00 1.24 11.21 9.04 
1.61 11.86 7.37 
Average 1.43±0.18 11.54±0.32 8.21±0.83 
9.00 4.71 13.23 2.80 
3.46 11.71 3.39 
4.84 13.19 2.72 
Average 4.34±0.88 12.71±1.0 2.97±0.42 
kobs(lo-4)/S-l [Eol 10-7/M kcat/Km (105)4\4-IS-1 
10.00 exp 2.75 4.19 0.07 
est 2.68 0.06 
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Table 3 L. 
Porton Down B-lactamase I catalysed hydrolysis of C7 4-nitrophenyl 
cohaloMorin over the pH mnge 3- 10 at 30 PC. Data from single curve progression, 
anajyýjý by microcomputer. 
0H 
02N-q: S,,,, 
Nr 
0// CH20COCH3 
02H 
-111 P-n Km (10-6W kcat (10-2ys-l kmt/ Km (10 4W-is-i 
4.00 8.24 14.86 1.80 
4.32 11.16 2.59 
3.29 9.33 2.83 
10.21 19.06 1.87 
4.93 12.66 2.57 
11.42 13.87 1.21 
5.22 10.40 1.99 
6.50 11.44 1.76 
Average 6.77±4.65 12.82±3.49 2.08±0.87 
5.04 14.28 11.70 0.82 
9.67 9.50 0.98 
9.92 9.95 1.00 
10.30 11.06 1.07 
15.73 14.15 0.90 
AveWe 11.98±2.3 11.27±1.77 0.95±0.13 
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Ta ble 3 1. (con t.. 
pH y, ým (10-6N kmt (10-2ys-I 6t/ Km (10 4W-is-i 
6.00 5.69 12.33 2.17 
3.43 10.98 3.20 
5.84 12.15 2.08 
6.16 12.81 2.08 
3.98 11.19 2.81 
5.48 12.24 2.23 
Average 5.10±1.67 11.95±0.97 2.43±0.77 
7.00 3.35 14.20 4.23 
3.44 15.02 4.36 
2.82 15.04 5.34 
Average 3.20±0.38 14.75±0.55 4.64±0.7 
8.00 2.39 21.29 8.92 
1.94 19.31 9.96 
Average 2.17±0.22 20.30±0.99 9.44±0.52 
9.00 11.19 14.71 1.31 
7.00 11.65 1.61 
7.89 12.72 1.61 
Average 8.69±2.5 13.03±1.38 1.51±0.2 
kobs(lo-4)/S-l [Eol 10-7/M 6t/Km (105W-Is-I 
10.00 exp 3.61 5.26 0.07 
est 3.6 1 0.07 
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Table 32. 
Porton Down B-lactamase I catalysed hydrolysis of C7 2-carboMhenyl 
cgpha]oMorin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
0 ý-ý 
\ 
R--M+ 
s 
C02 17N 
0 CH20COCH3 
TV + 02 M 
pH 
3.01 
verage 
k(obs) ( 10 - 5)IS -I 
exp 8.44 
est 10.40 
exp 7.30 
est 5.81 
kmt(lo-2)/s-I kcat/Km(103W-is-I Km (10-5M 
60.61 
42.75 
51.68±8.93 
Manual processing of curve 
Manual processing of curve 
Average 
6.83 
5.04 
5.94±0.9 
(Eo) (10-7N 
5.16 
4.13 
4.00 121.11 14.15 
155.35 18.18 
119.65 12.10 
Average 132.04±12.39 14.81±3.37 
0.113 
0.118 
0.116±0.003 
kmt/ Km (10 3W-IS-1 
0.164 
0.177 
0.118 
0.100 
0.132±0.03 
0.116 
0.117 
0.101 
0.111±0.01 
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Table 32. (cont.. ) 
Km (10-5M kmt(lo-2)/s-I kmt/KM(103M-IS-1 
5. o4 16.70 0.20 0.012 
23.53 0.40 0.017 
Average 19-93±3.6 0.30±0.1 0.015±0.03 
6.00 8.98 0.12 0.013 
12.05 0.15 0.012 
Average 10.52±1.53 0.14±0.02 0.013±0.001 
7.00 1.25 0.06 0.049 
2.38 0.07 0.027 
1.39 0.06 0.043 
Average 1.67±0.71 0.06±0.01 0.040±0.013 
8.00 5.24 0.05 0.009 
2.78 0.05 0.018 
2.58 0.03 0.011 
Average 3.53±1.71 0.04±0.01 0.013±0.004 
9.00 10.00 0.02 0.002 
5.00 0.02 0.004 
Average 7.50±2.5 0.02±0.001 0.003±0.001 
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Table 33. 
Porton Down B-lactamase I catalysed hydrolysis of C7 3-carbonThenyl 
cMhalospoiin over the pH range 3- 10 at 30 PC. Data from single curve prouession. 
0H 
'0 
\\ 
- 
HO2C 
EN 
0151ý 
pH Km (10-5N 
S 
kcat (10 -2)/s-i kcat/ Km (10 3»1-ls-i 
3.01 0.17 3.45 19.82 
0.42 5.50 13.08 
Average 0.30±0.12 4.48±1.02 16.45±3.37 
4.00 0.37 3.60 9.78 
0.97 7.33 7.56 
0.28 3.26 11.65 
Average 0.54±0.43 4.73±2.6 9.66±2.1 
4.50 1.05 5.18 4.94 
0.50 3.76 7.58 
0.65 4.13 6.39 
Average 0.73±0.32 4.36±0.82 6.30±1.36 
5.04 2.56 8.33 3.26 
L93 6.82 3.52 
1.01 5.40 5.33 
Average 1.83±0.73 6.85±1.48 4.04±1.29 
5.50 0.82 3.51 4.30 
0.40 3.08 7.63 
0.73 3.41 4.71 
Average 0.65±0.2 3.33±0.25 5.55±2.08 
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Table 33. (cont. 
pH Km (10-5W kcat (10 -2ys-l kcat/ Km (10 3ýM-IS-i 
6.00 1.16 5.89 5.09 
0.66 5.05 7.65 
1.02 5.60 5.49 
1.18 6.04 5.13 
Average 1.01±0.45 5.65±0.39 5.84±1.81 
6.55 0.49 3.64 7.46 
0.45 3.58 7.94 
0.41 3.51 8.59 
Average 0.45±0.04 3.58±0.06 7.99±0.6 
7.00 1.20 5.94 4.97 
0.59 5.00 8.54 
Average 0.90±0.3 5.47±0.47 6.76±1.78 
7.50 0.60 3.44 5.78 
0.55 3.39 6.12 
0.53 3.36 6.29 
Average 0.56±0.04 3.40±0.04 6.06±0.28 
8.00 2.31 7.53 3.26 
1.10 3.69 3.37 
3.31 8.64 2.61 
Average 2.24±1.07 6.62±2.93 3.08±0.47 
9.00 3.11 6.35 2.04 
1.65 4.83 2.98 
1.91 4.60 2.40 
2.03 4.64 2.29 
Average 2.18±0.93 5.11±1.24 2.45±0.53 
10.00 13.10 6.31 0.48 
16.10 9.12 0.57 
17.70 7.94 0.49 
Average 15.63±2.07 7.79±1.33 0.51±0.06 
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Table 34. 
Porton Down B-lactamase I catalysed hydrolysis of C7 4-carboLomhenyl 
cohalosipotin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
HO2C s 
CH2OCOCH3 
0, H 
oý 
pH Km (10-5W kcat(lo-2)/S-l kmt/Km(103W-is-I 
3.01 0.33 4.23 12.69 
0.94 9.31 9.93 
0.99 10.90 10.98 
Average 0.75±0.42 8.15±3.92 11.20±1.27 
4.00 0.34 2.91 8.60 
0.43 4.26 9.94 
0.56 4.68 8.30 
0.29 2.79 9.55 
Average 0.41±0.15 3.66±1.02 9.10±0.8 
4.50 3.00 11.98 3.98 
L92 10.35 5.40 
1.58 9.01 5.69 
Average 2.17±0.83 10.45±1.53 5.02±1.04 
5.04 1.56 2.28 1.46 
3.09 6.30 2.04 
5.52 5.16 0.93 
Aver-age 3.39±2.13 4.58±2.3 1.48±0.6 
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Table 34. (cont.. ) 
pH Km (10-5N kmt (10 -2ys-i 6t/ K,,, (10 3N-is-i 
5.50 2.54 2.07 0.81 
4.67 3.81 0.82 
Average 3.61±2.13 2.94±0.87 0.82±0.01 
6.00 1.07 4.34 4.06 
3.58 11.82 3.30 
Average 2.33±1.26 8.08±3.74 3.68±0.38 
6.55 4.94 10.41 2.11 
7.00 0.79 2.22 2.80 
1.50 4.36 2.91 
0.81 2.53 3.11 
1.09 3.94 3.61 
Average 1.05±0.41 3.26±1.1 3.11±0.5 
7.50 1.43 4.56 3.18 
1.49 3.81 2.56 
1.21 3.52 2.91 
Average 1.38±0.11 3.96±0.6 2.88±0.32 
8.00 3.58 11.83 3.30 
3.23 10.65 3.29 
Average 3.41±0.17 11.24±0.59 3.30±0.07 
9.00 3.46 3.69 1.07 
9.50 4.67 4.17 0.89 
7.61 5.47 0.72 
Average 6.14±1.47 4.82±0.65 0.81±0.08 
10.00 3.66 3.22 0.88 
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Table 35. 
Table of the results for the Porton Down B-lactamase I catalysed hydrolysis of 
C7 4-carbonTbenyl cephalospofin at pH 4 at 30 PC. Data from initial mte 
measurement. 
0H 
H02C 
\s 
, 
17N 
CH20COCH3 
O,, H 
0ý 
2H 
LB= Lineweaver-Burke plot. EH= Eadie-Hofstee plot. H= Hanes plot. EF= Enzfitter 
Michaelis-Menten plot. 
pH Km (10-5W 6t (10 -2)/s-i kcat/Km (10 3W-is-I 
4.00 0.39 4.74 12.22 EF 
0.14 1.74 12.43 H 
0.28 4.53 16.18 EH 
0.39 4.89 12.54 ILB 
[ Substrate I [ Rate I [ L/Sl [ I/Rate I [ RatwS I [ SRate 
8.81x 10 -5 1.64x 10-8 1.135x 10 
4 6.098x 10 7 1.862x 10 -4 5371.95 
6.61x 10 -5 1.62x 10-8 1.513x 10 
4 6.173x 10 7 2.45Ix 10 -4 4080.25 
4.41x 10 -5 1.86x 10-8 2.268x 10 
4 5.376x 10 7 4.218x 10 -4 2370.97 
2.21x 10 -5 1.81x 10-8 4.525x 10 
4 5.525x 10 7 8.19x 1 04 1220.99 
I. I Ix 10 -5 1.50x 10-8 9.009X 10 
4 6.667x 10 7 13.514x 10 -4 740.00 
5.5lx 10 -6 1.42x 10-8 18.149x 10 
4 7.042x 10 7 25.77Ix 10 -4 388.03 
4.41x 10 -6 1.17x 10-8 22.676x 10 
4 8.569x 10 7 26.463x 10 4 377.89 
2.20x 10 -6 6.78x 10-9 45.455x 10 
4 14.749x 10 7 30.818x 10 -4 324.48 
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Table 36. 
Poilon Down B-lactamase I catalysed hydrolysis of C7 4-carbonMhenyl 
cMhalospgrin over the pH mnize 3-4 at 30 PC. Illustrating the effects of changin 
buffers and ionic strength. Data from single curve progression. 
0H 
H02C 
s 
CH20COCH3 TO 
-, Hý'ý 
0ý 
2 
pH ym (10-5M kcat (10 -2W1 kcat / Km (10 3ýM- 1 s- 1 
3.01 
Glydne/HCI 0.75 8.15 11.20 
Citrate/Citric 0.62 7.12 11.45 
4.00 
Acetate 0.41 3.16 9.10 
Acetate/KCI 0.56 4.68 8.30 
Citrate/KCI 0.29 2.79 9.55 
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Table 37 
Porton Down B-lactamase I catalysed hydrolysis of C7 4-carbon2henyl 
dicMha]oMgrin (Dimer) over the pH mnge 3- 10 at 30 PC. Data from single curve 
progression. 
H00H 
N'-ý 0s 
sf 
N: 
l 
/-N 
CH30COH2C \\ 0 CH20COCH3 
H02 
02H 
LB=Lineweaver-Burke. EH=Eadie-Hofstee. H=Hanes. EF= Enzfitter. 
pH Km (10-5N kcat (10 -2)/s-I kcat/ Km (10 
3N-is-I 
Diffenz. 
4.00 0.41 0.39 0.95 ILB 
2.96 0.99 0.33 H 
2.23 0.96 0.43 EF 
5.04 1.04 1.64 1.57 IB 
1.08 1.65 1.53 EF 
6.00 2.26 1.00 0.44 LB 
1.21 0.75 0.62 EH 
2.06 0.97 0.47 H 
1.88 0.95 0.50 EF 
6.55 0.87 0.96 1.11 IB 
1.38 1.06 0.77 H 
1.76 1.14 0.65 EF 
7.00 1.12 0.69 0.62 EH 
6.22 2.57 0.42 EF 
8.00 3.11 1.69 0.54 H 
2.56 1.84 0.72 EF 
9.00 27.70 5.52 0.20 IB 
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Table 3Z (con t.. 
-Ir T Pri 
Initial Rates. 
3.01 
4.00 
5.04 
6.00 
6.55 
7.00 
8.00 
9.00 
Ynn (10-5M kcat (10 -2Wi kcat/ yIn (10 3ýM-is-i 
4.01 0.61 0.15 LB 
4.06 0.45 0.11 EH 
4.02 0.61 0.15 H 
2.05 0.62 0.30 LB 
1.97 0.62 0.31 H 
1.98 0.63 0.32 EH 
1.04 0.84 0.81 LB 
0.96 0.82 0.86 EH 
0.94 0.81 0.86 H 
2.89 0.94 0.32 ILB 
2.65 0.91 0.34 EFI 
2.69 0.92 0.34 H 
2.25 1.12 0.50 IB 
2.35 1.14 0.48 H 
2.37 1.14 0.48 EH 
5.63 1.58 0.28 LB 
6.69 1.82 0.27 EH 
7.01 1.89 0.27 H 
26.30 3.85 0.15 I-B 
37.40 5.02 0.13 EH 
40.80 5.44 0.13 H 
8.96 0.94 0.10 IB 
8.40 0.91 0.11 H 
6 
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Table 38. 
Porton Down B-lactamase I catalyýgd hydrolysis of C7 cyclohe 
cgphalosMiin over the pH range 3- 10 at 30 PC. Data from single curve prQgression. 
0H 
s 
0 CH20COCH3 
62M+ 
-'[ I Pill 
3.01 
Average 
4.00 
Average 
5.04 
6.00 
7.00 
8.00 
17.82 
12.24 
15.03±2.79 
2.33 
2.34 
2.33 
2.34±0.01 
2.62 
2.78 
2.98 
2.16 
9.00 2.38 
kobs(lo-5)/S-l 
10.00 exp 5.42 
est 6.28 
Km (10-5N kmt (10-2) /S-l 
4.00 
3.30 
3.65±0.35 
2.40 
2.40 
2.40 
2.40±0.001 
3.00 
3.40 
3.50 
3.20 
2.96 
[Eol 10-6/M 
1.23 
1.23 
kmt / Km (10 3W- I s-I 
0.23 
0.27 
0.25±0.02 
1.04 
1.03 
1.04 
1.04±0.001 
1.15 
1.24 
1.16 
1.48 
1.24 
kcat / Km (I 03W- I s- I 
0.044 
0.051 
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Table 39. 
Porton Down B-lactamase I catalysed hydrolysis of C7 cis-carbo cyclohe I Ny - nj 
cobalospgiin over the pH range 3-10 at 30 PC. Data from single curve progression. 
0H 
s 
CA CýM N 
0, CH2OCOCH3 
C'2M+ 
pH k(obs) (10 -4)/s -I (Eo) (10-6W kat/ Km (10 2W-is-I Std. Err. 
3.00 1.37 1.37 1.05 0.002 
0.70 0.69 1.01 0.004 
0.37 0.34 1.09 0.001 
Average 1.05±0.04 
4.00 7.13 1.30 5.48 0.05 
7.39 1.30 5.68 - 
Averdge 5.58±0.1 
5.00 2.90 1.27 2.28 
1.82 0.69 2.64 
0.83 0.34 2.45 
Average 2.46±0.18 
6.00 3.38 1.30 2.60 0.01 
3.52 1.30 2.71 0.01 
Average 2.66±0.06 
7.00 0.83 1.30 0.64 0.008 
0.78 1.27 0.62 - 
0.91 1.30 0.70 0.004 
Average 0.65±0.05 
6 
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Table 39. (cont.. ) 
-111 -6WI<, - -Is-I Std. Err. pri k(obs) (10-4)/s- I (Eo) (10 _at/ 
Km (10 2W 
8.00 0.35 1.30 0.27 
0.43 1.27 0.34 
Average 0.31±0.04 
9.00 0.18 6.00 0.03 
6 
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Table 40. 
Porton Down B-lactamase I caWysed hydrolysis of C7 2- trans-carbo 
UclohgMI cMha]oMgrin over the pH range 3- 10 at 30 PC. Data from single cury 
progression. 
C02- M+ 
H 
C-N 
c 2 
()COCH3 
-111 pn k(obs) (10-4)/s- I (Eo) (10-6)M kmt / Km (10 3W- I S-1 Std. Err. 
3.00 1.35 0.67 0.20 0.0001 
4.00 0.35 0.67 0.05 0.00005 
5.00 11.42 3.35 0.33 0.005 
13.15 3.35 0.40 0.002 
12.67 3.35 0.37 0.020 
Aver-age 0.37±0.04 
6.00 3.82 0.67 0.58 0.0004 
3.80 0.67 0.57 0.0004 
Average 0.58±0.01 
7.00 12.60 0.67 1.88 0.001 
8.00 19.17 3.35 2.87 0.020 
9.00 11.92 3.35 1.78 0.007 
10.00 1.58 0.67 0.23 0.0001 
6 
252 
Table 4 1. 
Porton Down B-lactamase I catalysed hydrolysis of beMl cephalogLoii 
lactone over the pH range 3- 10 at 30 PC. Data from single curve progression, 
0H 
CH 2ý 
crý 
Table No. I 
2 
-TY pri Km (10-3N kmt /s- I kcat/ Km (10 
4W-is-I 
3.01 1.57 22.70 1.45 
4.00 1.37 59.70 4.36 
5.04 1.54 101.70 6.60 
6.00 1.25 106.30 8.50 
7.00 1.55 214.00 13.81 
8.00 1.00 75.33 7.53 
9.00 1.35 98.67 7.31 
10.00 0.97 5.70 0.60 
6 
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Table 4 1. (con 
Table No. 2 
pH 
6.00 
6.50 
7.00 
7.50 
8.00 
y , In (10-3M kmt /s-1 
1.83 832 
2.03 1049 
1.32 766 
1.57 880 
9.76 357 
Table No. 3 
pH ]Km (10-3M kcat /s-1 
6.00 0.56 236 
6.50 0.72 456 
7.00 1.28 785 
7.50 0.61 407 
8.00 0.48 199 
pKa values. (kcaVKm) 
pKal = 4.84 
pKa2 = 9.20 
6t / Km (10 5W- I S-1 
4.55 
5.17 
5.80 
5.61 
3.66 
kcat / ym (10 5W- 1 s- 
4.18 
6.39 
6.10 
6.68 
4.12 
0 
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Table 42. 
Sig-ma B-1-actamase 2 catalysed hydrolysis of N-acyl penicillins at 309C, pH 7. 
RCONH 
CH3 
0// 
N ICH3 
C-02H 
The following results were obtained by 'Gil ford' single curve progression. 
k(obs) (10-2)/S- 1 (Eo) (10-7W kcat / Kur, (10 5W- I s- I 
C6H5CH2 
3.49 1.13 3.09 
1.70 56.50 3.02 
0.68 22.70 3.01 
3.93 1.13 3.48 
1.90 56.50 3.36 
Average. 3.19±0.2 
CH3CH2 3.89 1.13 3.44 
3.53 1.13 3.12 
4.09 1.13 3.62 
4.22 1.13 3.73 
3.34 0.91 3.68 
2.46 0.68 3.61 
1.39 0.46 3.05 
Average. 3.46±0.41 
CH3(CH2)2 2.36 1.13 2.09 
2.07 0.91 2.28 
1.63 0.68 2.39 
1.07 0.46 2.36 
0.59 0.23 2.61 
Average. 2.35±0.26 
CH3(CH2)3 
2.33 1.13 2.06 
2.07 0.91 2.30 
1.28 0.68 1.88 
1.10 0.46 2.41 
0.50 0.23 2.20 
Average. 2.17±0.29 
CH3(CH2)4 
2.03 1.13 1.80 
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1.73 
0.84 
Average. 
CH3(CH2)5 
4.02 
3.14 
1.41 
0.47 
Average. 
CH3(CH2)7 
1.67 
1.07 
0.62 
0.39 
Average. 
CH3(CH2)9 
1.53 
1.84 
0.90 
Average. 
CH3 (CH2) 10 2.80 
1.54 
Average. 
(CH3)2CHCH2 
0.81 
0.66 
0.39 
0.20 
Average. 
(CH3)3CCH2 
0.57 
0.46 
0.37 
0.23 
Average. 
0.91 
0.46 
1.13 
0.91 
0.68 
0.23 
1.13 
0.91 
0.68 
0.46 
1.13 
0.91 
0.46 
1.13 
0.68 
0.91 
0.68 
0.46 
0.23 
1.13 
0.91 
0.68 
0.46 
6 
1.90 
1.85 
1.85±0.05 
3.56 
3.45 
2.07 
2.08 
2.79±0.77 
1.48 
1.18 
0.91 
0.85 
1.11±0.26 
1.35 
2.03 
1.96 
1.78±0.25 
2.48 
2.26 
2.37±0.11 
0.90 
0.96 
0.87 
0.90 
0.92±0.05 
0.51 
0.50 
0.55 
0.51 
0.52±0.01 
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Table 43. 
Porton Down B-lactamase 2 catalysed hydrolysis of Penicillin G over the 
ranwe 3-10 at 30 PC. Data from single curve progression. 
PHCH2C0NH S CH3 
0/ 
'' ICH3 
,ZN -- 
C-02H 
pH k(obs) (10-3)/S- I (Eo) (10-8M kmt/Km (10 
5W-IS-1 
4.00 1.71 12.20 0.14 
4.52 24.30 0.19 
7.19 48.70 0.15 
Aver-age 0.16±0.03 
5.00 4.35 5.98 0.73 
11.30 11.96 0.94 
Average 0.84±0.1 
6.00 8.14 5.98 1.36 
12-90 11.96 1.08 
Average 1.22±0.14 
7.00 13.70 5.98 2.29 
6.89 2.98 2.31 
Average 2.30±0.01 
8.00 13.20 5.98 2.21 
6.48 2.98 2.17 
Average 2.19±0.02 
9.00 1.39 10.70 0.13 
10.00 0.58 23.90 0.05 
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Table 44. 
Porton Down B-lactamase 2 catalysed bydrolysis of 4-forrnylpbenvl pgnicillin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 0 
\\ 
H 
'. 000 N 
0// C02H 
pH k(obs) (I 0-3)/S- 1 (Eo) (I 0-8N kcat / Km (10 5W-is-I 
3.00 exp value 6.42 81.30 0.08 
est value 5.42 0.07 
4.00 exp value 32.09 81.30 0.39 
est value 12.63 0.16 
5.00 exp value 3.78 8.13 0.46 
est value 2.89 0.36 
6.00 exp value 16.05 8.13 1.97 
est value 17.02 2.09 
7.00 exp value 38.51 8.13 4.74 
est value 38.63 4.75 
8.00 exp value 46.21 8.13 5.68 
est value 50.88 6.23 
9.00 exp value 12.84 8.13 1.58 
est value 11.13 1.37 
10.40 exp value 2.51 8.13 0.31 
est value 2.88 0.35 
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Table 45 
Poilon Down B-lactamase 2 catalysed hydrolysis of 2-nitrophenyl pgnicillin 
ge 3- 10 at 30 PC. Data from single curve proggression. over the pH ran, 
0H 
NO, 0//, 2 
-C-02H 
-'r 
T 
Pri k(obs) (10 -3)/s -I (Eo) (10-8)M Jýcat / Km (10 
5W-Is-I Std. Err. 
5.00 16.90 15.80 1.07 0.0006 
6.00 36.57 15.80 2.31 0.004 
7.00 41.20 15.80 2.61 0.0008 
8.00 49.30 15.80 3.12 0.001 
9.00 31.99 15.80 2.03 0.0007 
10.00 13.42 61.00 0.22 0.004 
6 
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Table 46. 
Porton Down B-lactamase 2 catalvsed hvdrolvsis of 3-nitroi)henvi nenicillin over 
the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
ý- I 0Ns 
,o 02 NP // -NII 0 
-("02H 
-'FT pri k(obs) ( 10 - 3)/s -I (Eo) (10-8)M kcat/ Km (10 5W-is-1 Std. Err. 
5.00 11.27 4.50 2.50 0.0006 
10.42 4.50 2.31 0.0008 
Average 2.41±0.1 
6.00 13.15 4.50 2.92 0.0005 
12.69 4.50 2.82 0.0005 
Average 2.87±0.05 
7.00 15.97 4.50 3.55 0.002 
14.17 4.50 3.15 0.003 
Aver-age 3.35±0.2 
8.00 16.35 4.50 3.63 0.006 
15.95 4.50 3.54 0.003 
15.33 4.50 3.41 0.003 
18.07 4.50 4.02 0.002 
Average 3.65±0.37 
9.00 30.37 4.50 6.74 0.0009 
30.36 4.50 6.74 0.001 
Average 6.74±0.001 
10.00 6.68 22.50 0.30 0.0004 
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Table 47 
Porton Down B-lactamase 2 catalysed hvdrolvsis of 4-nitronhenvl mnicillin 
over the pH rang ýe 3- 10 at 30 PC. Data from single curve progression. 
0H 
02N Ns 
\ -40 
/ N, 
0/ 
-C02H 
pH k(obs) (10 -3)/s -I (Eo) (10-8W kmt / Km (10 5W- I s-I 
3.00 exp value 0.25 68.60 0.003 
est value 0.21 0.003 
4.00 (saturation kinetics observed) 
vmax ( 10-6Ws-1 V kcat / Km (10 5W-is-I , In (10- 
5W kcat /s-l 
0.19 3.80 0.26 0.07 
0.11 2.58 0.15 0.06 
0.21 5.76 0.30 0.05 
Average 4.05±1.47 0.24±0.09 0.06±0.01 
0.027 7.80 0.37 0.05 
0.012 2.68 0.17 0.06 
0.027 7.87 0.37 0.05 
Average 7.84±0.03 0.37±0.001 0.05±0.01 
5.00 exp value 19.25 14.50 1.33 
est value 15.43 1.06 
6.00 exp value 12.03 7.23 1.66 
est value 12.35 1.71 
4. 
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Table 47 (con t.. ) 
-Iry PFI k(obs) (10-3)/S- I (Eo) (10-8W kmt/ yrn (10 5W-is-I 
7.00 exp value 20.63 7.23 2.85 
est value 23.48 3.25 
exp value 42.79 14.50 2.95 
est value 47.97 3.31 
Average 2.90±0.05 
8.00 exp value 57.76 7.23 7.98 
est value 63.41 8.77 
9.00 exp value 21.39 14.50 1.48 
est value 28.19 1.94 
10.00 exp value 4.81 14.50 0.33 
est value 4.90 0.34 
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Table 48. 
Porton Down B-lactamase 2 catalyLed hydrolysis of 2-carbonphenyl pýýnicillin 
ge 3- 10 at 30 PC. Data from single curve progression. over the pH ran, 
0 
ý_H 
Ns 
cc 
C02- M+ O'ý, -N--_/ 
M+ = HN+(C2H5)3 
_C02- M+ 
pH k(obs) (I 0-3)/S- 1 (Eo) (10-8)M kmt/ Km (10 
5W-IS-1 
4.00 114.00 41.50 2.75 
110.00 38.30 2.87 
77.90 39.30 1.98 
Average 2.53±0.34 
5.00 20.00 41.50 0.48 
6.00 7.31 62.30 0.12 
7.00 5.53 31.10 0.18 
9.42 62.30 0.15 
Average 0.17±0.02 
8.00 30.30 41.50 0.73 
7.69 20.80 0.37 
Average 0.55±0.18 
9.00 0.74 62.30 0.01 
10.00 0.62 62.30 0.008 
0 
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Table 49. 
Porton Down B-lactamase 2 catalyýgd hydrolysis of 3-carbomhenyl pgnicillin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
ý-N 
s\", 
do 
M+ 02-C 
_CO2- M+ 
M'= Na+ 
pH k(obs) (10-3)/S- 1 (Eo) (10-8W 6t/ Km (10 5W-is-I 
4.00 114.00 39.30 2.90 
156.00 52.40 2.98 
Average 2.94±0.04 
5.00 17.04 8.13 2.10 
6.00 15.40 8.13 1.89 
7.00 30.32 8.13 3.73 
8.00 38.40 8.13 4.72 
9.00 15.40 8.13 1.89 
0 
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Table 50. 
Porton Down B-lactamase 2 catalvsed hvdrolvsis of 4-carboxvr)henvl r)enicillin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
M+ 02C--CC N 0 
>11000 
0//1: 
7N 
-/ 
'' 11 
-C-02- M+ 
M' = HN+(C2H5)3 Na+ 
-TY pH k(obs) (I 0-3)/S- 1 (Eo) (10-8N kcat/ Km (10 5W-is-I 
5.00 6.93 12.00 0.58 
6.00 15.80 12.00 1.32 
7.00 54.90 23.90 2.30 
8.00 45.60 12.00 3.80 
9.00 28.20 23.90 1.18 
10.00 2.43 23.9 0.10 
6 
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Table 51. 
Porton Down B-lactamase 2 catalvsed hvdrolVsis of cvclohexvi venicillin over 
the pH range 3- 10 at 30 PC. Data from sing] e curve progression. 
0H 
ý-N 
s 
ý'. Ioo 
//, -N, / " 11 
0 
M+ = Na+ 
C02- M+ 
--TT pn k(obs) (10-3)/S- I (Eo) (10-8N kcat/ Km (10 5W-Is-I Std. Err. 
5.00 98.20 31.30 3.14 0.02 
107.00 31.30 3.42 0.02 
112.00 31.30 3.57 0.02 
Average 3.38±0.24 
6.00 75.69 31.30 2.42 0.008 
7.00 174.00 31.30 5.55 0.03 
8.00 83.25 31.30 2.66 0.03 
9.00 17.55 31.30 0.56 0.09 
10.00 4.90 31.30 0.04 0.0008 
6 
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Table 52. 
Poilon Down B-lactamase 2 catalysed hydrolysis of 2-cis-carboLcycycloheLcyl 
pgnicillin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
14.1 
ý"s C02- M+ E-TN 
_C02- M+ 
M+ HN+(C2H5)3 
pH k(obs) (10-3)/S- I (Eo) (10-8W kcat / Km (10 5ýM- s- 
4.00 147.10 39.30 3.74 
110.00 38.30 2.87 
Average 3.31±0.43 
5.00 1.64 5.33 0.31 
5.28 10.70 0.49 
1.47 5.98 0.26 
4.28 11.96 0.36 
Average 0.36±0.13 
6.00 0.72 5.65 0.13 
2.86 22.60 0.13 
Average 0.13±0.001 
7.00 0.68 7.25 0.10 
0.82 5.65 0.15 
Average 0.13±0.03 
8.00 3.99 11.30 0.35 
9.31 22.60 0.41 
Average 0.38±0.03 
9.00 5.34 2.43 0.22 
10.00 1.78 2.43 0.07 
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Table 53. 
Porton Down B-lactamase 2 catalysed hydrolysis of 2- trans- carboncycl o 
henj pýýnicillin over the pH mnge 3- 10 at 30 PC. Data from single curve progression. 
02- M+ 
H 
-C-N 
-S 0 TT- 
O; 
FN-ý 
M+ HN+(C2H5)3 
C02-M+ 
-111 pri k(obs) ( 10 - 3)/s -I (Eo) (10-8N kcat/ Km (10 5W-is-I 
5.00 exp value 16.1 47.70 0.33 
est value 15.60 0.33 
6.00 exp value 5.16 35.80 0.16 
est value 5.70 0.16 
7.00 exp value 2.42 23.90 0.10 
est value 2.41 0.10 
8.00 exp value 6.88 35.80 0.18 
est value 6.42 0.18 
9.00 exp value 5.89 59.60 0.08 
est value 4.98 0.08 
10.00 exp value 1.93 59.60 0.03 
est value 1.66 0.03 
6 
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Table 54. 
Porton Down B-lactamase 2 catalvsed hvdrolvsis of benzvl ceDhalosi)orin over 
the pH range 3- 10 at 30 PC. Data from sing] e curve progression. 
0H 
-CH 
ý- I 
2- Ns 
N 
0// CH20COCH3 
02H 
-111 pri k(obs) (10 -2)/s -I (Eo) (10-8N kcat/ Km (10 
5W-is-I 
4.00 exp value 3.89 23-90 1.63 
est value 3.73 1.56 
5.00 exp value 2.25 5.96 3.78 
est value 3.08 5.17 
6.00 exp value 3.21 5.96 5.39 
est value 3.89 6.53 
7.00 exp value 5.78 5.96 9.70 
est value 6.18 10.37 
8.00 exp value 9.63 5.96 16.16 
est value 9.96 16.71 
9.00 exp value 3.21 5.96 5.39 
est value 4.33 7.27 
10.00 exp value 1.38 5.96 2.32 
est value 1.48 2.48 
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Table 55. 
Porton Down B-lactamase 2 catalysed hydrolysis of 2-carbonTheffl 
cgphalosl)ofin over the pH rame 3- 10 at 30 PC. Data from single curve progression. 
0H 
s 
C02M+ 
0//ý 
N-ý 
CH20COCH3 
0 6r, rv + 
2M 
pH k(obs) (10 - 1)/s I (Eo) (10- 7M kmt / Km (10 5ýM-is-i 
3.00 1. exp value 0.65 1.78 3.65 
2. est value 0.58 3.26 
4.00 1. exp value 0.65 1.78 5.46 
2. est value 0.48 4.03 
1. 0.53 1.19 4.37 
2. 0.58 4.87 
Average 4.92±0.89 
5.00 1. exp value 0.44 1.19 3.70 
2. est value 0.35 2.94 
1. 0.25 0.59 4.23 
2. 0.24 4.07 
Average 3.97±1.0 
6.00 1. exp value 0.22 1.78 1.24 
2. est value 0.22 1.24 
1. 0.15 1.19 1.26 
2. 0.14 1.18 
1. 0.09 0.59 1.52 
2. 0.08 1.36 
Average 1.34±0.18 
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Table 55. (con t- 
pH k(obs) (10- 1)/s- 1 
7.00 1. exp value 0.38 
2. est value 0.39 
1. 0.40 
2. 0.33 
Average 
8.00 1. exp value 0.80 
2. est value 0.76 
1. 0.52 
2. 0.46 
1. 0.30 
2. 0.26 
Average 
9.00 1. exp value 0.36 
2. est value 0.37 
1. 0.30 
2. 0.30 
1. 0.19 
2. 0.19 
Average 
10.00 1. exp value 0.15 
2. est value 0.15 
1. 0.12 
2. 0.10 
Average 
(Eo)(10-7M kmt/Km(105W-IS-1 
1.78 2.13 
2.19 
1.19 3.36 
2.77 
2.75±0.65 
1.78 4.49 
4.27 
1.19 4.37 
3.87 
0.59 5.08 
4.41 
4.65±0.8 
2.37 1.52 
1.56 
1.78 1.69 
1.69 
1.19 1.60 
1.60 
1.60±0.08 
5.93 0.25 
0.25 
2.96 0.40 
0.34 
0.33±0.08 
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Table 56.. 
Porton Down B-lactwnase 2 catalysed hydrolysis of 3-carbonThepyl 
MhalMorin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
0s 
H02C -N 
04ý 'rCH2()COCH3 
,I O, H 2H 
-'r T pri k(obs) (10- 1)/s- I (Eo) (10-8N kmt/ Km (10 5N-is-I 
4.00 exp value 1.44 7.25 19.86 
est value 1.25 17.24 
5.00 exp value 2.59 7.25 35.72 
est value 2.26 31.17 
6.00 exp value 1.12 7.25 15.45 
est value 1.38 19.03 
7.00 exp value 2.89 7.25 39.86 
est value 2.27 31.31 
8.00 exp value 3.85 7.25 53.10 
est value 4.00 55.17 
9.00 exp value 0.50 5.10 9.88 
est value 0.61 11.96 
10.00 exp value 0.25 5.10 4.35 
est value 0.30 5.88 
6 
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Table 57 
Porton Down B-lactamase 2 catalysed hydrolysis of 4-carboUphenyl 
cqphajoMotin over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
HO2C :Ds 
o,;, ýý/ 
N 
Pri k(obs) (10- 1)/s- I (Eo) (10-7N kcat/Kfn (10 5W-IS-1 
3.00 1. exp value 0.64 2.29 2.79 
2. est value 0.53 2.31 
4.00 1. exp value 1.38 2.95 4.68 
2. est value 1.22 4.14 
1. 1.15 2.36 4.87 
2. 1.11 4.70 
1. 0.88 1.77 4.97 
2. 0.89 5.03 
1. 0.61 1.18 5.17 
2. 0.59 5.00 
Average 4.92±0.8 
5.00 1. exp value 2.63 1.77 14.86 
2. est value 2.52 14.24 
1. 1.69 1.18 14.55 
2. 1.55 13.14 
1. 0.74 0.59 12.54 
2. 0.60 10.17 
1. 0.41 0.30 13.67 
2. 0.30 10.00 
Average 13.90±4.0 
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Table 57 (con t.. 
-TT pri k(obs) (10 -I Vs (Eo) (10-7)/N4kmt/Km (10 5N-is-i 
6.00 1. exp value 0.66 2.36 2.80 
2. est value 0.67 2.83 
1. 0.52 1.77 2.94 
2. 0.51 2.88 
1. 0.29 1.18 2.46 
2. 0.28 2.37 
Average 2.73±0.36 
7.00 1- exp value 1.20 2.36 5.08 
2. est value 1.19 5.08 
1. 0.85 1.77 4.80 
2. 0.83 4.69 
1. 0.64 1.17 5.47 
2. 0.65 5.56 
1. 0.32 0.59 5.42 
2. 0.31 5.25 
Average 5.19±0.4 
8.00 1. exp value 2.63 2.36 11.14 
2. est value 2.80 11.86 
1. 1.81 1.77 10.23 
2. 1.88 10.62 
1. 1.27 1.18 10.76 
2. 1.29 10.93 
1. 0.56 0.59 9.49 
2. 0.58 9.83 
Average 10.41±1.45 
9.00 1 exp value 0.64 2.36 2.71 
2. est value 0.65 2.75 
1. 0.51 1.77 2.88 
2. 0.50 2.82 
1. 0.29 1.18 2.46 
2. 0.29 2.46 
Average 2.68±0.22 
10.00 1. exp value 0.40 2.95 1.36 
2. est value 0.30 1.02 
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Table 58. 
Porton Down B-lactamase 2 catalysed hydrolysis of cycloheL(Yl cephalosp! glin 
over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
NI 
s 
N 
0// CH20COCH3 
02M+ 
-IT pri 
3.00 
Avefage 
4.00 
5.00 
6.00 
7.00 
8.00 
9.00 
Average 
10.00 
Avetage 
k(obs) (10 - 1)/s -I (Eo) (10-7M kmt/ Km (10 5W-IS-1 
4.72(lo-6) 
4.69(lo-6) 
0.13 
0.18 
0.32 
0.. 37 
0.30 
1.10 
1.11 
0.26 
0.29 
4.36 10.83(100) 
4.36 10.76(100) 
10.80±0.04 (10 0) 
4.36 
1.13 
1.13 
1.13 
1.13 
4.36 
4.36 
2.18 
2.18 
6 
0.30 
1.60 
2.83 
3.27 
2.65 
2.52 
2.55 
2.54±0.02 
1.20 
1.30 
1.25±0.05 
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Table 59. 
Potion Down B-lactamase 2 catal3Lsed hydrolysis of 2-cis-carboLcycyc joheul 
cgphajosporin over the pH mnge 3- 10 at 30 PC. Data from sing] e curve progression. 
0H 
s 
Co m+ 2ý4 "'ýCH2OCOCH3 
62M 
-T I pri 
5.00 
6.00 
7.00 
8.00 
9.00 
10.00 
k(obs) (10-2)/S- 1 (Eo) (10-7M 
3.92 
2.94 
Average 
1.85 
1.34 
Average 
1.80 
1.47 
Average 
2.94 
0.66 
0.72 
1.25 
1.25 
1.25 
1.25 
1.25 
1.25 
1.25 
1.25 
3.13 
0 
k, cat/ Kin (10 5ýM-1S-1 
3.14 
2.35 
2.75±0.4 
1.48 
1.07 
1.28±0.2 
1.44 
1.18 
1.31±0.13 
2.35 
0.52 
0.23 
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Table 60. 
Porton Down B-lactamase 2 catalysed hydrolysis of 2- trans-carboxy 
cvclohgU] cephaloýWfin over the -DH range 3- 10 at 30 PC. Data from single curve 
progression. 
C02- M+ 
H 
/C-N 
s 
0 
N r"ýCH 01// 2()CoCH3 
00 O'_ 
2- M 
pH k(obs) (I 0-4)/S- 1 (Eo) (10- 7M kcat/ Km (10 5M-is-I 
3.00 0.0323 0.525 0.00062 
0.0300 0.410 0.00073 
Average 0.00068±0.00006 
4.00 0.164 0.525 0.00312 
0.158 0.407 0.00387 
Average 0.00350±0.00037 
5.00 108.20 0.525 2.06 
90.00 0.407 2.21 
Average 2.14±0.08 
6.00 143.17 0.407 3.52 
97.33 0.407 2.39 
Average 2.96±0.57 
7.00 123.33 0.407 3.03 
104.66 0.407 2.57 
118.67 0.525 2.26 
Average 2.62±0.4 
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Table 60. (ýont.. 
-111 pH k(obs) (10 -4)/s -I (Eo) (10-7M 6t / Kn, (10 5W-1 S-1 
8.00 141.17 0.525 2.69 
149.33 0.525 2.84 
Average 2.77±0.07 
9.00 50.83 0.525 0.97 
10.00 30.83 0.525 0.59 
6 
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Table 61. 
Porton Down B-lactamase 2 catalvsed hvdrolvsis of benzvl cohalosvorin 
lactone over the pH range 3- 10 at 30 PC. Data from single curve progression. 
0H 
CH N 2S 
XT N 
0// CH2 
crý 
pH k(obs) (10 -4)/s -1 (Eo) (I 0-6W kcat/Km/M-Is-I StdError 
3.00 0.36 1.98 18.18 0.01 
4.00 0.42 1.98 21.06 0.002 
5.00 1.10 2.93 37.54 0.03 
6.00 9.52 2.93 32.49 0.01 
7.00 2.03 1.98 102.53 0.007 
2.62 2.93 89.42 0.005 
AveWe 95.98±6.56 
8.00 3.07 2.19 140.18 0.08 
9.00 0.88 2.93 30.34 0.003 
10.00 0.16 2.93 5.32 0.007 
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Conclusions. 
A comparison of the available published data from the three dimensional 
investigations of the B-lactamase enzymes, vAth those results from mutagenesis 
experiments and with those from kinetic studies, reveal that although there is a general 
agreement for the basis of the hydrolytic mechanism of the serine enzyme, notable 
differences exist. For the zinc B-lactamase little has been published and even less is 
understood. 
It has been shown that at pH7 the B-lactamase I catalysed hydrolysis of n-alkyl 
penicillins of increasing chain length produces an increase in kcaVKm. up to the octyl 
derivative. However, it has been shown that the active-site of the B-lactamase I enzyme 
does not display a strong recognition for B-lactarns, containing a hydrophobic C6 side- 
chain. The introduction of chain branching into the acyl side-chain of penicillins produces 
very little effect. With cephalosporins placing a t-butyl group in the side chain results in 
lower activity. It is thought that this reflects the specific differences existing between the 
binding ofpenicillins and cephalosporins for the B-lactamase enzymes. 
It was also found that the pH dependence for the enzyme catalysed hydrolysis of 
benzyl penicillin and benzyl cephalosporin did not decline as expected at low pH, but 
instead the rate levels off. The incorporation of a negatively charged group into the phenyl 
C7 side-chain of cephalospodns resulted in lower activity at pH7 compared with that of 
benzyl cephalosporin, but at low pH higher activity is seen: 2-Carboxyphenyl 
cephalosporin is 10 fold more reactive at pH3 than at pH7. The B-lactamase I catalysed 
hydrolysis of phenyl substituted penicillins containing a negatively charged functional 
group in the side chain is more complex: 2-Carboxyphenyl penicillin shows higher 
activity at low pH, while the 3 and 4-carboxyphenyl derivatives show typical bell-shaped 
profiles, but with the pKa I value shifted to a higher value compared to that of benzyl 
penicillin. It has been shown that the pKa values are not substrate independent and may 
reflect a kinetic-pKa. This was further investigated by preparing the cis/trans isomers of 
2-carboxycyclohexyl penicillin and cephalosporin. The results show that cis 2- 
carboxycyclohexyl penicillin displays high activity at low pH, while the trans isomer does 
not. Neither of the corresponding cephalosporin derivatives show evidence of higher 
activity at low pH. The C3 methyl ester and C3 alcohol of benzyl penicillin and the C4 
hactone of benzyl cephalosporin were made, the penicillin alcohol and the cephalosporin 
hactone were found to be good substrates for the B-lactamase I enzyme and produced 
normal pH-rate profiles. From these results two important observations emerge. Firstly, 
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there is undoubtedly a basic group on the serine enzyme which needs to be in its 
protonated form for maximum activity. It is often assumed that the high pKa value 
observed in the B-lactarnase I catalysed hydrolysis of 13-jactarns is due to Lys-234 
interacting with the C3 carboxylate group of the substrate, these results show that there is 
still a catalytically important group of high pKa even when the carboxylate group is 
absent. Secondly, the rate of hydrolysis of the the penicillin C3 alcohol derivative does 
decrease as expected at low pH. This indicates that the leveling off of the rate at low pH 
observed for substrates with an ionisable group at C3 may be due to its conversion into an 
undissociated carboxylic acid. 
It was found that the B-lactarnase 2 enzyme hydrolysis of n-alkyl penicillins 
proceeded at comparable rates irrespective of the chain length or chain branching of the C6 
side chain. The pH-rate behaviour was found to be complex when negatively charged 
carboxyphenyl and 2-carboxycyclohexyl B-lactams were tested. It was found that the rate 
of the enzyme catalysed hydrolysis was greatly reduced when the C3/4 carboxylate group 
of the substrate was converted into an alcohol, ester or lactone, suggesting the importance 
of this group in the B-lactarnase 2 hydrolysis mechanism - 
These results have raised important questions about the existing hypotheses which 
attempt to explain the mechanisms of action of the 13-lacLvmse enzymes. 
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